col blocks we are bridge builder col blocks
COVID answers in Scientific Journals all over the world

1762 Results       Page 1

Oxford University Press: Open Forum Infectious Diseases
  original article Date Title Authors   All Authors
1 [GO] 2023―Mar―21 COVID-19 Associated Pulmonary Aspergillosis: A Non-Invasive Screening Model for Additional Diagnostics Nitipong Permpalung, Teresa Po-Yu Chiang, Robin K Avery, Darin Ostrander, Kausik Datta, Dorry L Segev, et al. (+4)
2 [GO] 2023―Mar―21 Neutralizing Antibody Responses After SARS-CoV-2 BA.2 and BA.2.12.1 Infection Do Not Neutralize BA.4 and BA.5 and Can Be Blunted By Nirmatrelvir/Ritonavir (NM/r) Treatment Aaron F Carlin, Alex E Clark, Aaron F Garretson, William Bray, Magali Porrachia, AsherLev T Santos, et al. (+3)
3 [GO] 2023―Mar―18 Surveillance of SARS-CoV-2 and variants using digital droplet polymerase chain reaction at a large university and healthcare system in California Chrysovalantis Stafylis, Olivier Pernet, Cassidy Hernandez-Tamayo, Andrea Kovacs, Jane Emerson, Pamela M Ward, et al. (+25)
4 [GO] 2023―Mar―18 Analyzing An Emerging Pandemic on Twitter: Monkeypox Lauren N Cooper, Alexander P Radunsky, John J Hanna, Zachary M Most, Trish M Perl, Christoph U Lehmann, Richard J Medford
5 [GO] 2023―Mar―07 Community-onset bacterial coinfection in children critically ill with SARS-CoV-2 infection Kristin L Moffitt, Mari M Nakamura, Cameron C Young, Margaret M Newhams, Natasha B Halasa, J Nelson Reed, et al. (+31)
6 [GO] 2023―Mar―04 When should healthcare workers with COVID-19 return to work? An analysis of follow-up antigen test results after a positive COVID test Anthony Baffoe-Bonnie, Mandy C Swann, Hyun Sue Kim
7 [GO] 2023―Mar―04 Risk of Coronavirus Disease 2019-Associated Pulmonary Aspergillosis Based on Corticosteroid Duration in Intensive Care Patients Meera Shah, Kelly Reveles, Rebecca Moote, Elizabeth Hand, Dean Kellogg III, Rebecca L Attridge, et al. (+2)
8 [GO] 2023―Mar―02 Effectiveness of fourth dose of COVID-19 mRNA vaccine in elderly population during Omicron BA.2 and BA.5 circulation: nationwide cohort study in Korea (K-COVE) Seon Kyeong Park, Young June Choe, Eun Jung Jang, Ryu Kyung Kim, Do-Sang Lim, Seonju Yi, et al. (+6)
9 [GO] 2023―Feb―24 Optimal Duration of Systemic Corticosteroids in COVID-19 Treatment: A Systematic Review and Meta-analysis Paddy Ssentongo, Nyein Yu, Navya Voleti, Surya Reddy, David Ingram, Vernon M Chinchilli, Catharine I Paules
10 [GO] 2023―Feb―22 COVID-19 and Outpatient Antibiotic Prescriptions in the United States: A County-level Analysis Alisa Hamilton, Suprena Poleon, Jerald Cherian, Sara Cosgrove, Ramanan Laxminarayan, Eili Klein
11 [GO] 2023―Feb―21 Blood Inflammatory Biomarkers Differentiate Inpatient and Outpatient COVID-19 from Influenza Lauren L Luciani, Leigh M Miller, Bo Zhai, Karen Clarke, Kailey Hughes Kramer, Lucas J Schratz, et al. (+6)
12 [GO] 2023―Feb―21 Lessons From the Field: Rapid Antigen Testing Is Efficient and Practical for Mitigation of Coronavirus Disease 2019 Outbreaks in Long-Term Care Facilities David A Miller, Lael Duncan, Lindsey Termini, Lee Ann Prebil, David Witt, Stephen A McCurdy
13 [GO] 2023―Feb―18 Use of SARS-CoV-2 Antibody Tests by U.S. Infectious Disease Physicians: Results of an Emerging Infections Network Survey, March 2022 Adi V Gundlapalli, Susan Beekmann, Jefferson M Jones, Natalie Thornburg, Kristie E N Clarke, Timothy M Uyeki, et al. (+8)
14 [GO] 2023―Feb―14 Population-level effectiveness of an inactivated whole-virion COVID-19 vaccine: A test negative case-control study in the Dominican Republic Eddy Pérez-Then, Marija Miric, Han-Zhu Qian, Ying Qing Chen, Yixin Wang, Virginia Vallejo, et al. (+109)
15 [GO] 2023―Feb―13 Kinetics of the Antibody Response to Symptomatic SARS-CoV-2 Infection in Vaccinated and Unvaccinated Individuals in the Blinded Phase of the mRNA-1273 COVID-19 Vaccine Efficacy Trial Dean Follmann, Holly E Janes, Eric Chu, Lakshmi Jayashankar, Christos J Petropoulos, Leonid Serebryannyy, et al. (+18)
16 [GO] 2023―Feb―09 Impact of age and SARS-CoV-2 breakthrough infection on humoral immune responses after three doses of COVID-19 mRNA vaccine Francis Mwimanzi, Hope R Lapointe, Peter K Cheung, Yurou Sang, Fatima Yaseen, Rebecca Kalikawe, et al. (+17)
17 [GO] 2023―Feb―04 Association of cytomegalovirus serostatus with SARS-CoV-2 vaccine responsiveness in nursing home residents and healthcare workers Michael L Freeman, Oladayo A Oyebanji, Daniela Moisi, Michael Payne, Maegan L Sheehan, Alejandro B Balazs, et al. (+5)
18 [GO] 2023―Feb―03 SARS-CoV-2 Evolution and Escape from Combination Monoclonal Antibody Treatment in a Person Living With HIV Dara Khosravi, Hannah Soloff, Rose M Langsjoen, Andrei Bombin, Colleen F Kelley, Susan M Ray, et al. (+7)
19 [GO] 2023―Jan―28 Pneumocystis jirovecii infections among COVID-19 Patients: A Case Series and Literature Review Paul Amstutz, Nathan C Bahr, Karen Snyder, D Matthew Shoemaker
20 [GO] 2023―Jan―19 Correction to: 494. Characteristics and Outcomes of COVID-19 in Hospitalized Native American Patients: A Single-Site Retrospective Analysis
21 [GO] 2023―Jan―18 High SARS-CoV-2 antibody prevalence after the third epidemic wave (May - October 2021) in Matadi, Democratic Republic of the Congo Yannick Munyeku-Bazitama, Patient Okitale-Talunda, Patrick Mpingabo-Ilunga, Marc K Yambayamba, Paul M Tshiminyi, Aime Umba-Phuati, et al. (+12)
22 [GO] 2023―Jan―18 Correction to: Impact of Innate Immunity, Endothelial Damage, and Metabolic Biomarkers on COVID-19 Severity and Mortality
23 [GO] 2023―Jan―09 Validity of COVID-19 ICD10s in the Urgent Care Setting and Impact on Antibiotic Prescribing Rates Natalia Medvedeva, Sharon Ong’uti, Adam L Hersh, Amy Chang, Emily Mui, Edward Stenehjem, et al. (+2)
24 [GO] 2023―Jan―09 Correlates of COVID-19 Inpatient Mortality at a Southern California Community Hospital with a Predominantly Hispanic/Latino Adult Population Nicole M Gatto, Debbie Freund, Pamela Ogata, Lisa Diaz, Ace Ibarrola, Mamta Desai, et al. (+2)
25 [GO] 2023―Jan―08 Laboratory Evaluation Links Some False-Positive COVID-19 Antigen Test Results Observed in a Field Study to a Specific Lot of Test Strips Alyssa M Carter, Alexander Viloria Winnett, Anna E Romano, Reid Akana, Natasha Shelby, Rustem F Ismagilov
26 [GO] 2023―Jan―08 Challenges in harnessing shared within-host SARS-CoV-2 variation for transmission inference Katharine S Walter, Eugene Kim, Renu Verma, Jonathan Altamirano, Sean Leary, Yuan J Carrington, et al. (+7)
27 [GO] 2022―Dec―31 Absolute and Relative Vaccine Effectiveness (VE) of Primary and Booster Series of COVID-19 Vaccines (mRNA and Adenovirus Vector) Against COVID-19 Hospitalizations in the United States, December 2021-April 2022 Nathaniel M Lewis, Nancy Murray, Katherine Adams, Diya Surie, Manjusha Gaglani, Adit A Ginde, et al. (+51)
28 [GO] 2022―Dec―29 Clinical effectiveness of SARS-CoV-2 booster vaccine against Omicron infection in residents and staff of Long-Term Care Facilities: a prospective cohort study (VIVALDI) Oliver Stirrup, Madhumita Shrotri, Natalie L Adams, Maria Krutikov, Hadjer Nacer-Laidi, Borscha Azmi, et al. (+9)
29 [GO] 2022―Dec―28 A longitudinal study of SARS-CoV-2 antibody response in a subset of United States blood donors Laura Tonnetti, Roger Y Dodd, Donna D Burke, Paula Saá, Bryan R Spencer, Meng Xu, et al. (+2)
30 [GO] 2022―Dec―23 Which curve are we flattening? The disproportionate impact of COVID-19 among economically marginalized communities in Ontario, Canada, was unchanged from wild-type to omicron Huiting Ma, Adrienne K Chan, Stefan D Baral, Christine Fahim, Sharon Straus, Beate Sander, Sharmistha Mishra
31 [GO] 2022―Dec―22 Persistent symptoms and sequelae after SARS-CoV-2 infection not requiring hospitalization: Results from Testing Denmark, a Danish cross-sectional survey Maarten van Wijhe, Kamille Fogh, Steen Ethelberg, Kasper Karmark Iversen, Henrik Nielsen, Lars Østergaard, et al. (+23)
32 [GO] 2022―Dec―20 Pre-Existing Population Immunity and severe acute respiratory syndrome coronavirus 2 Variant Establishment and Dominance Dynamics in the United States: An Ecological Study Pierre O Ankomah, Mark J Siedner, Roby P Bhattacharyya
33 [GO] 2022―Dec―16 Antibiotic consumptions and bacterial resistance rates in hospitalized COVID-19 patients: a retrospective study during the three first surges Karim Jaffal, Frédérique Bouchand, Christine Lawrence, Hélène Mascitti, Clara Duran, Djillali Annane, Aurélien Dinh
34 [GO] 2022―Dec―16 Comparing Prospective Incident Severe Acute Respiratory Syndrome Coronavirus 2 Infection Rates During Successive Waves of Delta and Omicron in Johannesburg, South Africa Simiso Sokhela, Bronwyn Bosch, Andrew Hill, Bryony Simmons, Joana Woods, Hilary Johnstone, et al. (+13)
35 [GO] 2022―Dec―16 Association between population-level factors and household secondary attack rate of SARS-CoV-2: A systematic review and meta-analysis Can Wang, Xiaotong Huang, Eric H Y Lau, Benjamin J Cowling, Tim K Tsang
36 [GO] 2022―Dec―15 1911. A Pilot Study to Evaluate the Effectiveness of Nasal and Oral Povidone Iodine in Reducing the Burden of Severe Acute Respiratory Syndrome 2 RNA in Patients with COVID-19 Sarah Redmond, Lucas D Jones, Alexandria Nguyen, Hussein Ghaddara, Jennifer Cadnum, Curtis Donskey
37 [GO] 2022―Dec―15 1928. A Population-Based Propensity Score-Matched Study of COVID-19 Vaccination on Clinical Outcomes in Hospitalized Adult Patients with COVID-19 Jianli Niu, Candice Sareli, Daniel Mayer, Alvaro Visbal, Aharon E Sareli
38 [GO] 2022―Dec―15 2160. Mucosal Antiviral Cytokine Responses Are Impaired in Children and Adolescents with Severe COVID-19 Ana M Quintero, Shira H Cohen, Zhaohui Xu, Fang Ye, Sara Mertz, Kaitlyn N Massey, et al. (+6)
39 [GO] 2022―Dec―15 LB1528. Results from ACTIV-6: A Decentralized, Double-Blinded, Randomized, Placebo-Controlled Platform Trial of Repurposed Drugs for the Treatment of Mild-to-Moderate COVID-19 Matthew W McCarthy
40 [GO] 2022―Dec―15 LB750. Safety and Immunogenicity of a Bivalent Omicron-Containing Booster Vaccine against COVID-19 Spyros Chalkias, Charles Harper, Keith Vrbicky, Stephen R Walsh, Brandon Essink, Adam Brosz, et al. (+13)
41 [GO] 2022―Dec―15 1083. Clinical Features and Long-Term Follow-up of Children Evaluated for Persistent Unwellness Following Acute COVID-19 Kathryn E Weakley, Allegra Schikler, Julianne V Green, Daniel B Blatt, Shanna M Barton, Victoria A Statler, Gary S Marshall
42 [GO] 2022―Dec―15 1079. Casirivimab and Imdevimab (CAS + IMD) Antibody Combination for the Treatment of Immunocomprised Hospitalized Patients with COVID-19 Selin Somersan-Karakaya, Eleftherios Mylonakis, Ernesto Oviedo-Orta, Meagan P O’Brien, Veronica Mas Casullo, Jenni Mou, et al. (+10)
43 [GO] 2022―Dec―15 1146. Real-World Experience Highlighting Tocilizumab Use in the Treatment of COVID-19 Christina Maguire, Adrienne Terico, Hinal Patel, George L Anesi, Kathleen Degnan, Lauren Dutcher, et al. (+4)
44 [GO] 2022―Dec―15 1154. Safety, Tolerability, and Viral Pharmacodynamics of the IgG Monoclonal Antibody Sotrovimab Administered via Intramuscular Injection for the Treatment of Early Mild-to-Moderate COVID-19 Anil K Gupta, Maria Teresa Perez-Rodríguez, Yaneicy Gonzalez-Rojas, Moti Ramgopal, Almena Free, Jennifer Han, et al. (+16)
45 [GO] 2022―Dec―15 1155. Short vs. Long Symptom Duration Prior to Remdesivir for Hospitalized Patients with COVID-19 Ramy H Elshaboury, Meagan L Adamsick, Joanne Huang, Marisa Winkler, Musie Ghebremichael, Fiona Cheung, et al. (+5)
46 [GO] 2022―Dec―15 1147. Regional Trends in Favipiravir and Steroid Use in the Treatment of COVID-19 Yusuke Asai, Shinya Tsuzuki, Nobuaki Matsunaga, Norio Ohmagari
47 [GO] 2022―Dec―15 930. Weakening the waves: Impact of a syndrome-based antimicrobial stewardship intervention during COVID-19 Alfredo J Mena Lora, Fischer Herald, Brenna Lindsey, Stephanie Echeverria, Mirza Ali, Rodrigo M Burgos
48 [GO] 2022―Dec―15 1114. Comparative analysis between Polymerized Type I Collagen and Baricitinib as potential treatment for COVID-19 Luis Del Carpio-Orantes, Sergio García-Mendez, Jesús Salvador Sánchez-Díaz, Andrés Aguilar-Silva, Omar García-Hernández, Raúl Enrique Salazar-Lizárraga, et al. (+6)
49 [GO] 2022―Dec―15 1113. Clinical and Virologic Outcomes with Early Adintrevimab (ADI) Monoclonal Antibody Therapy in Mild and Moderate COVID-19 Kathryn Mahoney, Kristin Narayan, Natalia Betancourt, Yong Li, Deepali Gupta, Pamela Hawn, et al. (+2)
50 [GO] 2022―Dec―15 1139. Oral Antivirals Against SARS-CoV-2: a New Valid Strategy Against COVID-19 Neva Braccialarghe, Rosario Alessandro Cavasio, Drieda Zaçe, Ilaria Spalliera, Luigi Coppola, Iannetta Marco, et al. (+2)
51 [GO] 2022―Dec―15 1140. Outcomes and Complications of Tocilizumab and Baricitinib use in Transplant Patients with COVID-19 Maria A Mendoza, Raymund R Razonable, Omar M Abu Saleh
52 [GO] 2022―Dec―15 1132. Integrated Quantitative Systems Pharmacology (QSP) Characterizing Viral Dynamics After Intramuscular (IM) Adintrevimab (ADI) Administration in Participants with Mild to Moderate Coronavirus Disease (COVID-19) Evan Tarbell, Scott A Van Wart, Myra Popejoy, Kristin Narayan, Ellie Hershberger, Xia Pu, et al. (+4)
53 [GO] 2022―Dec―15 1044. Identification and Characterization of an Unconventional NK Subset in COVID-19 Andrew Platt, Izabella Lach, Jeffrey R Strich, Gustaf Wigerblad, Ryan Curto, Shreya Singireddy, et al. (+6)
54 [GO] 2022―Dec―15 1122. Early Infectious Diseases Consultation and Procalcitonin-Guided Therapy Limits Unnecessary Antibiotic Use in COVID-19 Joel A Kammeyer, Meghan M Deutsch, Victoria R Starnes, Makoto Ibaraki, Victoria Soewarna, Basmah Khalil, et al. (+10)
55 [GO] 2022―Dec―15 1063. Female sex and SARS-CoV-2 Serostatus Predict Nasopharyngeal RNA Clearance during Early COVID-19 Carlee Moser, Jonathan Z Li, Joseph J Eron, Evgenia Aga, Eric S Daar, David A Wohl, et al. (+11)
56 [GO] 2022―Dec―15 481. Risk Factors and Clinical Outcomes of Candidemia Associated with Severe Coronavirus Disease 2019 (COVID-19) Tanaya Bhowmick, Sugeet Jagpal, Tilly Varughese, Purvi Patel, Polly Jen, Tyler Maxwell, et al. (+10)
57 [GO] 2022―Dec―15 939. Barriers and facilitators in the implementation of ASP in Mexico and the impact of COVID-19 María Alejandra Cortés-Ortíz, Anahí Dreser, Jennifer Hegewisch-Taylor, Julián Romero-Mónico, Jorge Quiroz
58 [GO] 2022―Dec―15 304. Viral resistance analysis in the COMET-PEAK study: sotrovimab treatment in participants with mild-to-moderate COVID-19 Phillip J Yates, Jennifer Moore, Jennifer Han, Andrew Skingsley, Gretja Schnell, Andrea L Cathcart, et al. (+3)
59 [GO] 2022―Dec―15 305. Clinical scoring system to predict viable viral shedding in patients with COVID-19 Sung Woon Kang, Ji Yeon Kim, Heedo Park, Sunghee Park, So Yun Lim, SeongMan Bae, et al. (+9)
60 [GO] 2022―Dec―15 274. Epidemiology and Antimicrobial Treatment Impact of Procalcitonin in Patients with COVID-19 Anna Conlon, Krishna Rao, Sandro Cinti, Zoey Chopra, Shannon E Cahalan
61 [GO] 2022―Dec―15 281. Not the sharpest of tools: Procalcitonin and bacterial co-infections in patients admitted with COVID-19 Alfredo J Mena Lora, Fischer Herald, Brenna Lindsey, Stephanie Echeverria, Sorel Lira, Rodrigo M Burgos
62 [GO] 2022―Dec―15 283. Post COVID-19 syndrome and quality of life impairment in a cohort of severe COVID-19 Carla M Roman-Montes, Guillermo A Guaracha-Basañez, Yesenia C Flores-Soto, Maria Fernanda Gonzalez, Luis Alfredo Ponce-de-leon, Karla M Tamez-Torres, José Sifuentes-Osornio
63 [GO] 2022―Dec―15 881. Nasal and Plasma SARS-CoV-2 RNA Levels Predict Timing of Symptom Resolution in the ACTIV-2 Trial of Non-hospitalized Adults with COVID-19 Yijia Li, Linda J Harrison, Kara W Chew, Joseph J Eron, Eric S Daar, David A Wohl, et al. (+10)
64 [GO] 2022―Dec―15 242. Association Between Procalcitonin and Antimicrobial Usage in Patients with COVID-19 Mahmoud H Aly, Eris Cani, Lendelle Raymond, Cosmina Zeana
65 [GO] 2022―Dec―15 2358. Dementia and Cognitive Concerns are Risk Factors for Mortality in People with Human Immunodeficiency Virus and COVID-19 Shibani S Mukerji, Douglas R Wilcox, Emily A Rudmann, Elissa Ye, Ayush Noori, Colin Magdamo, et al. (+5)
66 [GO] 2022―Dec―15 251. Clinical Features and Outcomes of Pneumothorax and Pneumomediastinum in COVID-19 Sangeeta Adusumilli, Ashish Bhargava, Rene Franco
67 [GO] 2022―Dec―15 300. Trends in electrocardiographic and cardiovascular manifestations of patients hospitalized with COVID-19 Jinghao Nicholas Ngiam, Wilson Goh, Meng Ying Sim, Srishti Chhabra, Tze Sian Liong, Nicholas W S Chew, et al. (+5)
68 [GO] 2022―Dec―15 319. Clinical accuracy and utility of plasma microbial cell free DNA NGS for the diagnosis of invasive aspergillosis in patients with hematologic malignancy and COVID-19 Ki Hyun Lee, Joon-sup Yeom, Jun Yong Choi, Nam Su Ku, Su Jin Jeong, Jung Ho Kim, et al. (+9)
69 [GO] 2022―Dec―15 289. Prolonged Corticosteroid Usage, Associated Infectious Complications, and High Mortality in Adult Patients with COVID-19 Rebecca Chu, Veronica B Zafonte, Kelly L Cervellione, Andrew S Miele, Farshad Bagheri, Javeria Shakil
70 [GO] 2022―Dec―15 878. Association between Anterior Nasal and Plasma SARS-CoV-2 RNA Levels and Hospitalization or Death for Non-Hospitalized Adults with Mild-to-Moderate COVID-19 Mark Giganti, Kara W Chew, Joseph J Eron, Jonathan Z Li, Mauricio Pinilla, Carlee Moser, et al. (+10)
71 [GO] 2022―Dec―15 79. Long-term Health Outcomes of Individuals who are Infected with SARS-CoV-2 and Develop COVID-19 Lilac Tene, Tobias Bergroth, Anna Eisenberg, Gabriel Chodick
72 [GO] 2022―Dec―15 785. Bacterial Co-infection and Empirical Antibiotic Therapy in Patients with COVID-19 Jiyoung Lee, Jiwon Jung, Min Jae Kim, Yong Pil Chong, Sung-Han Kim, Sang-Oh Lee, et al. (+3)
73 [GO] 2022―Dec―15 257. Coinfection Characteristics among Children with COVID-19 Itzel Villanueva García, Nancy Evelyn Aguilar Gómez, Aarón Espinosa Atri, Angela Patricia Vedia Márquez, Juan Antonio Gallegos Marin, Ana Ruth Hernández Tepach
74 [GO] 2022―Dec―15 297. Secondary Bacterial Blood Stream Infections in Patients Hospitalized with COVID-19 Fareeha Adnan, Mariam A Khan, Amna Umer, Nazia Khursheed
75 [GO] 2022―Dec―15 925. Remdesperate for Stewardship: Impact of a Remdesivir Stewardship Strategy on the Care of Patients with COVID-19 Admitted to a Community Teaching Hospital Jillian Hayes, Ahmed Ghonim, Leslie Wooten, Jenny Sippel-Tompkins, Victor Herrera, Amy L Carr
76 [GO] 2022―Dec―15 1867. Characteristics and Outcomes of Patients with SARS-CoV-2 Reinfections Requiring Treatment in a COVID-19 Ambulatory Treatment Program Kelsie Cowman, Austin Golia, Yi Guo, Terrence D McSweeney, Mei H Chang, Hongkai Bao, Priya Nori
77 [GO] 2022―Dec―15 1402. Expand accessibility of monoclonal antibody in COVID-19 among different ethnicities and races. Hina Farooq, Shivanjali Shankaran
78 [GO] 2022―Dec―15 1788. COVID-19 and Antibiotic Prescriptions in the United States: A County-level Analysis Alisa Hamilton, Suprena Poleon, Jerald Cherian, Sara E Cosgrove, Ramanan Laxminarayan, Eili Y Klein
79 [GO] 2022―Dec―15 261. COVID-19 and Diabetes Mellitus: Glycemic Control and Risk Factors for Mortality, experience from Pakistan. Asma Nasim, Sunil Kumar
80 [GO] 2022―Dec―15 293. Risk factors for COVID-19 associated pulmonary aspergillosis (CAPA) in severe COVID-19 and impact of airborne fungal contamination within negative pressure isolation room Jung Ah Lee, Sanggwon Ahn, Se Ju Lee, Jinnam Kim, Ki Hyun Lee, Chang Hyup Kim, et al. (+8)
81 [GO] 2022―Dec―15 1922. Outbreak and Management of COVID-19 and Infection Prevention Control Practices at a Community Living Center in Veterans Administration Hospital, North Texas John J Hanna, Denisse Silva-Rodriguez, Angela Christie-Smith, Andrew O Psenicka, Sherry R Reid, Ikwo K Oboho
82 [GO] 2022―Dec―15 290. Quantitative Antibody Levels Against SARS-CoV-2 Spike Protein in Children with COVID-19 and MIS-C Gulhadiye Avcu, Sema Yıldırım Arslan, Mehmet Soylu, Melis Bilen, Candan Çiçek, Zümrüt Şahbudak Bal, et al. (+2)
83 [GO] 2022―Dec―15 1039. Clinical and Economic Impact of COVID-19 and Serologic Protection among Farm Workers: Results from the Guatemala Agricultural Workers and Respiratory Illness Impact (AGRI) Study Daniel Olson, Diva M Calvimontes, Molly Lamb, Kelsey Lesteberg, Edgar Barrios, Neudy Rojop, et al. (+15)
84 [GO] 2022―Dec―15 1217. An outbreak of carbapenem-resistant Acinetobacter baumannii in an isolation ward for COVID-19 and successful outbreak control with infection control measures Ki Hyun Lee, Joon-sup Yeom, Nam Su Ku, Su Jin Jeong, Jin Young Ahn, Jung Ho Kim, et al. (+6)
85 [GO] 2022―Dec―15 1074. Surveillance of SARS-CoV-2 variants of concern (VOC) in hospital wastewater (WW) and its correlation with hospitalized cases of COVID-19 and the occurrence of outbreaks Nicole Acosta, Maria Bautista Chavarriaga, Barbara Jean M Waddell, Janine McCalder, Kristine Du, Puja Pradhan, et al. (+33)
86 [GO] 2022―Dec―15 1043. Gastrointestinal manifestations of COVID-19 and their association with disease severity and death in the Dominican Republic Yori A Roque, David De Luna, Alfredo J Mena Lora, Ysalda E Santana, Alicia Rodriguez, Johan Ramos, Mariel Suarez
87 [GO] 2022―Dec―15 262. COVID-19 associated fungal co-infections in Solid Organ Transplant Recipients: A single center case series Akshay M Khatri, Jacques Simkins, Neeraj Sinha, Anita Phancao, Gaetano Ciancio, Lilian M Abbo, et al. (+3)
88 [GO] 2022―Dec―15 266. Cumulative Steroid Dose in Hospitalized Patients and COVID-19 Associated Pulmonary Aspergillosis Diego Ramonfaur, Jack Salto-Quintana, Nadia Hernández-Mata, Gloria Mayela Aguirre-García, Hiram Villanueva-Lozano, Michel Martínez-Reséndez
89 [GO] 2022―Dec―15 263. COVID-19 Associated Pulmonary Aspergillosis (CAPA) at a Hospital in Nicaragua: Prevalence and Risk Factors for Mortality. Armando J López-Gaitán, Sunaya V Marenco-Avilés, Maikelyn A Castillo-Cano, Guillermo D Porras-Cortés
90 [GO] 2022―Dec―15 294. Risk factors of COVID-19 associated pulmonary aspergillosis in a high endemic setting and development of a bedside clinical risk prediction score. Merlin Moni, Teny M M John, Abdul Razak Moosa, Kiran G Kulirankal, Fabia Edathadathil, T S Dipu
91 [GO] 2022―Dec―15 264. COVID-19 Associated Pulmonary Aspergillosis in Intensive Care Patients Based on Duration of Corticosteroid Administration Meera D Shah, G Christina Gutierrez, Rebecca Moote, Kelly R Reveles, Elizabeth O Hand
92 [GO] 2022―Dec―15 1041. Association of SARS-CoV-2 Viral load in COVID-19 at the hospital representation Ashish Bhargava, Hemang Patel, Natali Salaytah, Elisa Akagi, Louis Saravolatz, Mamta Sharma
93 [GO] 2022―Dec―15 1042. Inflammatory Representation of COVID-19 at the Time of Hospitalization: An Insight into the Mild, Moderate, Severe and Critical COVID-19 Disease Ashish Bhargava, Hemang Patel, Elisa Akagi, Mamta Sharma, Claudia V Santos, Wei Zhao, et al. (+7)
94 [GO] 2022―Dec―15 282. Occurrence of adverse events and factors related to prognosis in a cohort of patients hospitalized with COVID-19 at University hospital - UNICAMP, Brazil. Maitê V Luz, Julian F Silva, Hugo D Ceccato, Paulo J Souza, Pedro M E Villar, Paulo R A Mendes, et al. (+3)
95 [GO] 2022―Dec―15 1951. Guiding COVID-19 Booster Vaccinations by COVID-19 Quantitative Spike Ig Antibody Titers Regardless of HIV Status, Immunosuppression, and Age Ricky K Hsu, Laurence Brunet, Jennifer S Fusco
96 [GO] 2022―Dec―15 788. Risk Factors for Severe COVID-19 Breakthrough Infections: A Retrospective, Nationwide Cohort Study Austin D Vo, Westyn Branch-Elliman, Jennifer La, Matthew Ronan, Mary Brophy, Julie Wu, et al. (+4)
97 [GO] 2022―Dec―15 1571. Hospital COVID-19 Burden Impact on Inpatient Antibiotic Use Rates Elizabeth Dodds Ashley, Yuliya Lokhnygina, Danielle Doughman, Katherine R Foy, Alicia D Nelson, April Dyer, et al. (+13)
98 [GO] 2022―Dec―15 1121. Does Anti-Vaccine Equal Anti-Antibody? Differing Rates of Veteran Acceptance of Monoclonal Antibody Therapies for COVID-19 By Prior Vaccination Status Martha Brennan, Amy Hirsch Shumaker, Usha Stiefel
99 [GO] 2022―Dec―15 1078. Vaccine-induced antibody level predicts the clinical course of breakthrough infection of COVID-19 caused by delta and omicron variants: a prospective observational cohort study Yong Chan Kim, Bongyoung Kim, Nak-Hoon Son, Namwoo Heo, Yoon Soo Park, Heejung Kim
100 [GO] 2022―Dec―15 1542. MR-proADM Biomarker Predicts COVID-19 Clinical Outcomes: a US-based Cohort Study Michael Mansour
101 [GO] 2022―Dec―15 1065. Patient-Reported Reasons for Non-Participation in Inpatient COVID-19 Clinical Research: Results from a Multi-Center VA Embedded Randomized Trial Samira Reyes Dassum, Ryan Ferguson, Patricia Woods, Maura Flynn, Karen Visnaw, Sara J Schiller, et al. (+3)
102 [GO] 2022―Dec―15 1942. Effect of SARS-CoV-2 Vaccination in a Frailty COVID-19 Cohort: a Real Life Experience in a Northern Italy Hospital Chiara Russo, Luca Tagliafico, Laura Labate, Marta Ponzano, Michele Mirabella, Federica Portunato, et al. (+7)
103 [GO] 2022―Dec―15 781. COVID-19 Outcomes in the Immunocompromised Population of the COVID-19 Community Research Partnership John C Williamson, Gregory B Strylewicz, Michael E DeWitt, Diane Uschner, Ashvi Soni, Morgana Mongraw-Chaffin, et al. (+11)
104 [GO] 2022―Dec―15 530. Characterization of the Proteomic Changes via SARS-CoV-2 Infection or Vaccination in the COVID-19 Community Research Partnership (CCRP) Michael E DeWitt, David M Herrington, John C Williamson, Austin L Seals, Thomas F Wierzba, Aleksandra Binek, et al. (+2)
105 [GO] 2022―Dec―15 1868. Characterization of COVID-19 Symptoms and Outcomes by Variant Period in the North Carolina COVID-19 Community Research Partnership (NC-CCRP) Michael E DeWitt, Sharon Edelstein, Ashley H Tjaden, David M Herrington, John Schieffelin, Michael A Gibbs, et al. (+2)
106 [GO] 2022―Dec―15 1049. Breakthrough SARS-CoV-2 Infections after Vaccination in the North Carolina COVID-19 Community Research Partnership (NC-CCRP) Diane Uschner, Matthew Bott, Gregory B Strylewicz, Sharon Edelstein, Kristen Miller, William H Lagarde, et al. (+13)
107 [GO] 2022―Dec―15 1523. Association between Self-reported Masking Behavior and SARS-CoV-2 Infection Wanes from Pre-Delta to Omicron-Predominant Periods - North Carolina COVID-19 Community Research Partnership (NC-CCRP) Ashley H Tjaden, Michael A Gibbs, Michael S Runyon, William Weintraub, Yhenneko Taylor, Sharon Edelstein
108 [GO] 2022―Dec―15 1913. Baltimore City Health Department COVID-19 Community-based Testing Results Shamola Dye, Isabella Agnes, Darcy Phelan-Emrick, Adena Greenbaum
109 [GO] 2022―Dec―15 249. Characteristics and outcomes of cryptococcosis among patients with COVID-19 compared to non-COVID-19 controls Daniel B Chastain, Vanessa Kung, Sahand Golpayegany, Brittany T Jackson, Carlos Franco-Paredes, George R Thompson, Andrés F Henao-Martínez
110 [GO] 2022―Dec―15 303. Viral and bacterial infections among adults hospitalized with COVID-19, Coronavirus Disease 2019-Associated Hospitalization Surveillance Network, 14 states, March 2020-February 2022 Shah Melisa, Christopher Taylor, Kadam Patel, Jennifer Milucky, Michael Whitaker, Huong Pham, et al. (+16)
111 [GO] 2022―Dec―15 1059. The Experiences of Healthcare Workers during the Second Wave of COVID-19 Crisis in the South Indian State of Kerala Aleena Issac, Jose J Kochuparambil
112 [GO] 2022―Dec―15 1076. The Role of Bronchoalveolar Lavage in COVID-19 Diagnoses and Management Edie Zhang, Shuman Liu, Rosemary She
113 [GO] 2022―Dec―15 1885. Experience using combined antigen and RT-PCR tests for COVID-19 diagnosis at a Veterans Affairs (VA) Health Care System during the Omicron surge Siri Chirumamilla, Krista Powell, David Gutman, Andrew S Webster, Abeer Moanna, Lauren H Epstein
114 [GO] 2022―Dec―15 1097. Risk of Severe COVID-19 Disease in Individuals with Down syndrome: a Matched Cohort Study from a Large, Integrated Health Care System Jennifer H Ku, Myron J Levin, Yi Luo, Ana Florea, I Chun Lin, Yun Tian, Hung Fu Tseng
115 [GO] 2022―Dec―15 1148. Relationship Between the Duration of Symptoms Before and COVID-19 Disease Outcome After Monoclonal Antibody Therapy Michael J Hubbard, James Polega, Diana K Haggerty, Nicholas A Andersen, Gordana Simeunovic
116 [GO] 2022―Dec―15 1895. SingHealth COVID-19 Disease Registry Jin Yee Shoon, Edwin P Conceicao, Yue Yang, Shalvi Arora, Eng Hock Marcus Ong, Sze Ling Chan, et al. (+2)
117 [GO] 2022―Dec―15 1112. Evaluating the Effects of Casirivimab-Imdevimab in Mild-to-Moderate COVID-19 Disease: A Matched Cohort Study Cindy Hage, Aileen Martinez, Alexis Dunham, Nathan Mohseni, Jarelys Hernandez-Jimenez, Lyssette L Cardona
118 [GO] 2022―Dec―15 1968. SARS-CoV-2 Anti-Spike IgG Antibodies in Neonates After Maternal Vaccination Against COVID-19 During Pregnancy and Outcomes Maria C Casillas Casillas, Claudia C Lopez-Enriquez, Jimena Reyes, Jose L Ramírez Haua, Mario E Rendon Macias
119 [GO] 2022―Dec―15 1105. A Matched-Group Comparison of Interventions for COVID-19 During the First and Second Waves of the COVID-19 Pandemic in a County Hospital in Chicago. Ruben A Hernandez Acosta, Carlos Corpuz, Sriram Gonakoti, Palak Patel, Hillary Chang, Elikplim Akaho, et al. (+3)
120 [GO] 2022―Dec―15 269. Outcomes comparison of hospitalized patients with COVID-19 during the first three pandemic waves. Experience in Colombia, South America. Fernando Rosso, Sarita Rodriguez, Estefanía Beltrán, Alvaro Martinez Valencia, Virginia Zarama, Eric Tafur, Tania Guzmán
121 [GO] 2022―Dec―15 1037. Access to hospitalization for patients with severe COVID-19 during the first wave of the pandemic in Caracas, Venezuela. Jose Orejas, David Forero, Daniela Mendoza, Oscar Omana, Fhabián S Carrión-Nessi, Maria Landaeta, Alejandro Diaz
122 [GO] 2022―Dec―15 346. Aspergillosis in COVID-19 era in Dominican Republic Rita A Rojas-Fermin, Ann S Sanchez-Marmolejos, Ricardo Acra-Tolari, Anel E Guzman-Marte, Irina Suero
123 [GO] 2022―Dec―15 1972. Sources of COVID-19 Exposure Among Health Care Personnel in a Large Tertiary Care Medical Center. Jana Shaw, Heidi Steigerwald, Paul Suits, Stephen J Thomas, Margaret Formica
124 [GO] 2022―Dec―15 258. Comparison of Different COVID Waves during COVID-19 Pandemic: A Retrospective Study from a Dedicated COVID-19 Facility of Karachi Pakistan Muneeba A Sayeed
125 [GO] 2022―Dec―15 306. Development a Predictive Score for Severe Coronavirus Disease 2019 (COVID-19) from High Risk Factor of Patient Described by Thai Government Policy Preudtipong Noopetch, Rutporn Benchamanon, Samerjan Kongsuwan, Chatree Chai-adisaksopha
126 [GO] 2022―Dec―15 1965. Promoting COVID-19 Health Equity through Partnership with Community-Based Organizations and Home Vaccination Services Justin Daniels, David P Holland, Tanner Forbes, Jane Y Scott
127 [GO] 2022―Dec―15 1396. COVID-19 Hospitalization Impact of Age, Race and Ethnicity Among Medicaid and Uninsured Mamta K Jain, Yi Zhang, Mae Thamer, Michael Harms, Jillian Smartt, Stefanie Baierlipp, Kavita Bhavan
128 [GO] 2022―Dec―15 287. Procalcitonin and D-dimer levels at baseline, but not CRP, were informative of COVID-19 hospitalization outcomes Trini Mathew, Julie George, Christine N Yost, Mustafa Deebajah, Paul C Johnson, James Huang, Christopher F Carpenter
129 [GO] 2022―Dec―15 1053. Comorbidities Associated with All-Cause Readmission to the Same Hospital after Index COVID-19 Hospitalization: A Retrospective Cohort Study of 232155 Patients in the United States Gita Nadimpalli, Lyndsay M O’Hara, Lawrence Magder, J Kristie Johnson, Abdolreza Haririan, Lisa Pineles, et al. (+4)
130 [GO] 2022―Dec―15 1397. COVID-19 Hospitalizations in North Texas: Impact of Insurance Status Mamta K Jain, Yi Zhang, Mae Thamer, Michael Harms, Jillian Smartt, Stefanie Baierlipp, Kavita Bhavan
131 [GO] 2022―Dec―15 1924. Outpatient Treatment With the SARS-CoV-2-Neutralizing Antibody Combination AZD7442 (Tixagevimab/Cilgavimab) for Preventing COVID-19 Hospitalizations in the Phase 3 TACKLE Trial F D Richard Hobbs, Hugh Montgomery, Francisco Padilla, Kenneth Kim, Jesus Abraham Simón Campos, Douglas Arbetter, et al. (+7)
132 [GO] 2022―Dec―15 240. Antibiotic Overuse Among Children with COVID-19 Hospitalized in a Pediatric Intensive Care Unit Jessica Gillon, Kathryn Garguilo, Kerry LeBlanc, Ritu Banerjee
133 [GO] 2022―Dec―15 288. Prognostic Factors for In-hospital Mortality of Patients with Severe COVID-19 Hospitalized in the University Medical Center, Lithuania Ieva Kubiliute, Jurgita Urboniene, Akvile Rudenaite, Birute Zablockiene, Giedre Gefenaite, Ligita Jancoriene
134 [GO] 2022―Dec―15 301. Use of a multiplex PCR assay for detection of respiratory co-infections in COVID-19 hospitalized non-ICU patients: an ace up a clinician’s sleeve Christina Louka, Lemonia Velentza, Nektaria Rekleiti, Anastasia Apanomeritaki, Vasiliki Mamali, Alexandra Stamati, et al. (+6)
135 [GO] 2022―Dec―15 1159. Treatment experience of regdanvimab for mild to moderate COVID-19 hospitalized patients in the Delta variant-predominant period in Korea Yee Gyung Kwak, Je Eun Song, Myung Jin Lee, Baek-Nam Kim
136 [GO] 2022―Dec―15 789. Viral and Immunologic biomarkers of COVID-19 improve risk stratification and identify patients most likely to benefit from therapy with remdesivir Kanal Singh, Kevin Rubenstein, Viviane Callier, Katy Shaw-Saliba, Adam Rupert, Robin L Dewar, et al. (+14)
137 [GO] 2022―Dec―15 1111. Baricitinib versus Tocilizumab for Hospitalized Adults with Severe COVID-19 in a Community Health System: A Retrospective Cohort Alexandra Gonzalez, Aileen Martinez, Lyssette L Cardona, Jarelys Hernandez-Jimenez
138 [GO] 2022―Dec―15 1086. COVID-19 in a Comprehensive Cancer Center: 2020-2022 Patricia Mulanovich, Roy F Chemaly, Bruno Granwehr, Kelly McConn, Physician Assistant, Nina Patel, et al. (+3)
139 [GO] 2022―Dec―15 1871. Clinical epidemiological characterization of patients affected by COVID-19 in a General Hospital of Veracruz, Mexico Luis Del Carpio-Orantes, Sergio García-Mendez, Daniel Márquez-Uscanga, Jesús Salvador Sánchez-Díaz, Omar García-Hernández, Andrés Aguilar-Silva, et al. (+7)
140 [GO] 2022―Dec―15 1062. Examining the impact of type 2 diabetes status and severity on in-hospital outcomes amongst patients hospitalized with COVID-19 in a southwest Virginia healthcare system Jesse Bendetson, Anthony Baffoe-Bonnie
141 [GO] 2022―Dec―15 1894. Sensitivity of Symptom-Based Screening for COVID-19 in Active Duty Service Members Zachary Matthews, Daniel Cybulski, Dianne Frankel, John Kieffer, Theresa Casey, Angela Osuna, Joseph E Marcus
142 [GO] 2022―Dec―15 1160. Treatment-Emergent Viral Variants in the Phase 3 TACKLE Trial Investigating Efficacy and Safety of AZD7442 (Tixagevimab/Cilgavimab) for the Treatment of Mild to Moderate COVID-19 in Adults Gustavo H Kijak, Bahar Ahani, Douglas Arbetter, Tyler Brady, Fernando Chuecos, Vancheswaran Gopalakrishnan, et al. (+7)
143 [GO] 2022―Dec―15 784. Real-world effectiveness of the mRNA-12733-dose primary series against COVID-19 in an immunocompromised population Interim results from a prospective observational cohort study Jennifer H Ku, Lina S Sy, Lei Qian, Bradley Ackerson, Yi Luo, Julia Tubert, et al. (+7)
144 [GO] 2022―Dec―15 2159. Monoclonal Antibody Treatment for COVID-19 in Children: Experience of a Pediatric Tertiary Care Center Osama Ibrahim, Kristen Ferlisi, Winston McCormick, Cristina E Alcorta, Michael Koster
145 [GO] 2022―Dec―15 933. Antibiotic Prescribing Changes in Adults During COVID-19 in Outpatient Patient-Centered Medical Homes (PCMH) in Arkansas Jill Johnson, Cheng Peng, Ryan K Dare, Jacob T Painter, Holly Maples, Jeremy Thomas, et al. (+3)
146 [GO] 2022―Dec―15 1142. Plasma with high titers of anti-SARS-Cov2 antibodies improves outcome of COVID-19 in patients with hematological malignancy and cancer in a randomized controlled trial Claudia M Denkinger, Maike Janssen, Ulrike Schäkel, Julia Gall, Albrecht Leo, Patrick Stelmach, et al. (+43)
147 [GO] 2022―Dec―15 2298. Clinical and Demographic Characteristics of COVID-19 in Pediatric Patients in the United States Milan Ho, Zachary M Most, Marlon Diaz, Julia A Casazza, Bhaskar Thakur, Sameh Saleh, et al. (+5)
148 [GO] 2022―Dec―15 1087. COVID-19 in Solid Organ Transplant Recipients: A Single Transplant Center Experience Suhel A Sabunwala, Tuhina Cornelius, Sadaf Aslam, Sally Alrabaa
149 [GO] 2022―Dec―15 2116. Long-term (2-year) outcomes and complications of COVID-19 in solid organ transplant (SOT) recipients Daniel Burack, Marcus R Pereira, Elizabeth Verna
150 [GO] 2022―Dec―15 1104. A comparison of remdesivir versus remdesivir plus tocilizumab for patients with severe COVID-19 in the Dominican Republic Yori A Roque, David De Luna, Alfredo J Mena Lora, Liz De la Nuez, Ana Hernando, Cesar Jimenez, et al. (+2)
151 [GO] 2022―Dec―15 LB1577. Outcomes of Pregnant Women Exposed to Sotrovimab for the Treatment of COVID-19 in the Omicron Predominant Era (PRESTO) Jessica Tuan, Manas Sharma, Jehanzeb Kayani, Matthew W Davis, Dayna McManus, Jeffrey E Topal, Onyema Ogbuagu
152 [GO] 2022―Dec―15 LB1528C. Ivermectin for Treatment of Mild-to-Moderate COVID-19 in the Outpatient Setting A Decentralized, Placebo-controlled, Randomized, Platform Clinical Trial Susanna Naggie
153 [GO] 2022―Dec―15 1077. Understanding the Psychosocial Burden Associated with Hospitalization Among Adults Diagnosed with COVID-19 in the United States Wajeeha Ansari, Florin Draica, Joanna Atkinson, Kathy Annunziata, Martine C Maculaitis, Amie Scott
154 [GO] 2022―Dec―15 1145. Real-world Effectiveness of Sotrovimab for the Early Treatment of COVID-19 in the US Mindy M Cheng, Daniel C Gibbons, Helen Birch, Vishal Patel, Christopher F Bell, Myriam Drysdale, et al. (+2)
155 [GO] 2022―Dec―15 1923. Outcomes of the adsorbed Sinovac CoronaVac COVID-19 inactivated vaccine among the employee recipients in St. Luke’s Medical Center Quezon City: an observational cohort study Almira V Uy, Medical Doctor, Ryan Llorin, Medical Doctor
156 [GO] 2022―Dec―15 1901. Utilizing Antiviral Prescription Data as a Predictor of Increasing COVID-19 Incidence: A Retrospective Study of Citywide Data Christina Kaul, Gabriel M Cohen, Matthew Silverstein, Andrew B Wallach, Elizabeth Diago-Navarro, Mary K Foote
157 [GO] 2022―Dec―15 1091. HIV Does Not Increase Risk of Disease Severity in Patients with COVID-19 Infection Salman Bangash, Adriana Betancourth, Ayesha Khan, Chiu-Bin Hsiao, Cassandra Oehler, Charmaine Clarisse D Abalos
158 [GO] 2022―Dec―15 1088. Evaluating the Effect of Donepezil on Mortality Among Alzheimer’s Disease Patients With and Without COVID-19 Infection Taissa A Bej, Elizabeth Edmiston, Brigid Wilson, Joy Phillips, Robin L Jump
159 [GO] 2022―Dec―15 2357. Risk Factors for COVID-19 Infection and Outcomes in People Living with HIV John J Hanna, Liyu B Geresu, Marlon Diaz, Madison Pickering, Julia A Casazza, Milan Ho, et al. (+9)
160 [GO] 2022―Dec―15 1889. Knowledge, beliefs and practices about COVID-19 infection and vaccination in healthcare personnel at non-acute care facilities Armaghan-e-Rehman Mansoor, Caroline A ONeil, David McDonald, Victoria J Fraser, Hilary Babcock, Jennie H Kwon
161 [GO] 2022―Dec―15 354. Invasive fungal disease in patients with severe COVID-19 infection at a midwestern academic medical center Stephen M Maurer, Kathleen A Linder, Marisa H Miceli
162 [GO] 2022―Dec―15 1092. Management of Transplant Graft and Role of Immunosuppression in the Outcome of Covid-19 Infection in Solid Organ Transplant Recipients Suhel A Sabunwala, Tuhina Cornelius, Sadaf Aslam, Sally Alrabaa, Ambuj Kumar
163 [GO] 2022―Dec―15 1161. Vaccination During Acute COVID-19 Infection Protects Against 30 Day Adverse Outcomes Julia A Casazza, Robert W Turer, Sameh N Saleh, Madison Pickering, Marlon Diaz, Milan Ho, et al. (+5)
164 [GO] 2022―Dec―15 1126. Effect of Remdesivir on Recovery, Quality of Life, and Long-COVID Symptoms One Year after Hospitalization for COVID-19 Infection: A Randomized Controlled SOLIDARITY Finland Trial Olli P O Nevalainen, Saana Horstia, Sanna Laakkonen, Jarno Rutanen, Jussi Mustonen, Ilkka Kalliala, et al. (+15)
165 [GO] 2022―Dec―15 265. Cryptococcal disease in Covid-19 infection: Case series from South Texas Sumbal Babar, Marcos I Restrepo, Delvina Ford, Jose Cadena-Zuluaga
166 [GO] 2022―Dec―15 239. Acute Thromboembolism in Non-ICU Hospitalized Patients with COVID-19 infection: Examining the Impact of Prior COVID Vaccination James McKinnell, Felix Pham, Volha Yarashenka, John Kunesh, Lisa Hughes, Kyle Fu, et al. (+3)
167 [GO] 2022―Dec―15 1116. Comparative Efficacy of Tocilizumab and Baricitinib in Treatment of Severe COVID-19 Infections Phylicia Pellot, Nikunj M Vyas, Cindy Hou, Michael Rosati
168 [GO] 2022―Dec―15 1934. Association between Receipt of COVID-19, Influenza, and Pneumococcal Vaccination Chris Choi, Ashley Tippett, Luis W Salazar, Laila Hussaini, Olivia D Reese, Khalel De Castro, et al. (+11)
169 [GO] 2022―Dec―15 1130. Ensovibep antiviral activity in ambulatory patients with COVID-19 is independent of baseline anti-SARS-CoV-2 antibodies and exhibits minimal selective pressure - Results from the placebo-controlled EMPATHY trial Luis Abrishamian, Marc Bonten, Richa Chandra, Damodaran Solai Elango, Pierre Fustier, Kinfemichael Gedif, et al. (+19)
170 [GO] 2022―Dec―15 2058. Effect of Covid-19 lockdowns on identification of advanced HIV disease in outpatient clinics in Uganda Preethiya Sekar, Elizabeth Nalintya, Paul Kavuma, Joanita Kigozi, Martin Ssuna, Paul Kirumira, et al. (+7)
171 [GO] 2022―Dec―15 1119. Covid-19 Mab Use in High-Risk Pediatric Patients Hannah Bahakel, Catherine R Murphy, Robert W Frenck, Michael Grimley, Christine Phillips, Grant Schulert, et al. (+4)
172 [GO] 2022―Dec―15 1117. COVID-19 Monoclonal Antibodies: A Single Center Real World Experience Sara Brenner, Alexander Knee, Douglas Salvador, Erica Housman, Gladys Fernandez, Armando Paez
173 [GO] 2022―Dec―15 316. The Value of Monocyte-Lymphocyte Ratio, Neutrophil-Lymphocyte Ratio and Platelet-Lymphocyte Ratio in Predicting COVID-19 Mortality: A Single-Center Retrospective Study Denise Marie J Nanas, Marjorie A Nolasco, Divina Cristy R Samin
174 [GO] 2022―Dec―15 255. Clinical, echocardiographic and electrocardiographic manifestations of COVID-19 multisystem inflammatory syndrome in children in the Dominican Republic Yori A Roque, David De Luna, Alfredo J Mena Lora, Kelvin Espinal, Franzory Peralta, Hilario Maria
175 [GO] 2022―Dec―15 1909. Steak with a Side of Omicron? Efficacy of Coordinated Outbreak Response during an early COVID-19 Omicron Outbreak amongst Restaurant Workers in Riverside County, CA Shunling Tsang, Wendy Hetherington, Wendy Hetherington, Juan Landeros-Tavera, Jennifer Chevinsky, Marshare Penny
176 [GO] 2022―Dec―15 736. Impact of COVID-19 on Mortality Associated with Pseudomonas aeruginosa Bloodstream Infection in the Veterans Health Administration System Leila S Hojat, Brigid Wilson, Federico Perez, Robert A Bonomo
177 [GO] 2022―Dec―15 LB1532. The Impact of COVID-19 on nursing home residents’ clinical, functional, and psychosocial outcomes Lori Popejoy, Amy Vogelsmeier, Gregory Petroski, Daivd Mehr, Marilyn Rantz, Steven Miller, et al. (+3)
178 [GO] 2022―Dec―15 1020. The Impact of COVID-19 on Outpatient Intravenous Antimicrobial Therapy (OPAT) at an Academic Medical Center Ravitej Goteti, Lea M Monday, Allison J Weinmann
179 [GO] 2022―Dec―15 LB1530. Clinical Benefit of Oral sabizabulin for Hospitalized Adults with CoVID-19 on Supplemental Oxygen Tara L Gonzales, Paula Skarda, Thomas G Bird, Michael Schnaus, Mitchell Steiner, Alan Skolnick, et al. (+7)
180 [GO] 2022―Dec―15 2199. Herpesviridae lung reactivation and infection in patients with severe Covid-19 or influenza virus pneumonia: a comparative study Charles-Edouard Luyt, Sonia Burrel, Vincent Guiraud, Alain Combes, David Boutolleau
181 [GO] 2022―Dec―15 1093. Multiparametric Investigation Of Spike-Protein Specific T-cell Cytokine Expression Profile In Children With Symptomatic COVID-19 Or Multisystem Inflammatory Syndrome Filippos Filippatos, Marianna Tzanoudaki, Elizabeth-Barbara Tatsi, Vasiliki Efthymiou, Manolis Liatsis, Vasiliki Syriopoulou, Athanasios Michos
182 [GO] 2022―Dec―15 1883. Epidemiological investigation of the COVID-19 outbreak in Vellore district in South India using Geographic Information Surveillance (GIS) Priscilla Rupali, Malathi Murugesan, Venkata Raghava Mohan, Padmanaban Venkatesan, Senthil Kumar, Premkumar Thangavelu, et al. (+2)
183 [GO] 2022―Dec―15 1879. Detection of COVID-19 Outbreaks in Long-Term Care Homes Using Built Environment Testing for SARS-CoV-2: A Multicentre Prospective Study Michael Fralick, Jason Moggridge, Lucas Castellani, Sylva Donaldson, David S Guttman, Aaron Hinz, et al. (+11)
184 [GO] 2022―Dec―15 2213. Increased Early Syphilis Detection and Treatment in an Urban Emergency Department During the COVID-19 Pandemic Ashley Lipps, Carlos Malvestutto, Susan L Koletar, Michael Dick, Sommer E Lindsey, Jose A Bazan
185 [GO] 2022―Dec―15 2214. National Testing Assessment of Select Bacterial STIs During the COVID-19 Pandemic Giuiseppe A Fonseca, Marissa Maier, Shimrit Keddem, Joleen Borgerding, Elliott Lowy, Lorenzo McFarland, et al. (+6)
186 [GO] 2022―Dec―15 2017. Comparison of California Acute Care Hospital Central Line-Associated Bloodstream Infection Incidence by Hospital Location Before and During the COVID-19 Pandemic Lizette Brenes, Monise Magro, Tisha Mitsunaga, Erin Epson
187 [GO] 2022―Dec―15 1919. Implementation of Hydrogen Peroxide Vapor (HPV) Decontamination of N95 Respirators for Reuse During COVID-19 Pandemic Nancy L Havill, Richard A Martinello, Patrick Kenney, Cherie Bragg, Jacqueline Epright, Margaret Cintron, et al. (+2)
188 [GO] 2022―Dec―15 1921. Leveraging Bluetooth Low-Energy Technology to Improve Contact Tracing in Healthcare Settings during the COVID-19 Pandemic M Cristina Vazquez Guillamet, Ashraf Rjob, Jingwen Zhang, Reshad Hamauon, Ruixuan Dai, Ruiqi Wang, et al. (+5)
189 [GO] 2022―Dec―15 2205. Potential Causative Association between Respiratory Viruses and Pneumococcus-Associated Disease in Young Children in Israel: Lessons from the COVID-19 Pandemic Ron Dagan, Bert Adriaan van der Beek, David Greenberg, Yonat Shemer Avni, Shalom Ben-Shimol, Daniel M Weinberger
190 [GO] 2022―Dec―15 2203. Involvement of Respiratory Viruses in Community-Acquired Alveolar Pneumonia (CAAP) in Children < 5 Years in Southern Israel, Before and During the COVID-19 Pandemic Dana Danino, Bert Adriaan van der Beek, Shalom Ben-Shimol, Yonat Shemer Avni, David Greenberg, Ron Dagan
191 [GO] 2022―Dec―15 1912. Addressing Uncertainty: An Evidence-Based, Data-Driven, Decision Matrix for Healthcare Operations During The COVID-19 Pandemic Valerie Ausborn, Luis Ostrosky-Zeichner, Misti G Ellsworth, Tawanna A McInnis-Cole, Kristine Aleman Verrill, Shannon Lutz, et al. (+2)
192 [GO] 2022―Dec―15 1907. Initiation of Comfort Measures Only Care in the Medical Intensive Care Unit during the COVID-19 Pandemic Max Jacobs, Helene Rovnan, Deeksha Ramanujam, Amina Hamza, Stephen Caucci, Tariq Cheema
193 [GO] 2022―Dec―15 1765. Antibiotic Consumption in a Healthcare System in Bolivia During the First Wave of COVID-19 Pandemic Rodolfo E Quiros, Elvio D Escobar, Juan Carlos Tapia, Valeria Fabre
194 [GO] 2022―Dec―15 1400. Emergency Department (ED) Use among Persons With HIV (PWH) before and during the COVID-19 Pandemic Deana Agil, Lindsay Browne, Thibaut Davy-Mendez, Amy Durr, Heather Henderson, Kuo-Ping Li, et al. (+3)
195 [GO] 2022―Dec―15 1425. Changes in Clinical Presentation of TB due to the COVID-19 pandemic Nazia Khan, Surksha Sirichand, Xianhong Xie, Jacqueline M Achkar
196 [GO] 2022―Dec―15 1321. Increased Prevalence of Group A Streptococcus (GAS) High Level Macrolide Resistance During the COVID-19 Pandemic Ami B Patel, Judith A Guzman-Cottrill, Katherine E Fleming-Dutra, Sopio Chochua, Bernard Beall, Preeti Jaggi, et al. (+6)
197 [GO] 2022―Dec―15 1215. Variation in Hand Hygiene Improvement After Implementation of an Electronic Hand Hygiene System During the COVID-19 Pandemic James P Steinberg, Elizabeth Overton, Nancye Feistritzer, Kari L Love, Jill Holdsworth, Margaret Whitson`, et al. (+4)
198 [GO] 2022―Dec―15 1329. Pediatric Group A Streptococcus (GAS) Pharyngitis Incidence has Decreased During the COVID-19 Pandemic Ami B Patel, Matthew McHugh, Stanford Shulman, Robert R Tanz
199 [GO] 2022―Dec―15 961. Pandemic Hits: Evaluation of an Antimicrobial Stewardship Program Website for Hospital Communication During the COVID-19 Pandemic Reinaldo Perez, Michael E Yarrington, Rebekah Wrenn, Connor R Deri, Martha B Adams, Richard H Drew, et al. (+3)
200 [GO] 2022―Dec―15 580. Influenza, SARS-CoV-2, and routine childhood vaccines - trends in vaccine hesitancy in hospitalized children before and during the COVID-19 pandemic Marisa Orbea, Rachel Cunningham, C Mary Healy, Julie A Boom, Claire Bocchini
201 [GO] 2022―Dec―15 1007. Impact of an Interdisciplinary Outpatient Parenteral Antimicrobial Therapy (OPAT) Clinic During the COVID-19 Pandemic Amir Zaki, Teena H Xu, Parisa Khan, Amna Ahmed, Katharine Breaux
202 [GO] 2022―Dec―15 944. Development & Implementation of a Biomarker-based Remotely-delivered Antimicrobial Stewardship (AMS) Strategy during the COVID-19 Pandemic Divya Deodhar, Jane Miracline, Hanna Alexander, Naveena gracelin princy Zacchaeus, Premkumar Thangavelu, Priscilla Rupali
203 [GO] 2022―Dec―15 1107. A Survey on Remdesivir Use and Antimicrobial Stewardship Restrictions Throughout the COVID-19 Pandemic Alfredo J Mena Lora, Fischer Herald, Rodrigo M Burgos, Scott Borgetti, Brenna Lindsey, Lelia H Chaisson, Susan C Bleasdale
204 [GO] 2022―Dec―15 268. Dengue - SARS-CoV-2 co-infection: Experience in hospitalized patients during COVID-19 pandemic Fernando Rosso, Isabel L Zapata-Vasquez, Sarita Rodriguez, Diana M Martinez, Olga Agudelo, Sebastián Robles-Castillo, Alejandro Tejada
205 [GO] 2022―Dec―15 105. Expanding and Sustaining Influenza Vaccination Acceptance amongst Adults with HIV in Delaware during the COVID-19 Pandemic Deborah A Kahal, Christopher James, Brian Wharton
206 [GO] 2022―Dec―15 355. Outcome of patients with non-COVID-19 related Aspergillosis during the COVID-19 pandemic Carla M Roman-Montes, Adriana Guzman-Pérez, Medical Student, Rosa Areli Martinez-Gamboa, Maria Fernanda Gonzalez, Paulette G Díaz-Lomelí, et al. (+4)
207 [GO] 2022―Dec―15 1437. Investigation of Increased Latent Tuberculosis Infection Rates During the COVID-19 Pandemic Among International Students at a U.S. University Campus Wajih Askar, Lauri E Nandyal, RaeJean Hardig, Tina Coberley, Amanda Doner, Lisa Haglund, et al. (+4)
208 [GO] 2022―Dec―15 1905. High food insecurity during the COVID-19 pandemic among secondary school teachers - Tajikistan, 2021 Davron Akhmedov, Roberta Horth, Dilyara Nabirova
209 [GO] 2022―Dec―15 1903. Factors associated with response to a phone-administered alcohol and substance use survey during the COVID-19 pandemic among women in the MACS/WIHS Combined Cohort Study: Who are we missing? Hannah R Tierney, Yifei Ma, Peter Bacchetti, Ralph J DiClemente, Mirjam-Colette Kempf, Deborah L Jones, et al. (+10)
210 [GO] 2022―Dec―15 2014. Central Line - Associated Bloodstream Infections and Their Increase With the COVID-19 Pandemic at Veterans Affairs in San Antonio, Texas Divya Chandramohan, Delvina Ford, Erica Beck, Lauren N Garza, Kelly R Reveles, Jose Cadena
211 [GO] 2022―Dec―15 385. Impact of the COVID-19 Pandemic First Wave on Clostridioides difficile Infection Rafael Mendo-Lopez, Lauren Pacheco, Javier A Villafuerte-Galvez
212 [GO] 2022―Dec―15 248. Change in Incidence of Multisystem Inflammatory Syndrome in Children Across the COVID-19 Pandemic in Chicago - March 2020 - March 2022 Hillary Spencer, Jennifer Seo, Massimo Pacilli, Candice L Robinson, Hannah Matzke, Maria Joseph, Stephanie Gretsch
213 [GO] 2022―Dec―15 2040. Healthcare-Associated Infection Surveillance During the COVID-19 Pandemic in New Mexico Morgan Edwards-Fligner, Erin C Phipps
214 [GO] 2022―Dec―15 1393. Body Mass Index Change In People Living With HIV During The COVID-19 Pandemic In New York Kai-Ming Chang, Guillermo Ramirez, Praveen Vikraman, Lemar Nadi, Cristina Sison, Michael Oey
215 [GO] 2022―Dec―15 2209. RSV-associated Hospitalizations in Adults Aged ≥18 Years and the Impact of the COVID-19 Pandemic in the United States, October 2018 - February 2022 Fiona P Havers, Michael Whitaker, Huong Pham, Onika Anglin, Jennifer Milucky, Kadam Patel, et al. (+17)
216 [GO] 2022―Dec―15 275. Evaluating the COVID-19 Pandemic in US Veterans: Transitioning from Delta to Omicron Variants Audun J Lier, Zeena Lobo, George Psevdos
217 [GO] 2022―Dec―15 1573. Impact of the COVID-19 Pandemic on Antibiotic Use among Hospitalized Adults in Argentina, Brazil, and Chile Twisha S Patel, Olivia L McGovern, Garrett W Mahon, Icaro Boszczowski, Jose M Munita, Maria I Garzon, et al. (+18)
218 [GO] 2022―Dec―15 1917. Impact of the COVID-19 Pandemic on Antimicrobial Stewardship, Infection Prevention & Control, and Clinical Microbiology Practices in Argentina, Brazil, and Chile Hanako Osuka, Twisha S Patel, Olivia L McGovern, Icaro Boszczowski, Jose M Munita, Maria I Garzon, et al. (+11)
219 [GO] 2022―Dec―15 2019. Understanding the Impact of COVID-19 Pandemic on Central Line-Associated Bloodstream Infections (CLABSIs): Expanding Analysis to the Microbiologic Level Jay Raj Krishnan, Elizabeth Dodds Ashley, Andrea Cromer, Deverick J Anderson, Sonali D Advani, Melissa D Johnson
220 [GO] 2022―Dec―15 2042. Impact of the COVID-19 Pandemic on Healthcare-Associated Infections (HAI) by Race and Ethnicity in a Large Network of Community Hospitals: A Call to Action Erin Gettler, Ibukunoluwa Kalu, Sonali D Advani, Jessica Seidelman, Jay Raj Krishnan, Melissa Campbell, et al. (+3)
221 [GO] 2022―Dec―15 1209. The Impact of the COVID-19 Pandemic on Hospital-Acquired Infections at a Comprehensive Cancer Center Rita Wilson Dib, Amy Spallone, Fareed Khawaja, Adina Feldman, Jalen Bartek, Sherry Cantu, et al. (+8)
222 [GO] 2022―Dec―15 2200. Impact of COVID-19 Pandemic on Influenza-like Illness (ILI) Experience among Healthcare Workers in Military Treatment Facilities Ryan Liberg, Christina Schofield, Stephanie A Richard, Limone Collins, Christina Spooner, Srihari Seshadri, et al. (+13)
223 [GO] 2022―Dec―15 1223. The Impact of the COVID-19 Pandemic on the Prevalence of Multidrug-resistant Organisms in Veterans Affairs Nursing Homes Monirul I Sajib, Florence M Ford, George Psevdos
224 [GO] 2022―Dec―15 267. Delayed Pulmonary Tuberculosis (PTB) Diagnosis During the COVID-19 Pandemic: A Case Series Mikhail Khaitov, Nadim Salomon, David Perlman, Sarah Humphreys
225 [GO] 2022―Dec―15 1214. The Effects of Modified Personal Protective Equipment (PPE) Protocols on Healthcare Personnel Providing Patient Care During the COVID-19 Pandemic: A Qualitative Assessment Emily E Chasco, Jaqueline Pereira da Silva, DeShauna Jones, Kimberly Dukes, Melissa Ward, Loreen Herwaldt
226 [GO] 2022―Dec―15 929. A Nationwide Survey on the Role of Antimicrobial Stewardship Programs during the COVID-19 Pandemic: What is restricted and who decides? Alfredo J Mena Lora, Fischer Herald, Brenna Lindsey, Rodrigo M Burgos, Scott Borgetti, Lelia H Chaisson, Susan C Bleasdale
227 [GO] 2022―Dec―15 485. A hypermutator strain of Pseudomonas aeruginosa in a COVID-19 patient with ventilator-associated pneumonia Sophia Nozick, Egon A Ozer, Rachel Medernach, Jori Mills, Richard Wunderink, Alan R Hauser
228 [GO] 2022―Dec―15 Reconsideration of anti-nucleocapsid IgG antibody as a marker of SARS-CoV-2 infection post-vaccination for mild COVID-19 patients Santosh Dhakal, Tong Yu, Anna Yin, Nora Pisanic, Zoe O Demko, Annukka A R Antar, et al. (+4)
229 [GO] 2022―Dec―15 1945. Effects of COVID-19 Vaccines on Outcomes Among Hospitalized COVID-19 Patients Serene Hoskins, Marcos I Restrepo, Jose Cadena
230 [GO] 2022―Dec―15 907. Impact of Antimicrobial Stewardship Prospective Audit and Feedback on Antibiotic Utilization in Hospitalized COVID-19 Patients Ashfaq Shafiq, Taylor Hori, Selena Pham
231 [GO] 2022―Dec―15 1123. EDP-235, A Potent and Once-daily Oral Antiviral, Demonstrates Excellent Penetration into Macrophages and Monocytes, with the Potential for Mitigation of Cytokine Storm in High-Risk COVID-19 Patients Yang Li, Tianzhu Indy Zang, Lisha Xu, Daniel Leonard, Khanh Hoang, Tim Greizer, et al. (+7)
232 [GO] 2022―Dec―15 1124. Effect of High-Dose versus Standard-Dose Dexamethasone on Mortality Among Mechanically Ventilated COVID-19 Patients Pramodini Kale-Pradhan, Regina Pacitto, Lauren Krumm, Anna Hejnar, Christopher Giuliano, Leonard B Johnson
233 [GO] 2022―Dec―15 276. Factors Predicting Bacterial Coinfection in Hospitalized COVID-19 Patients Yi Guo, Kelsie Cowman, Hongkai Bao, Victor Chen, Mimi Kim, Xianhong Xie, et al. (+4)
234 [GO] 2022―Dec―15 165. Biofire pneumonia panel use in severe pneumonia and antibiotic treatment in COVID-19 patients Erica J Stohs, Maureen McElligott, Hannah M Creager, Paul D Fey, Trevor C Van Schooneveld
235 [GO] 2022―Dec―15 270. Secondary bacterial infection in hospitalized COVID-19 patients. Experience in Colombia, South America Fernando Rosso, Sarita Rodriguez, Isabel L Zapata-Vasquez, Eric Tafur, Diana M Martinez, Tania Guzmán, et al. (+2)
236 [GO] 2022―Dec―15 1875. Continued demographic shifts in hospitalised COVID-19 patients from migrant workers to a vulnerable and more elderly local population at risk of severe disease Jinghao Nicholas Ngiam, Srishti Chhabra, Wilson Goh, Meng Ying Sim, Tze Sian Liong, Nicholas W S Chew, et al. (+3)
237 [GO] 2022―Dec―15 1090. Factors effecting mortality among Covid-19 patients in Renal Transplant Recipients from a single center in Pakistan Asma Nasim, Sunil Kumar
238 [GO] 2022―Dec―15 291. Retrospective Study on Bacteremia in COVID-19 Patients in the Delta and Omicron Era Sunghee Park, Tark Kim, Eun Ju Choo
239 [GO] 2022―Dec―15 1106. A Retrospective Assessment of the Effects of Baricitinib and Tocilizumab on COVID-19 Patients requiring High Flow Oxygen Kathy Tin, Annamarie Fernandes, Alexander Njoroge, Roderick Go
240 [GO] 2022―Dec―15 1067. Predicting next 7-day Discharges of Hospitalized COVID-19 Patients Using Ensemble Learning Xiangyang Ye, Mingyuan Zhang, Matthew H Samore, Jincheng Shen, Julia Bohman, Yue zhang, Jeffrey Humpherys
241 [GO] 2022―Dec―15 1071. Retrospective study evaluating the cytokine dynamics in COVID-19 patients who were treated with casirivimab/imdevimab Akiho Sugita, Masahiro Ishikane, Noriko Iwamoto, Masaya Sugiyama, Katsuji Teruya, Masayuki Hojo, et al. (+2)
242 [GO] 2022―Dec―15 1045. Longitudinal Evaluation of the QuantiFERON-TB Gold Plus Assay in Hospitalized COVID-19 Patients with a First Indeterminate Result: Resolution of Inflammation and Restoration T-lymphocyte Counts and Interferon-gamma Production Alessandra Imeneo, Grazia Alessio, Andrea Di Lorenzo, Laura Campogiani, Alessandra Lodi, Filippo Barreca, et al. (+10)
243 [GO] 2022―Dec―15 349. Characteristics and Outcomes of COVID-19 Patients with Candidemia at a Community Teaching Hospital in Chicago - One Year Follow Up. Oluwadamilola A Adeyemi, David Okoh, Gregg Gonzaga, Sean Cariño, Steve B Kalish
244 [GO] 2022―Dec―15 LB1533. Impact of Treatment of Hospitalised COVID-19 Patients With Inhaled Interferon Beta-1a (SNG001) on Long COVID Symptoms: Results From the SPRINTER trial Phillip D Monk, Rachael A Evans, Victoria J Tear, Jody L Brookes, Toby Batten, Marcin Mankowski, et al. (+4)
245 [GO] 2022―Dec―15 245. Can Inflammatory Markers be used as an Early predictor for Mechanical ventilation in COVID-19 patients with Stages IIIb-V Chronic Kidney Disease? Harinivaas Shanmugavel Geetha, Maya Gogtay, Sushmita Prabhu, Abinesh Sekar, Yuvaraj Singh, George M Abraham, Suzanne Martin
246 [GO] 2022―Dec―15 1128. Efficacy and Safety of Nelfinavir in Asymptomatic and Mild COVID-19 Patients: A Multicenter, Randomized Controlled Trial Shigeru Kohno, Taiga Miyazaki, Naoki Hosogaya, Shinpei Morimoto, Hiroshi Yamamoto, Shingo Iwami, et al. (+2)
247 [GO] 2022―Dec―15 1157. The Clinical Impact of Casirivimab-Imdevimab Monoclonal Antibody Therapy (CIMAT) in COVID-19 patients: A real-world insight from India. Jose J Kochuparambil, Aleena Issac
248 [GO] 2022―Dec―15 277. Frequency of Pneumomediastinum and Pneumothorax in COVID-19 Patients: a Retrospective Cohort Study in a Community Hospital in Evanston, Illinois Goar Egoryan, Guillermo Rodriguez Nava, Guillermo Rodriguez Nava, Armen Kishmiryan
249 [GO] 2022―Dec―15 LB1529. Randomized, Controlled Phase 3 Study of anti-C5a Vilobelimab's Effect on Mortality in Critically Ill COVID-19 Patients: A Therapy for Viral Pneumonia Bruno Mourvillier, Alexander Vlaar, Martin Witzenrath, Michael Bauer, Leo Heunks, Luis Hercilla Vasquez, et al. (+23)
250 [GO] 2022―Dec―15 1058. Development of a Steroid Stewardship Bundle to tackle the Glucocorticoid-Induced Hyperglycemia in COVID-19 patients: Results of SUPER Diabetes Study. Aleena Issac, Jose J Kochuparambil
251 [GO] 2022―Dec―15 1134. Lenzilumab Treatment in COVID-19 Pneumonia Reduces Circulating Cytokines and Markers of Systemic Inflammation Dale Chappell, Adrian Kilcoyne, Frank Cerasoli, John Lukas, Cameron Durrant, Zelalem Temesgen, et al. (+3)
252 [GO] 2022―Dec―15 1125. Effect of intravenous pulses of methylprednisolone 250 mg versus dexamethasone 6 mg in hospitalized adults with severe COVID-19 pneumonia: an open-label randomized trial. Carlos Dueñas Gutierrez, Jesica Abadia-Otero, Ivan Cusacovich, Jose Ignacio Martín-González, Alberto Muela-Molinero, Luis Corral-Gudino, et al. (+16)
253 [GO] 2022―Dec―15 LB1531. Administration of Abatacept or Infliximab Reduces Mortality in Hospitalized Patients with COVID-19 Pneumonia: Results from the ACTIV-1 IM Master Protocol Emily R Ko
254 [GO] 2022―Dec―15 272. Do Empiric Antibiotics Improve Outcomes in Clinically Stable Patients Admitted with COVID-19 Pneumonia? Retrospective Cohort Study of 221 U.S. Hospitals, March 1st, 2020-December 31st, 2020 Alexander Lawandi, Jeffrey R Strich, Xioabai Li, Christina Yek, Sarah Warner, Sameer S Kadri
255 [GO] 2022―Dec―15 1127. Effectiveness of Remdesivir as Treatment for COVID-19 Positive US Veterans Sujee Jeyapalina, Margaret Lundquist, Guo Wei, Gregory Stoddard, Jay Agarwal
256 [GO] 2022―Dec―15 591. Adintrevimab (ADI) Population Pharmacokinetics (PPK) in Phase 1 and Phase 2/3 COVID-19 Prevention and Treatment Study Participants Christopher M Rubino, Anthony P Cammarata, Paul Ambrose, Pete Schmidt, Myra Popejoy, Jean Gong, Xia Pu
257 [GO] 2022―Dec―15 1892. Rise of COVID-19 Re-infections as Omicron Variant Prevailed: Implications on Monitoring the Course of the Pandemic Kassiani Mellou, Kassiani Gkolfinopoulou, Kyriaki Tryfinopoulou, Ioannis Panagoulias, Panagiota Psallida, Gerasimos Gerolymatos, et al. (+4)
258 [GO] 2022―Dec―15 202. Vintage or Vogue? The Utility of Procalcitonin for Identifying Secondary Infections in Patients With Influenza or Covid-19 Receiving Extracorporeal Membrane Oxygenation Kajal D Patel, Michal J Sobieszczyk, Joseph E Marcus, James Aden
259 [GO] 2022―Dec―15 1152. Risk factors for 30-day all-cause mortality in hospitalized patients with COVID-19 receiving immunomodulator therapy: a retrospective cohort study Chas A Hoffmann, Adam R Patrick, David J Hutchinson, Lauren M Finoli, Tiffany L Guliano, Matthew A Moffa, et al. (+2)
260 [GO] 2022―Dec―15 1954. Immunogenicity against SARS CoV-2 ancestral strain and variants of two new COVID-19 recombinant adjuvanted vaccines compared to BNT162b2 as a third dose following two doses of BNT162b2: a single-blinded multicenter randomized controlled trial Odile Launay, Marine Cachanado, Liem Binh Luong, Laetitia Ninove, Marie Lachâtre, Inès Ben Ghezala, et al. (+26)
261 [GO] 2022―Dec―15 1878. Demographic and Clinical Characteristics of COVID-19 Reinfection Robert Hoard, Eric Coate, Elizabeth A Macias, Luke B Jackson, Alice E Barsoumian, Jason Okulicz, Elizabeth Markelz
262 [GO] 2022―Dec―15 1876. COVID-19 Reinfection and Disease Severity in the New York City Health + Hospitals System Jenny R Smolen, Thomas D Filardo, Annie George, Sakil Bhuiyan, Sowmya Kalava, Noor Shahin, et al. (+7)
263 [GO] 2022―Dec―15 2119. Predictive Value of the Immunodeficiency Scoring Index for COVID-19 Related Outcomes in Hematopoietic Transplant Recipients Marilyne Daher, Fareed Khawaja, Georgios Angelidakis, Gabriella Rondon, Amy Spallone, Jeremy Ramdial, et al. (+3)
264 [GO] 2022―Dec―15 78. Longitudinal Analysis of T cells in COVID-19 Survivors with Post-Acute Sequelae of COVID-19 Reveals Associations between Individual Symptoms and Inflammatory Indexes Stephanie LaVergne, Stephanie LaVergne, Taru Dutt, Kim McFann, Bridget Baxter, Tracy Webb, et al. (+5)
265 [GO] 2022―Dec―15 317. Use cases for rapid antigen-detecting tests for COVID-19 screening and surveillance: a systematic review Apoorva Anand, Jacob Bigio, Emily MacLean, Talya Underwood, Nitika Pant Pai, Sergio Carmona, et al. (+2)
266 [GO] 2022―Dec―15 1069. Psychometric Properties of the Symptoms of Infection with Coronavirus-19: A Patient-Reported Outcome Measure for COVID-19 Signs and Symptoms Eric K H Chan, Jeffrey Stoddard, Jerald Sadoff, Yan Liu, Ilse van Dromme, Eva G Katz, et al. (+2)
267 [GO] 2022―Dec―15 1061. Evaluation of Measures for the Assessment of Covid-19 Signs and Symptoms in Children and Adolescents Carla Romano, Margaret Mayorga, Javier Ruiz-Guiñazu, Géralyn C Trudel, Sheri Fehnel, Kelly McQuarrie, et al. (+2)
268 [GO] 2022―Dec―15 1888. Implementation of COVID-19 Surveillance Testing Procedures in Dental School Holly Shoemaker, Jeri Bullock, Kristina Stratford, Melodie L Weller, Wendy L Hobson-Rohrer, Wendy L Hobson-Rohrer, et al. (+3)
269 [GO] 2022―Dec―15 1953. Immune responses, viral shedding, and COVID-19 symptom burden from breakthrough SARS-CoV-2 infection in a 2:1 randomized, double-blind, placebo-controlled Phase 3 study of AZD1222 (ChAdOx1 nCoV-19) vaccination Magdalena E Sobieszczyk, Ann R Falsey, Anne F Luetkemeyer, Grant C Paulsen, Sharon A Riddler, Merlin L Robb, et al. (+15)
270 [GO] 2022―Dec―15 1054. Comparison of Post-Acute COVID-19 Symptoms in Infected Individuals Pre- and Post-Vaccination Dylan McDonald, Jennifer Logue, Nicholas M Franko, Megan M Kemp, Denise J McCulloch, Eric J Chow, Helen Y Chu
271 [GO] 2022―Dec―15 1918. Impact of the SARS-CoV-2-Neutralizing Antibody Combination AZD7442 (Tixagevimab/Cilgavimab) on the Severity and Progression of COVID-19 Symptoms in the Phase 3 TACKLE Trial Jesus Abraham Simón Campos, Douglas Arbetter, Hugh Montgomery, F D Richard Hobbs, Francisco Padilla, Kenneth Kim, et al. (+4)
272 [GO] 2022―Dec―15 1156. Sustained Alleviation and Resolution of Targeted COVID-19 Symptoms with Nirmatrelvir/Ritonavir versus Placebo Jennifer Hammond, Heidi Leister-Tebbe, Annie Gardner, Paula Abreu, Weihang Bao, Wayne Wisemandle, et al. (+6)
273 [GO] 2022―Dec―15 1401. Evaluating Barriers and Potential Solutions to Speaking Up About COVID-19 Symptoms: A Survey Among Nursing Home Workers Gabrielle M Gussin, Raveena D Singh, Thomas T Tjoa, Raheeb Saavedra, Sherrie H Kaplan, Susan S Huang
274 [GO] 2022―Dec―15 1070. Quality of life and intrinsic capacity in patients with post-acute COVID-19 syndrome is in relation to frailty and resilience phenotypes Giovanni Guaraldi, Jovana Milic, Sara Barbieri, Tommaso Marchio’, Agnese Caselgrandi, Federico Motta, et al. (+16)
275 [GO] 2022―Dec―15 1407. Increasing access to COVID-19 testing in underserved Black American neighborhoods Elizabeth Avery, Tamara Olinger, Sumihiro Suzuki, Yolanda Cartwright, LaDawne Jenkins, Lelia H Chaisson, et al. (+5)
276 [GO] 2022―Dec―15 1898. The Impact of Polymerase Chain Reaction Versus Antigen Based COVID-19 Testing on Subsequent Infections in Military Trainees Daniel Cybulski, Zachary Matthews, John Kieffer, Theresa Casey, Angela Osuna, Korey Kasper, et al. (+3)
277 [GO] 2022―Dec―15 903. Formulary Edits and Consistent Messaging for Unproven COVID-19 Therapeutics Tyler Stephen, Alyssa Tutino, Justin Bender, Michelle Sageer, Mona Chitre, Ted Louie
278 [GO] 2022―Dec―15 1118. COVID-19 Therapeutics: Real-World Experience in Flint, Michigan (MI) Mariam Younas, Danielle Osterholzer, Carlos Rios-Bedoya, Brandon R Flues, Ghassan Bachuwa, Ghassan Bachuwa
279 [GO] 2022―Dec―15 1109. Rise and Fall of COVID-19 Therapies Throughout Different Waves of the Pandemic: Results of a Nationwide Survey Alfredo J Mena Lora, Fischer Herald, Brenna Lindsey, Scott Borgetti, Lelia H Chaisson, Rodrigo M Burgos, Susan C Bleasdale
280 [GO] 2022―Dec―15 1046. Assessing School-Based COVID-19 Transmission in Middle and High Schools in an Underserved Population through Qualitative Interviews Grace Yuan, Samantha Hayes, Sara Malone, Sewuese Akuse, Tremayne Watterson, Summer M Reyes, et al. (+8)
281 [GO] 2022―Dec―15 1150. Resistance Analysis in the COMET-TAIL Study: Participants with Mild-to-Moderate COVID-19 Treated with Intramuscular or Intravenous Sotrovimab Maria L Agostini, Gretja Schnell, Julia di Iulio, Anita Kohli, Adrienne E Shapiro, Elias H Sarkis, et al. (+7)
282 [GO] 2022―Dec―15 1149. Resistance Analyses of Patient Viral Samples from the Remdesivir Phase 3 Adaptive COVID-19 Treatment Trial-1 (ACTT-1) Charlotte Hedskog, Lauren Rodriguez, John H Beigel, Walla Dempsey, Alexander L Greninger, Pavitra Roychoudhury, et al. (+10)
283 [GO] 2022―Dec―15 1138. Optimal Duration of Systemic Corticosteroids Use in COVID-19 Treatment: A Meta-analysis Nyein Yu, Paddy Ssentongo, David Ingram, Catharine I Paules
284 [GO] 2022―Dec―15 284. Post-Acute Sequelae of COVID-19 Two Years After Acute Infection Jennifer Logue, Nicholas M Franko, Megan M Kemp, Denise J McCulloch, Eric J Chow, Helen Y Chu
285 [GO] 2022―Dec―15 1959. Lower B-Cell Responses Rather Than Circulating Antibody Titres Are Associated With SARS-CoV-2 Infection Post Third Dose COVID-19 Vaccination Joanne Byrne, Lili Gu, Riya Negi, Alejandro Garcia-Leon, Dana Alalwan, Colette Marie Gaillard, et al. (+15)
286 [GO] 2022―Dec―15 1935. Cardiac Tamponade Following COVID-19 Vaccination Christopher B Murphy, Sabirah N Kasule, Holenarasipur R Vikram
287 [GO] 2022―Dec―15 1967. Receipt of Influenza Vaccination as Predictor of COVID-19 Vaccination among United States Veterans Gina Oda, Aditya Sharma, Cynthia A Lucero-Obusan, Patricia Schirmer, Mark Holodniy
288 [GO] 2022―Dec―15 1963. Peripartum Outcomes Associated With COVID-19 Vaccination during Pregnancy: A Systematic Review and Meta-analysis Atsuyuki Watanabe, Jun Yasuhara, Masao Iwagami, Yoshihisa Miyamoto, Yuji Yamada, Yukio Suzuki, et al. (+2)
289 [GO] 2022―Dec―15 1969. SARS-CoV-2 seroprevalence among patients with cancer and healthcare workers from an oncology referral center during the first year of COVID-19 vaccination in Mexico Rodrigo Villaseñor-Echavarri, Daniel De-la-Rosa-Martinez, Emmanuel Frias-Jimenez, Alexandra Martin-Onraet, Erika Ruiz-Garcia, Alonso Cruz-Cruz, et al. (+2)
290 [GO] 2022―Dec―15 1929. A Qualitative Analysis of COVID-19 Vaccination Intent and Recommendations to Increase Uptake Among Residents and Staff in Six Seattle Homeless Shelters Sarah N Cox, Nicholas Thuo, Julia H Rogers, Ashley A Meehan, Amy C Link, Natalie K Lo, et al. (+7)
291 [GO] 2022―Dec―15 433. COVID-19 Vaccination Uptake Among Health Care Workers (HCW) Requesting Medical Exemptions to Vaccination. Jana Shaw, Loren Brown, Stephen J Thomas, Lynn M Cleary, Jarrod Bagatell
292 [GO] 2022―Dec―15 1526. Time from last COVID-19 vaccination’s impact on rapidity of viral culture conversion following SARS-CoV-2 infection: a prospective cohort study Madison Gilbert, Atarere Joseph, Jacquelyn Turcinovic, Scott Seitz, Cole Sher-Jan, Laura F White, et al. (+12)
293 [GO] 2022―Dec―15 1979. Waning of humoral immunity depending on the types of COVID-19 vaccine So Yun Lim, Ji Yeon Kim, Jiwon Jung, Sung-Cheol Yun, Sung-Han Kim
294 [GO] 2022―Dec―15 LB746. Safety and Immunogenicity of a Booster Dose of Novavax COVID-19 Vaccine, Adjuvanted (NVX-CoV2373) in Adults from the PREVENT-19 Trial in the United States Germán Áñez, Lisa M Dunkle, Cynthia L Gay, Karen L Kotloff, Nita Patel, Joyce S Plested, et al. (+4)
295 [GO] 2022―Dec―15 1976. Using a Patient Portal as a Recruitment Tool to Diversify the Pool of Participants in COVID-19 Vaccine Clinical Trials Tiffany Yuh, Tuhina Srivastava, Danielle Fiore, Harald Schmidt, Ian Frank, David Metzger, Florence Momplaisir
296 [GO] 2022―Dec―15 1094. Multisystem Inflammatory Syndrome in Children (MIS-C) in Persons Fully Vaccinated with Two Doses of mRNA COVID-19 Vaccine Compared with Persons with Partial or No Vaccination Reported, U.S. National MIS-C Surveillance Anna R Yousaf, Allison D Miller, Katherine Lindsey, Michael J Wu, Michael Melgar, Laura D Zambrano, Angela P Campbell
297 [GO] 2022―Dec―15 1937. COVID-19 Vaccine Distribution in Massachusetts Jails Nicole Cassarino, Emma Smyth, Alysse Gail Wurcel
298 [GO] 2022―Dec―15 2297. COVID-19 Vaccine Effectiveness Among Pregnant People Ousseny Zerbo, G Thomas Ray, Kristin Goddard, Evan Layefsky, Bruce Fireman, Nicola P Klein
299 [GO] 2022―Dec―15 1956. Impact of an Implementation Science-Based Project to Address COVID-19 Vaccine Hesitancy Scott C Ratzan, Erin Hultgren, Jeffrey D Carter, Melissa Rodriguez, Laura Simone, Leah Molloy
300 [GO] 2022―Dec―15 1938. COVID-19 Vaccine Hesitancy among Adults Who Rely on Social Media for Health Care Information in Cameroon, Africa Kendall Baecher, Alexander Boutwell, Nuwan Gunawardhana, Nuwan Gunawardhana, Denis M Tebit, Jodie Dionne
301 [GO] 2022―Dec―15 1939. COVID-19 vaccine immunogenicity among CD19 receptor T-cell (CAR-T) therapy Muneerah M Aleissa, Jessica S Little, Sonya Davey, Isabel H Gonzalez-Bocco, Andrew Looka, Nicolas C Issa, et al. (+3)
302 [GO] 2022―Dec―15 224. Effect of a Mobile App Chatbot and an Interactive Small Group Webinar on COVID-19 Vaccine Intention and Confidence in Japan: A Randomized Clinical Trial Yuji Yamada, Hana Tomoi, Yuka Nishina, Ko Harada, Kyuto Tanaka, Shugo Sasaki, et al. (+10)
303 [GO] 2022―Dec―15 99. COVID-19 Vaccine related Attitudes and Beliefs among Black and/or Hispanic respondents in Brooklyn, NY: Lessons Learned Lalitha Parameswaran, Mark Mulligan, Yangjin Park
304 [GO] 2022―Dec―15 1950. Factors Influencing COVID-19 Vaccine Uptake among Reproductive-Aged Women in Jamaica Jodian A Pinkney, Kamali Carroll, Lenroy Bryan, Givana Witter, Dina Ashour, Fatma Shebl, et al. (+3)
305 [GO] 2022―Dec―15 1962. Perceptions of the COVID-19 Vaccine within the Sudanese-American Community Jonathan R Freese, Harlan R Sayles, Fatima Ahmed, Mujtaba Abdellatif, Nada Fadul
306 [GO] 2022―Dec―15 1947. Evaluating the Relationship Between Obesity and the Humoral Immune Response to COVID-19 Vaccines LaKesha Tables, Fatima Ali, Eric Gaines, Yul Eum Sim, Erica L Johnson, Lilly Immergluck
307 [GO] 2022―Dec―15 1944. Effectiveness of COVID-19 Vaccines Against Severe Disease and Death and its Durability Over Time Against the Omicron Variant Theodore Lytras, Kassiani Mellou, Kassiani Gkolfinopoulou, Gerasimos Gerolymatos, Dimitrios Paraskevis, Theoklis Zaoutis, Sotirios Tsiodras
308 [GO] 2022―Dec―15 1933. Assessment of Effectiveness of mRNA COVID-19 Vaccines Among Health Care Personnel: Monroe County, NY December 2020-March 2022 Savanah Russ, Christopher J Myers, Infectious Diseases, Erin Licherdell, Thomas Peer, Christine Hurley, et al. (+5)
309 [GO] 2022―Dec―15 1941. Describing the immune response kinetics to mRNA COVID-19 vaccines among previously SARS-CoV-2-infected and -uninfected nursing home residents, a prospective longitudinal observational cohort evaluation-Georgia, October 2020 - September 2021 Zeshan A Chisty, Melia Haile, Juliana DaSilva, M A Biology, Hollis Houston, Shoshona Le, et al. (+17)
310 [GO] 2022―Dec―15 1940. COVID-19 Vaccines and Related Adverse Effects among Health Sciences and Non-Health Sciences Students from Two Large Public Universities in Thailand Kanathip Jongmekwamsuk, Sirashat Hanvivattanakul, Jakapat Vanichanan, Thana Khawcharoenporn
311 [GO] 2022―Dec―15 584. Prospective Observational Cohort Study of Serological Responses to COVID-19 Vaccines in Pediatric Kidney Transplant Recipients at a Single Institution Kathryn P Goggin, Elizabeth Sun, Emily J Yun, Margret Kamel, Maria Perez, Hui-Mien Hsiao, et al. (+5)
312 [GO] 2022―Dec―15 84. One-month Humoral Response Following Two Doses of Covid-19 Vaccines in Specific populations - ANRS0001S COV POPART Cohort Study Paul LOUBET, L I nda Wittkop, Mathieu Chalouni, David-Axel Laplaud, Martine Laville, Bruno Laviolle, et al. (+10)
313 [GO] 2022―Dec―15 786. Effect of Nirmatrelvir/Ritonavir versus Placebo on COVID-19─Related Hospitalizations and Other Medical Visits Jennifer Hammond, Heidi Leister-Tebbe, Annie Gardner, Paula Abreu, Weihang Bao, Wayne Wisemandle, et al. (+4)
314 [GO] 2022―Dec―15 1877. COVID-19-Associated Hospitalizations among Long-Term Care Facility Residents Ages ≥65 Years - COVID-NET, 14 U.S. States, March 2020-January 2022 Christopher Taylor, Michael Whitaker, Onika Anglin, Huong Pham, Kadam Patel, Jennifer Milucky, et al. (+15)
315 [GO] 2022―Dec―15 783. Lung Transplantation for COVID-19-Associated Lung Injury (CALI): An International Registry Maha M Alamri, Rebecca Osborn, Reda Girgis, Nicholas Marschalk, Ryan Rivosecchi, Michael G Ison, et al. (+2)
316 [GO] 2022―Dec―15 478. Lung Hybrid Neutrophils and Subsequent Extracellular Traps Are Protective In COVID-19-Associated Pulmonary Aspergillosis Simon Feys, Sam Vanmassenhove, Sirima Kraisin, Seppe Cambier, Cato Jacobs, Bram Boeckx, et al. (+10)
317 [GO] 2022―Dec―15 247. Catching CAPA: The Healthcare Impact of COVID-19-Associated Pulmonary Aspergillosis in an Academic Medical Center Caroline Hamilton, Sarah Tran, Judy Dinh, Gina Askar, Gina Askar, Gina Askar, Gina Askar
318 [GO] 2022―Dec―15 1068. Prior SARS-CoV-2 infection and risk of subsequent COVID-19-related hospitalization: a test negative design Khalel De Castro, Ashley Tippett, Laila Hussaini, Luis W Salazar, Olivia D Reese, Meg Taylor, et al. (+11)
319 [GO] 2022―Dec―15 1908. Social Risk Factors for COVID-19-Related Hospitalizations in Adults Olivia D Reese, Ashley Tippett, Laila Hussaini, Luis W Salazar, Meg Taylor, Caroline R Ciric, et al. (+11)
320 [GO] 2022―Dec―15 348. Cell-free plasma next-generation sequencing assists in the evaluation of invasive mold infection in patients with COVID-19: a case series Joshua David, Bharadhwaj Kolipakkam, Megan M Morales, Nicole C Vissichelli
321 [GO] 2022―Dec―15 1893. Risk Categorization and Outcomes among Healthcare Workers Exposed to COVID-19: A Cohort Study from A Thai Tertiary-care Center Thana Khawcharoenporn, Watcharee Chancharoenrat, Sirinporn Sajak, Suphannee Phetsaen, Padcharadda Hanchai, Kanokporn Thongphubeth, Thanus Pienthong
322 [GO] 2022―Dec―15 1975. Trends in the parents’ intention to vaccinate their children against COVID-19: A comparative study in Peru Jose A Gonzales-Zamora, David Soriano-Moreno, Linda Ponce-Rosas, Mariano G Alarcón Parra, Noelia Morocho-Alburqueque, Valentina Murrieta-Ruiz, et al. (+6)
323 [GO] 2022―Dec―15 1404. Factors Associated to Decrease in Quality of Life After Mild-Moderate COVID-19: A Cross-Sectional Study. Alberto Ordinola Navarro, Hector Rivera Villegas, Bruno Ali Lopez Luis
324 [GO] 2022―Dec―15 LB1528A. Fluvoxamine for Outpatient Treatment of Covid-19: A Decentralized, Placebo-controlled, Randomized, Platform Clinical Trial Matthew W McCarthy
325 [GO] 2022―Dec―15 LB1528B. Inhaled Fluticasone for Outpatient Treatment of Covid-19: A Decentralized, Placebo-controlled, Randomized, Platform Clinical Trial David R Boulware
326 [GO] 2022―Dec―15 1115. Effect of polymerized type I collagen in hyperinflammation of adult outpatients with symptomatic COVID-19: a double blind, randomised, placebo-controlled clinical trial Silvia Méndez-Flores, Angel Priego-Ranero, Daniel Azamar-Llamas, Héctor Olvera-Prado, Kenia Ilián Rivas-Redondo, Eric Ochoa-Hein, et al. (+13)
327 [GO] 2022―Dec―15 252. Clinical Outcomes and Risk Factor of Severe Disease in Young Adult Patients Compared with Middle-Aged Patients Who Infected with COVID-19: A Large Cohort Study in Tertiary Hospital Preudtipong Noopetch, Rutporn Benchamanon, Samerjan Kongsuwan, Chatree Chai-adisaksopha
328 [GO] 2022―Dec―15 292. Risk factor and clinical characteristics of pneumothorax and pneumomediastinum in COVID-19: a matched case-control study Se Ju Lee, Jinnam Kim, Ki Hyun Lee, Jung Ah Lee, Chang Hyup Kim, Su Hwan Lee, et al. (+6)
329 [GO] 2022―Dec―15 1153. Safety and Potential Efficacy of Exosomes Overexpressing CD24 (EXO-CD24) for the Prevention of Clinical Deterioration in Patients with Moderate or Severe COVID-19: A Phase II, Randomized, Single-blinded Study. Ioannis Grigoropoulos, Georgios Tsioulos, Artemis Kastrissianakis, Shiran Shapira, Nadir Arber, Garyfallia Poulakou, et al. (+18)
330 [GO] 2022―Dec―15 244. Bacterial co-infection in COVID-19: an analysis of a National Cohort of Hospitalized U.S. Veterans Karim Khader, Haojia Li, Barbara E Jones, Michael Rubin, Candace Haroldsen, Tina M Willson, et al. (+3)
331 [GO] 2022―Dec―15 787. Predictors of Co-infection with Multidrug Resistant Organisms among Hospitalized Patients with COVID-19: An Exploratory Analysis Yue Zhang, Haojia Li, Barbara E Jones, Michael Rubin, Candace Haroldsen, Tina M Willson, et al. (+3)
332 [GO] 2022―Dec―15 2045. IVAC Plus in the Time of COVID-19: An Imperfect Metric? Camille Spears, Delvina Ford, Jose Martinez, Kelly R Reveles, Erica Beck, Lauren N Garza, et al. (+3)
333 [GO] 2022―Dec―15 1887. Hyperglycemia and COVID-19: An independent risk factor for disease severity and death in the Dominican Republic Yori A Roque, David De Luna, Alfredo J Mena Lora, Lisa Maria Castillo Mercado, Carlos Perdomo, Mariela Acosta
334 [GO] 2022―Dec―15 1781. Antibiotic Prescription Trends of Patients with COVID-19: Analysis of National Health Insurance Data in Republic of Korea Yunsang Choi, Minsun Kang, Dong Hoon Shin, Jongtak Jung, Seong Jin Choi, Nak-Hyun Kim, et al. (+5)
335 [GO] 2022―Dec―15 1294. Covid-19: Impacts on Medical Students’ Mental Health in Medical Education Center of Chaophya Abhaibhubejhr Hospital Subencha Pinsai, Chalalai Klaipim
336 [GO] 2022―Dec―15 226. Higher Doses of Adintrevimab, an Extended Half-Life Monoclonal Antibody, for the Treatment and Prevention of COVID-19: Preliminary Results from a Phase 1 Single Ascending-Dose Study Xia Pu, Jean Gong, Ed Campanaro, Kristin Narayan, Deepali Gupta, Frank Engler, et al. (+2)
337 [GO] 2022―Dec―15 1141. Phase 3 Trial (in progress) of the SYK Inhibitor Fostamatinib in Patients Hospitalized with COVID-19: Protocol and Study Implementation Updates Lucy Yan, Ziad Mallat, Suzana Margareth Lobo, Anuj Malik, Wolfgang Dummer
338 [GO] 2022―Dec―15 1349. Lesson Learned from Investigators of Clinical Trials to Identify Therapeutics for COVID-19: Qualitative Study Kazuaki Jindai, Hiroki Saito, Satoko Horii, Kazuhiro Kamata
339 [GO] 2022―Dec―15 308. Do lung ultrasound abnormalities change during hospitalization for COVID-19? Jimin Hwang, Paul W Blair, Trishul Siddarthan, Gigi Liu, Erjia Cui, Jiawei Bai, et al. (+18)
340 [GO] 2022―Dec―15 298. Successful Treatment of Persistent Severe Acute Respiratory Syndrome Coronavirus 2 Infection in an Immunocompromised Patient Victoria Overbeck, Jacquelyn Turcinovic, Xueting Qiu, Scott Seitz, John Connor, Beau Schaeffer, et al. (+3)
341 [GO] 2022―Dec―15 2318. A Composite Peptide Vaccine Comprised of Conserved SARS-CoV-2 and Influenza Epitopes Generated Antisera Reponses to Both Coronavirus and Influenza Nimisha Rikhi, Kevin Muema, Kellie Kroscher, Richard F Schuman, Aba Assiaw-Dufu, Clara J Sei, Gerald W Fischer
342 [GO] 2022―Dec―15 302. Using Severe Acute Respiratory Syndrome Coronavirus-2 Spike Protein Antibody Serology in addition to the ISARIC 4C Risk Score to Better Discriminate Adverse Clinical Outcomes in Hospitalized Patients with Coronavirus Disease 2019. Wilson Goh, Jinghao Nicholas Ngiam, Srishti Chhabra, Meng Ying Sim, Paul Anantharajah Tambyah, Gail Brenda Cross, et al. (+2)
343 [GO] 2022―Dec―15 1080. Clinical Characteristics and Outcomes of 104 Pregnant Women with Coronavirus Disease 2019 during delta wave; single-center observational study Shin Hee Hong, Hye Jin Shi, Yoonseon Park, Joong Sik Eom
344 [GO] 2022―Dec―15 1038. Assessment of risk factors for coronavirus disease 2019 in healthcare workers: a nested case-control study, Bishkek, Kyrgyzstan, June 2020-May 2021 Venera Alymkulova, Dilyara Nabirova, Nasyat Kemelbek kyzy, Dinara Otorbaeva, Chynar Zhumalieva, Nazgul Abamuslimova
345 [GO] 2022―Dec―15 2041. Impact of Coronavirus Disease 2019 pandemic on healthcare-associated infections at intensive care unit in South Korea: Data from Korean National Healthcare-associated Infections Surveillance System (KONIS) Yu-Mi Lee, Dong Youn Kim, Eun Jin Kim, Ki-Ho Park, Mi Suk Lee
346 [GO] 2022―Dec―15 309. Genetic Diversity and Conservation of Envelope Gene of SARS-CoV-2 and its Variants B.1.1.7, B.1.351, P.1, B.1.617.2 and B.1.1.529 with comparison with other human coronaviruses Benjamin Liu
347 [GO] 2022―Dec―15 1943. Effect of Vaccination on Household Transmission of SARS-CoV-2 Julianne E Burns, Jonathan Altamirano, Jorge Salinas, Clea Sarnquist, Rasika Behl, Rosita Thiessen, et al. (+6)
348 [GO] 2022―Dec―15 1174. Liposomal Co-Formulation of MPL and QS-21 Favors the Development of T-helper 1 Cells and Promotes the Induction of CD8+ T Cells Against SARS-CoV-2 Simon D van Haren, Sanya Thomas, Ofer Levy, Guzman Sanchez-Schmitz, Simon Doss-Gollin, Yamile Lugo Rodriguez
349 [GO] 2022―Dec―15 1101. Spectrum of Disease in Children Infected with SARS-CoV-2 Sarah Gillen, Taylor Wells, Bazak Sharon
350 [GO] 2022―Dec―15 1048. Biological Determinants of Post-Acute Sequelae of SARS-CoV-2 Scott Lu, Khamal Anglin, Michel Tassetto, Miguel Garcia-Knight, Jesus Pineda-Ramirez, Ruth Diaz Sanchez, et al. (+19)
351 [GO] 2022―Dec―15 375. Performance Evaluation of RT-qPCR and RT-dPCR Platforms for the wastewater surveillance of SARS-CoV-2 Hosoon Choi, John David Coppin, Piyali Chatterjee, Jing Xu, Lynn Mayo, Emma Brackens, et al. (+4)
352 [GO] 2022―Dec―15 254. Clinical significance of antineutrophil cytoplasmic antibody positivity in patients infected with SARS-CoV-2 Lucy Eunju Lee, Wooyong Jeong, Yong-Beom Park, Su Jin Jeong, Sang-Won Lee
353 [GO] 2022―Dec―15 2301. Neurodevelopment in Infants with Antenatal or Early Neonatal Exposure to SARS-CoV-2 Sarah B Mulkey, Meagan E Williams, Nadia Jadeed, Anqing Zhang, Smitha Israel, Roberta L DeBiasi
354 [GO] 2022―Dec―15 1133. Investigation of Treatment-Emergent Amino Acid Substitutions in Nonstructural Protein 5 from Ph2a Study of Ensitrelvir, a Novel Oral SARS-CoV-2 3C-Like Protease Inhibitor Takao Sanaki, Keiko Baba, Atsuko Yamamoto, Haruaki Nobori, Shota Uehara, Yoko Kajiwara, et al. (+8)
355 [GO] 2022―Dec―15 1874. Comprehensive, longitudinal wastewater surveillance for SARS-CoV-2 across a university campus, demonstrates low levels of SARS-CoV-2 activity relative to the surrounding community Jangwoo Lee, Nicole Acosta, Jennifer Van Doorn, Kashtin Low, Paul Westlund, Maria Bautista Chavarriaga, et al. (+19)
356 [GO] 2022―Dec―15 1890. Molecular Biology of SARS-CoV-2 and its Evolution within the Princeton University Campus Community Jesse T Brewer, Qiqi Yang, Irina Aranovich, Wei Wang, Daniel Notterman, Irini Daskalaki
357 [GO] 2022―Dec―15 1060. Duration of Seroprevalence among Individuals Previously Infected with SARS-CoV-2 and their Household Contacts Jonathan Altamirano, Marcela Lopez, Marcela Lopez, Leanne X Chun, Grace K Tam, India Robinson, et al. (+10)
358 [GO] 2022―Dec―15 1958. Longitudinal SARS-COV-2 anti-spike antibody response in pregnant people with natural infection and variable vaccine uptake Sylvia M LaCourse, Morgan C Aurelio, Jaclyn N Escudero, Sascha R Ellington, Lauren B Zapata, Margaret C Snead, et al. (+6)
359 [GO] 2022―Dec―15 1072. SARS-CoV-2 Antibody Levels Associate with Neutrophil Activation Seth Warner, Rui Miao, Marcos J Ramos-Benitez, Xin Tian, Robert Reger, Peter D Burbelo, et al. (+10)
360 [GO] 2022―Dec―15 295. SARS-CoV-2 Associated Multisystem Inflammatory Syndrome in Adults (MIS-A): a Multicenter Case Series. Ricardo Trigueros, Travis Denmeade, Danielle Pannebaker, Ryan C Maves
361 [GO] 2022―Dec―15 314. Performance of Saliva Compared to Nasopharyngeal Swab in Detection of SARS-CoV-2 at a Field Site in Rural Guatemala Using the Roche Cobas® Liat® Point-of-Care Assay Kareen Arias, Eliceo Díaz, Claudia Paiz, Neudy Rojop, Molly Lamb, Edgar Barrios, et al. (+6)
362 [GO] 2022―Dec―15 260. Corticosteroid treatment in influenza virus and SARS-CoV-2 co-infected patients Maaike C Swets, Clark Russell, Ewen Harrison, Annemarie Docherty, Nazir Lone, Michelle Girvan, et al. (+6)
363 [GO] 2022―Dec―15 2125. Determinants of Placental Transfer of HSV-specific Antibodies and the Impact of SARS-CoV-2 Coinfection Aakash Mahant Mahant, Fatima Estrada, Jennifer Aguilan, Simone Sidoli, Betsy Herold, Betsy Herold
364 [GO] 2022―Dec―15 1537. Influenza-Associated Hospitalization Rates and Proportion of Hospitalizations with Influenza and SARS-CoV-2 Coinfection, FluSurv-NET, October 1, 2021-April 23, 2022 Shikha Garg, Charisse N Cummings, Dawud Ujamaa, Pam Daily Kirley, Nisha B Alden, Maria Correa, et al. (+13)
365 [GO] 2022―Dec―15 253. Clinical Presentations of Hospitalized Adult Patients Infected with SARS-CoV-2 during the Omicron Variant Surge in South Florida Jianli Niu, Myeongji Kim, Ayesha T Jalal, Jessica E Goldberg, Elsa M Acevedo Martinez, Nathalie P Suarez Moscoso, et al. (+6)
366 [GO] 2022―Dec―15 1064. Intra-Host SARS-CoV-2 Evolution Dynamics Kim El Haddad, Frank Esper, Thamali Madhushani Adhikari Mudiyanselage, Jing Li, Tu Zheng, Yu-Wei Cheng, et al. (+7)
367 [GO] 2022―Dec―15 1143. Prophylactic and Therapeutic Activity of AZD7442 (Tixagevimab/Cilgavimab) in SARS-CoV-2 Hamster Challenge Models Yueh-Ming Loo, Andrew S Herbert, Ana I Kuehne, Patrick M McTamney, Richard Roque, Alicia M Moreau, et al. (+9)
368 [GO] 2022―Dec―15 296. SARS-CoV-2 Illness Severity and Early Hospitalization Outcomes in a Multicenter Prospective Cohort Study Among Veterans Jennifer M Ross, Jonathan D Sugimoto, Andrew Timmons, Kathryn Moore, Jonathan Adams, Deanna Wilson, et al. (+15)
369 [GO] 2022―Dec―15 86. Antibiotic-resistant gram-negative bacterial infections among persons with or without a prior positive test for SARS-CoV-2 in 10 U.S. sites, 2020 Sandra N Bulens, Julian E Grass, Nadezhda Duffy, Jigsa Tola, Jesse T Jacob, Gillian Smith, et al. (+17)
370 [GO] 2022―Dec―15 1931. Antibodies to SARS-CoV-2 in a Medical School Department of Pediatrics Gabriela P Del Bianco, Roukaya Al Hammoud, Mary E Aitken, Anoma Somasunderam, Stacy Gomez Hernandez, Gilhen Rodriguez, et al. (+3)
371 [GO] 2022―Dec―15 2299. Longitudinal Serological Surveillance of SARS-CoV-2 in Children and Adolescents Using Serial At-Home Testing Amina Ahmed, Michael E DeWitt, Diane Uschner, William H Lagarde, DeAnna J Friedman-Klabanoff, Roberto P Santos, et al. (+3)
372 [GO] 2022―Dec―15 280. Monoclonal Antibodies Against SARS-CoV-2 in Fragile Outpatients: Clinical and Laboratory Risk Factors and Protective Role of Vaccination Rosario Alessandro Cavasio, Neva Braccialarghe, Drieda Zaçe, Ilaria Spalliera, Luigi Coppola, Laura Campogiani, et al. (+6)
373 [GO] 2022―Dec―15 1880. Detection of Infectious SARS-CoV-2 in Specimens with High CT Values Is More Common for Omicron than for Delta Variants Michel Tassetto, Miguel Garcia-Knight, Khamal Anglin, Dan Kelly, Scott Lu, Jesus Pineda-Ramirez, et al. (+10)
374 [GO] 2022―Dec―15 1906. Impact of Mask Mandate Timing on Community Transmission of SARS-CoV-2 in the St. Louis Metropolitan Area Karthik W Rohatgi, Branson Fox, Khai Hoan Tram, Elvin Geng, Aaloke Mody
375 [GO] 2022―Dec―15 1873. Comparative performance of RTqPCR vs RTddPCR for the detection of SARS-CoV-2 in wastewater (WW) collected from a range of sites and scales across the sewer network of Calgary, Alberta Barbara Jean M. Waddell, Lisa Oberding, Nicole Acosta, Maria Bautista Chavarriaga, Janine McCalder, Noah Toppings, et al. (+16)
376 [GO] 2022―Dec―15 1081. Clinical Characteristics and Predictive Factors for the Development of Hypoxemia in SARS-CoV-2 Infected Women during Pregnancy Young Keun Kim, Eui Hyeok Kim, Hee Kyoung Choi
377 [GO] 2022―Dec―15 2133. Protective Factors Against Infant SARS-CoV-2 Infection Anne-Marie Rick, John Williams, Judith M Martin
378 [GO] 2022―Dec―15 1811. Use of Procalcitonin and Antimicrobial Stewardship Intervention to Limit Antibiotic Utilization in Patients Admitted to a Community Hospital with SARS-CoV-2 Infection Paula A Politis, Michael J Oravec, Lisa Hoisington, Michael J Tan, Shanu Agarwal, Thomas M File
379 [GO] 2022―Dec―15 1120. Descriptive Analysis of Monoclonal Antibody Administration for Pregnant Patients with SARS-CoV-2 Infection Praveen Kumar Vikraman, Kai Ming Chang, Thien-Ly Doan, Henry Donaghy
380 [GO] 2022―Dec―15 1129. Efficacy of a Polyclonal Ovine Fab (PR020) Against SARS-CoV-2 Infection Zainab Bascal, Aled Griffiths, Ellen Dentten, Christon Hill, Suzanne Ward
381 [GO] 2022―Dec―15 307. Diagnostic Test Kinetics, Infectivity, and Immunological Responses Among Unvaccinated Adults During Acute SARS-CoV-2 Infection Paul K Drain, Ronit Dalmat, Meagan Bemer, Elvira Budiawan, Jennifer F Morton, Linhui Hao, et al. (+16)
382 [GO] 2022―Dec―15 237. A Case-Control Study Investigating Household, Community, and Clinical Risk Factors Associated with Multisystem Inflammatory Syndrome in Children (MIS-C) after SARS-CoV-2 Infection Laura D Zambrano, Michael J Wu, Lora M Martin, Lacy Malloch, Margaret M Newhams, Mary Beth Son, et al. (+21)
383 [GO] 2022―Dec―15 1872. Clusters of SARS-CoV-2 infection across six schools for children with intellectual and developmental disabilities Michael P Gemmell, Tyler Walsh, Adwoa Imbeah, Kelly Bono, Megan Baldenweck, Michael R Sherby, et al. (+2)
384 [GO] 2022―Dec―15 310. Longitudinal Assessment of Point-of-Care LumiraDx Antigen and Antibody Test Performance During Acute SARS-CoV-2 Infection and Recovery Ronit Dalmat, Roshni Prabhu, Marie Bauer, Matthew H Ikuma, Daphne Hamilton, Elena A Rechkina, et al. (+3)
385 [GO] 2022―Dec―15 1082. Clinical Characteristics and Vertical Transmission of Pregnant Women with SARS-CoV-2 Infection and Their Neonates Jiyoung Lee, Mi-Young Lee, Euiseok Jung, Ji-Na Lee, SeongMan Bae, Jiwon Jung, et al. (+6)
386 [GO] 2022―Dec―15 1769. Characterizing Antibiotic Prescribing for Nursing Home Residents with SARS-CoV-2 Infection, April 2020-November 2021 Katryna A Gouin, Ronald M Clouse, Cameron C Mandley, Olakunle Lawal, Sarah H Yi, Qunna Li, et al. (+3)
387 [GO] 2022―Dec―15 1102. The Host Response to SARS-CoV-2 Infection Differs by Age Emily Parsons, Stephanie A Richard, Eric D Laing, Anthony C Fries, Jeffrey Livezey, Milissa Jones, et al. (+23)
388 [GO] 2022―Dec―15 LB1534. Cord blood and maternal cytokine levels following SARS-CoV-2 infection during pregnancy Ashwin Sunderraj, Sebastian Otero, Emily Miller, Elisheva D Shanes, Jeffery A Goldstein, Leena B Mithal
389 [GO] 2022―Dec―15 1866. Burden of Death Associated with SARS-CoV-2 Infection during the Pandemic in Flint, Michigan (MI): Mortality Trends over the 2-year time period Mariam Younas, Carlos Rios-Bedoya, Danielle Osterholzer, Ghassan Bachuwa, Ghassan Bachuwa, Philip McDonald, Elfateh Seedahmed
390 [GO] 2022―Dec―15 76. Clinical Features and Burden of Post-Acute Sequelae of SARS-CoV-2 Infection in Children and Adolescents Suchitra Rao, Grace Lee, Vitaly Lorman, Hanieh Razzaghi, Asuncion Mejias, Nathan Pajor, et al. (+7)
391 [GO] 2022―Dec―15 1095. Retrospective Review of SARS-CoV-2 Infection in Immunocompromised Children at a Single Pediatric Institution Aslam Khan, Roshni Mathew, Ayelet Rosenthal
392 [GO] 2022―Dec―15 1925. Prevalence of SARS-CoV-2 Infection in Immunocompromised Patients Following Receipt of Tixagevimab/Cilgavimab Sarah Lim, Keeley Morris, Lydia J Fess, Kathy Como-Sabetti, Ruth Lynfield
393 [GO] 2022―Dec―15 2137. Effectiveness of Four Vaccines in Preventing SARS-CoV-2 Infection in Kazakhstan Dilyara Nabirova, Roberta Horth, Gaukhar Nukenova, Manar Smagul, Aizhan Yesmagambetova, Daniel Singer, et al. (+2)
394 [GO] 2022―Dec―15 278. Long-term impact of pulmonary function among patients recovered from SARS-CoV-2 infection in Lima, Peru: a preliminary analysis of the FUNCTION cohort study Rodrigo Antonio A Cachay Figueroa, Takashi Watanabe, Katiuska Cuno, Carolina Coombes, Fernando Mejia, Felix Medina, et al. (+4)
395 [GO] 2022―Dec―15 2300. Neonates born to mothers with SARS-CoV-2 infection in pregnancy: a follow-up and serological study Concetta Marsico, Liliana Gabrielli, Santo Arcuri, Caterina Vocale, Caterina Borgatti, Tiziana Lazzarotto, et al. (+2)
396 [GO] 2022―Dec―15 1946. Efficacy of Approved versus Unapproved Vaccines for SARS-CoV-2 Infection in Randomised Blinded Clinical Trials Andrea Perez Navarro, Victoria Pilkington, Andrew Hill, Toby Pepperrell
397 [GO] 2022―Dec―15 1524. SARS-CoV-2 Infection Incidence Following Exposure Assessments for Healthcare Workers Alon Vaisman, Rob Cairns, Danielle De Graeve, Tamara Dus, Susy S Hota, John Granton
398 [GO] 2022―Dec―15 80. SARS-CoV-2 infection is associated with decreased reported physical fitness in a US military longitudinal cohort Stephanie A Richard, Ann Scher, Jennifer Rusiecki, Celia Byrne, Catherine M Berjohn, Anthony C Fries, et al. (+24)
399 [GO] 2022―Dec―15 312. Performance and validation of an adaptable multiplex assay for detection of serologic response to SARS-CoV-2 infection or vaccination. Grace Kenny, Sophie R O’Reilly, Riya Negi, Alejandro Garcia-Leon, Dana Alalwan, Colette Marie Gaillard, et al. (+12)
400 [GO] 2022―Dec―15 1047. Asymptomatic SARS-CoV-2 Infections, BNT162b2 mRNA COVID 19 Vaccine-Related Symptoms, and Correlates of Immunity in Post-Vaccination Breakthrough Infections in the Prospective Assessment of SARS-CoV-2 Seroconversion (PASS) Study Emilie Goguet, Carol D Weiss, Cara Olsen, John H Powers, Si’Ana A Coggins, David Tribble, et al. (+26)
401 [GO] 2022―Dec―15 1084. Comparison of Pediatric SARS-CoV-2 Infections During Spring 2020 and Spring 2021 Lynda Ngo, Jessica E Ericson, Patrick Gavigan, Amanda Williams, Michelle Kwon, Leah Musser
402 [GO] 2022―Dec―15 1882. Effects of BA.1/BA.2 Subvariant, Vaccination, and Prior Infection on Infectiousness of SARS-CoV-2 Omicron Infections Suelen Qassim, Laith J Abu-Raddad, Hiam Chemaitelly, Sawsan AlMukdad
403 [GO] 2022―Dec―15 1052. Characteristics and Outcomes in Hospitalized Adult Patients Infected with the SARS-CoV-2 Omicron Variant at a Large Healthcare System in South Florida, January 1-14, 2022 Paula A Eckardt, Myeongji Kim, Ayesha T Jalal, Jessica E Goldberg, Elsa M Acevedo Martinez, Nathalie P Suarez Moscoso, et al. (+6)
404 [GO] 2022―Dec―15 273. Emergence of the SARS-CoV-2 Omicron Variant in the Pragmatic Assessment of Influenza Vaccine Effectiveness in the Department of Defense (PAIVED) Study Stephanie A Richard, Catherine M Berjohn, Limone Collins, Srihari Seshadri, Christina Spooner, Wesley R Campbell, et al. (+14)
405 [GO] 2022―Dec―15 2195. Etiologies of medically attended acute respiratory infections among young Ecuadorian children prior to the start of the 2020 SARS-CoV-2 pandemic Manika Suryadevara, Freddy A Pizarro Fajardo, Cinthya Cueva Aponte, Jorge Carrillo Aponte, Cynthia Bonville, Irene Torres, Joseph B Domachowske
406 [GO] 2022―Dec―15 1916. Evaluation of nasal swab collection methods on a university campus during the SARS-CoV-2 pandemic Jessica A O’Hanlon, Zack Acker, Julia C Bennett, Peter D Han, Devon McDonald, Tessa Wright, et al. (+12)
407 [GO] 2022―Dec―15 1331. Pneumococcal Colonization Among Children 5 years of Age and Younger During SARS-CoV-2 Pandemic Liset Olarte, Dithi Banerjee, Douglas S Swanson, Brian R Lee, Christopher J Harrison, Rangaraj Selvarangan
408 [GO] 2022―Dec―15 1103. Virologic and Immunologic Outcomes in People Living with HIV in a Correctional Setting During the SARS-CoV-2 Pandemic Dimple Patel, Sarah M Michienzi, Scott Borgetti, Mahesh C Patel, Anne Zheng, Michael Zhu, Melissa E Badowski
409 [GO] 2022―Dec―15 1904. Health Behavioral Trends and Absenteeism Associated with Acute Respiratory Illness Before and During the SARS-CoV-2 Pandemic in a Community Household Cohort, King County, Washington Erin Chung, Jessica Heimonen, Jessica A O’Hanlon, Yongzhe Wang Wang, Eric J Chow, Constance E Ogokeh, et al. (+7)
410 [GO] 2022―Dec―15 89. On-going impact of the SARS-CoV-2 pandemic on the evolution of carbapenemase-producing Enterobacterales in Ontario, Canada Mohammad Mozafarihashjin, Alainna J Jamal, Christopher Kandel, Philipp Kohler, Laura Mataseje, Michael Mulvey, et al. (+18)
411 [GO] 2022―Dec―15 1897. The Decline of Respiratory Viruses During the SARS-CoV-2 Pandemic: Public Health Interventions vs. Viral Competition? Waleed Malik, Ritche Hao, James Shepherd
412 [GO] 2022―Dec―15 1364. Providing preventative care during the SARS-CoV-2 pandemic: Street medicine interventions amongst those experiencing unsheltered homelessness in the City of Detroit Seema Joshi, Yasmeen Mann, Anneliese Petersen, Eliana Small, Iven T Ayyar, Justin R Abadejos, et al. (+7)
413 [GO] 2022―Dec―15 1099. SARS-CoV-2 Positive Pregnant Women Delivering in a Hospital From March 2020 - February 2021 in Three California Counties Brenna Hall, Jane E Lee, Pam Daily Kirley, Jeremy L Roland, Kareena Hundal
414 [GO] 2022―Dec―15 153. Molnupiravir Exhibits a High Barrier to the Development of SARS-CoV-2 Resistance in vitro Julie Strizki, Nicholas Murgolo, John Gaspar, John Howe, Beth Hutchins, Hiroshi Mohri, et al. (+3)
415 [GO] 2022―Dec―15 1902. Whole Genome Sequence analysis of early community transmission SARS-CoV-2 samples in the Philippines Geraldine Arevalo, Nina Theresa Dungca, Edsel Maurice Salvana, Brian Schwem
416 [GO] 2022―Dec―15 1899. The magnitude and durability of the antibody response to mRNA-based vaccination among SARS-CoV-2 seronegative and seropositive healthcare personnel Emily Ciccone, Deanna Zhu, Samuel Hawke, Rawan Ajeen, Annika Gunderson, Evans Lodge, et al. (+9)
417 [GO] 2022―Dec―15 1891. Repeated Assessment of SARS-CoV-2 Seroprevalence among Health Care Workers Early in the Pandemic: Relationship to Workplace Exposures Sherry Demian, Dominic O Awuah, Danielle Osterholzer, Lina Altameemi, Carlos Rios-Bedoya, Ahmad Taftaf, Hoang C Nguyen
418 [GO] 2022―Dec―15 1100. SARS-CoV-2 Seroprevalence in Kenyan Youth living with HIV Mary Boyle, Winstone Nyandiko, Allison DeLong, Ashley Chory, Josephine Aluoch, Celestine Ashimosi, et al. (+13)
419 [GO] 2022―Dec―15 1960. Mucosal rAd5 Immunization against SARS-CoV-2 Spike Elicits Cross-Reactive Nasal and Serum Neutralizing Antibodies and Protects Against Beta Variant Challenge in African Green Monkeys Becca A Flitter, Sarah N Tedjakusuma, Colin A Lester, Elena D Neuhaus, Susan Johnson, Emery G Dora, et al. (+3)
420 [GO] 2022―Dec―15 2140. INO-4800, a DNA Plasmid Vaccine Encoding the Ancestral SARS-CoV-2 Spike Protein, Is Stable Over a Range of Temperatures Not Requiring Ultra-Cold Chain Storage Robert J Juba, Anthony Samawova, Katherine Seals, Peggy Kinney, E J Brandreth
421 [GO] 2022―Dec―15 1110. AZD7442 (Tixagevimab/Cilgavimab) Demonstrates Potent In Vitro Activity Against SARS-CoV-2 Spike Variants Identified in Circulation and in Prophylaxis Clinical Studies Kevin M Tuffy, Michael E Abram, Tiffany L Roe, Bahar Ahani, Tyler Brady, Nicolette Schuko, et al. (+9)
422 [GO] 2022―Dec―15 1527. Use of a SARS-CoV-2 Strand-specific Assay to detect Relapse or Ongoing Infection at a Tertiary Care Center, California 2020-2022 Gustavo A Contreras Anez, Jessica Ferguson, Caitlin A Contag, Lucy S Tompkins, John Shepard, Ayelet Rosenthal, et al. (+3)
423 [GO] 2022―Dec―15 1927. Use of a SARS-CoV-2 Strand-specific Assay to evaluate for Prolonged Viral Replication among Hospitalized Patients. Tertiary Care Center, California 2020-2022 Jessica Ferguson, Gustavo A Contreras Anez, Lucy S Tompkins, John Shepard, Ayelet Rosenthal, Aruna Subramanian, et al. (+2)
424 [GO] 2022―Dec―15 1358. Establishing Genomic SARS-CoV-2 Surveillance at the National Level: Germany, 2021 Djin-Ye Oh, Martin Hölzer, Sofia Paraskevopoulou, Maria Trofimova, Felix Hartkopf, Matthias Budt, et al. (+25)
425 [GO] 2022―Dec―15 1884. Evaluating SARS-CoV-2 Surveillance Strategies at the United States Naval Academy: A Comparison of Saliva and Dried Blood Spot Serosurveillance Against Molecular-Confirmed Case Detection Liana R Andronescu, Stephanie A Richard, Eric D Laing, Adam K Saperstein, Jitendrakumar Modi, Christopher D Heaney, et al. (+8)
426 [GO] 2022―Dec―15 1970. SARS-CoV-2 T-cell specific responses in allogeneic hematopoietic stem cell transplant recipients after second and third dose of BNT162b2 mRNA vaccine Iannetta Marco, Ilaria Spalliera, Flavia Mallegni, Lisa Mercante, Alessandra Imeneo, Angela Crea, et al. (+7)
427 [GO] 2022―Dec―15 311. Modeling Diagnostic Testing Strategies for SARS-CoV-2 to Minimize Societal Costs and Return People to Work Sofia Zavala, Gary M Cox, Robert W Belknap, Becky A Smith, Sarah S Lewis, Christopher R Polage, et al. (+2)
428 [GO] 2022―Dec―15 1920. Lack of SARS-CoV-2 transmission from a Healthcare Worker to a Cohort of Immunosuppressed Patients during the Omicron Surge, California, 2022 Abraar Karan, Jessica Ferguson, Jorge Salinas
429 [GO] 2022―Dec―15 1881. Detection of SARS-CoV-2 Transmission on a College Campus using a Combined Contact Tracing and Molecular Strategy Jesse T Brewer, Wei Wang, Irina Aranovich, Daniel Notterman, Irini Daskalaki
430 [GO] 2022―Dec―15 1886. External Validation of the 4C Mortality Score and the qSOFA for Different Variants of Concerns of SARS-CoV-2 Using Data of the NAPKON Cross-Sectoral Cohort Platform (SUEP) Katharina S Appel, Daniel Maier, Sina M Hopff, Lazar Mitrov, Melanie Stecher, Margarete Scherer, et al. (+40)
431 [GO] 2022―Dec―15 1974. Title: A novel low-dose self-amplifying mRNA vaccine (GRT-R910) induces strong and broad boost in cellular and humoral immune response following primary series with a chimpanzee adenovirus SARS-CoV-2 vaccination Tolga Turgut, Uzma Ahmed, Melissa Kachura, Lauren Kraemer, Charmaine Nganje, Meghan Hart, et al. (+11)
432 [GO] 2022―Dec―15 1971. Severity of Self-Reported Systemic Reactions Following SARS-CoV-2 Vaccination and Immunological Response in the Danish National Cohort Study of Effectiveness and Safety of SARS-CoV-2/COVID-19 Vaccines (ENFORCE) Wendy P Bannister
433 [GO] 2022―Dec―15 585. Safety and Immunogenicity of SARS-CoV-2 Vaccination in Children with a History of MIS-C Harrison L Howe, Justin Z Amarin, Haya Hayek, Rana Talj, Andrew J Spieker, Sophie E Katz, et al. (+13)
434 [GO] 2022―Dec―15 1949. Evaluation of cellular and humoral immune-responses at different times after SARS-COV-2 vaccination in health care workers cohort Chiara Dentone, Daniela Fenoglio, Matteo Cerchiaro, Marta Ponzano, Tiziana Altosole, Diego Franciotta, et al. (+14)
435 [GO] 2022―Dec―15 1932. Antibody Response to SARS-CoV-2 Vaccination in US Veterans Living with HIV Alexander Njoroge, Florence M Ford, George Psevdos
436 [GO] 2022―Dec―15 1395. COVID 19 Incidence rates were not different among high risk health-care workers and non-health workers after SARS-CoV-2 vaccination: a prospective study in Cali-Colombia. Fernando Rosso, Laura A Torres-Canchala, Isabel L Zapata-Vasquez, Julio Llanos-Torres, Eric Tafur, Jenny P Muñoz-Lombo, et al. (+2)
437 [GO] 2022―Dec―15 1955. Immunogenicity And Safety of a Virus-Like Particle (VLP) Protein Subunit SARS-CoV-2 Vaccine in Adults: a Phase 1/2 Study Robert Scott, Susan Thackwray, Nicholas Hourguettes, Huub Gelderblom, Niranjan Kanesa-thasan
438 [GO] 2022―Dec―15 1073. SARS-CoV-2 Vaccine-Induced Immunogenicity among Hematopoietic Stem Cell Transplant Recipients (HSCT) Afoke Kokogho, Muneerah M Aleissa, Jun Bai Park Chang, Stephen R Walsh, Trevor A Crowell, Lindsey R Baden, Amy C Sherman
439 [GO] 2022―Dec―15 1525. The Impact of Traveler-Based Genomic Surveillance on SARS-CoV-2 Variant Detection in Arriving International Air Travelers- United States, November 29, 2021-April 24, 2022 Grace D Appiah, Teresa C Smith, Renee Wegrzyn, Robert C Morfino, Sarah Guagliardo, Scott Milford, et al. (+23)
440 [GO] 2022―Dec―15 1964. Pre-existing Population Immunity and SARS-CoV-2 Variant Dynamics in the United States: An Ecological Study Pierre Ankomah, Mark Siedner, Roby P Bhattacharyya
441 [GO] 2022―Dec―15 1135. Monoclonal Antibody Therapeutics in US Veterans against Delta and Omicron SARS-CoV-2 Variants Inderjit Mann, Morgan Froehlich, Audun J Lier, George Psevdos
442 [GO] 2022―Dec―15 246. Cardiac involvement in children with multisystem inflammatory syndrome (MIS-C) following infection with different SARS-CoV-2 variants Swetha Pinninti, Camden Hebson, Connie Trieu, Sushma Boppana, Markus Buchfellner, April Yarbrough, et al. (+5)
443 [GO] 2022―Dec―15 1896. Statewide Genomic Surveillance of SARS-CoV-2 Variants in Rhode Island Manjot Singh, Vladimir Novitsky, Mark Howison, Kristin Carpenter-Azevedo, Richard Huard, Ewa King, Rami Kantor
444 [GO] 2022―Dec―15 1096. Riding the Waves: Infection by SARS-CoV-2 Variants in Solid Organ Transplant Recipients at Texas Children’s Hospital Leanne Buffaloe, Claire Bocchini, Elizabeth A Moulton, Daniel Ruderfer, Kristen Valencia Deray, Flor M Munoz
445 [GO] 2022―Dec―15 1978. Vaccine effect on household transmission of omicron and delta SARS-CoV-2 variants in South Korea Yong Chan Kim, Bongyoung Kim, Nak-Hoon Son, Namwoo Heo, Yoon Soo Park, Heejung Kim
446 [GO] 2022―Dec―15 1057. Development of a Flow Cytometry-Based Micro-Neutralisation Assay to Evaluate Humoral Immunity Against SARS-CoV-2 Variants of Concern in Vaccine Trials Sophie R O’Reilly, Grace Kenny, Tamara Alrawahneh, Nathan Francois, Matthew Angeliadis, Valentin de Masson d’Autume, et al. (+9)
447 [GO] 2022―Dec―15 2164. Shared and Specific Systemic Cytokine Responses in Infants Hospitalized with SARS-CoV-2 versus RSV Infection Raquel Giacomelli Cao, Zhaohui Xu, Fang Ye, Sara Mertz, Shira H Cohen, Traci Pifer, et al. (+4)
448 [GO] 2022―Dec―15 243. Association Between SARS-CoV-2 Viral Load and Patient Symptoms and Clinical Outcomes Using Droplet Digital PCR Elizabeth Hastie, Harold Amogan, David Looney, Sanjay R Mehta
449 [GO] 2022―Dec―15 315. Standardized Measurement of SARS-CoV-2 Viral Load Over Time in Respiratory Compartments and in Response to Remdesivir Treatment Curt Beckwith, Soya Sam, Vladimir Novitsky, Jimin Shin, Kevin Lethbridge, Jon Steingrimsson, et al. (+11)
450 [GO] 2022―Dec―15 1056. Correlates of Omicron SARS-CoV-2 viral load: diagnostic and clinical implications Simon Pollett, Stephanie A Richard, Anthony C Fries, Allison M Malloy, Anuradha Ganesan, Jeffrey Livezey, et al. (+14)
451 [GO] 2022―Dec―15 2129. Maternal Transmission of SARS-CoV-2-specific Antibodies, but not Cytokines/Chemokines to Neonates Following Infection and Vaccination During Pregnancy Jonathon M Monroe, Sohan Punia, Huy Quang Quach, Elizabeth A Enninga, Yaroslav Fedyshyn, Bohdana Fedyshyn, et al. (+12)
452 [GO] 2022―Dec―15 1050. Breath Sample Collection from Individuals Infected with SARS-CoV-2: Biosafety Methodology Marcela Lopez, Marcela Lopez, Emma Stainton, Leanne X Chun, Grace K Tam, Rosita Thiessen, et al. (+11)
453 [GO] 2022―Dec―15 1930. Answering the Call: Inpatient Vaccination for SARS-CoV2 Infection in an Academic Hospital Benjamin Albrecht, Sarah B Green, Peter Moran, Morgan E Corkish, Carrie Tilton, Ashley Rizzo, et al. (+11)
454 [GO] 2022―Dec―15 2084. Importance of the Primary Care Physician in HIV PrEP Adherence During a Pandemic Isaac Daudelin, Bret McCarty, Shawn K Ahmad Chaustre, Diana Finkel
455 [GO] 2022―Dec―15 1760. Selection of appropriate inpatients for outpatient parenteral antimicrobial therapy (OPAT) during the COVID pandemic Angela Y McKnight, Angelike P Liappis, Ayne Adenew
456 [GO] 2022―Dec―15 1290. A Structural Intervention Improves ID Fellow Wellness Amid a Pandemic Michael Czapka, Christopher J Lehmann, Erica MacKenzie, Elizabeth Bell, John Flores, Aniruddha Hazra
457 [GO] 2022―Dec―15 950. Impact of the COVID 19 pandemic on antimicrobial stewardship program, broad-spectrum antibiotics consumption and Clostridioides difficile diarrhea incidence Jose Luis Lamas Ferreiro, Judith Álvarez Otero, Ana Sanjurjo Rivo, Ignacio Enríquez de Salamanca Holzinger, Jorge Cavero, Jose Carlos de Miguel Bouzas, et al. (+5)
458 [GO] 2022―Dec―15 1357. Collateral consequence of COVID pandemic: Increased incidence of cat scratch disease. Maria L Praino, Peditric Infectologist, Grigioni Julia, Peditric Infectologist, Soledad Tineo, Peditric Infectologist, et al. (+7)
459 [GO] 2022―Dec―14 Tale of the Titers: Serologic Testing for SARS-CoV-2 -Yes, No, and Maybe, with Clinical Examples from the IDSA Diagnostics Committee Robert Colgrove, Lou Ann Bruno-Murtha, Cody A Chastain, Kimberly E Hanson, Francesca Lee, Audrey R Odom John, Romney Humphries
460 [GO] 2022―Dec―07 Immune-based therapy for hospitalized patients with COVID-19 and risk of secondary infections: A systematic review and meta-analysis Dima Kabbani, Ashlesha Sonpar, Benson Weyant, Keith C K Lau, Mark Robbins, Sandra Campbell, et al. (+6)
461 [GO] 2022―Dec―01 Meeting the Challenges of Sepsis in Severe COVID-19: A Call to Arms Thomas J Walsh, Rick A Bright, Aparna Ahuja, Matthew W McCarthy, Richard A Marfuggi, Steven Q Simpson
462 [GO] 2022―Nov―30 Younger Children Develop Higher Effector Antibody Responses to SARS-CoV-2 Infection Lisa Tomasi, Anais Thiriard, Leo Heyndrickx, Daphnée Georges, Sigi Van den Wijngaert, Véronique Olislagers, et al. (+6)
463 [GO] 2022―Nov―28 High co-circulation of influenza and SARS-CoV-2 John T Kubale, Aaron M Frutos, Angel Balmaseda, Cristhiam Cerpas, Saira Saborio, Sergio Ojeda, et al. (+10)
464 [GO] 2022―Nov―24 Impact of COVID-19 Pandemic on Antiretroviral Therapy Initiation and Care Delivery for Newly Diagnosed HIV in an Integrated Health Care System Kurtis B Mohr, Christian Lee-Rodriguez, Zahra Samiezade-Yazd, Jennifer O Lam, Brandon M Imp, Mitchell N Luu
465 [GO] 2022―Nov―24 Statistical analysis of mortality rates of COVID-19 patients in Japan across the 4C mortality score risk groups, age groups, and epidemiological waves: A report from the nationwide COVID-19 cohort Hiroaki Baba, Saori Ikumi, Shotaro Aoyama, Tetsuo Ishikawa, Yusuke Asai, Nobuaki Matsunaga, et al. (+5)
466 [GO] 2022―Nov―24 Effectiveness of a third dose of COVID-19 mRNA vaccine during the Omicron BA.1- and BA.2-predominant periods in Japan: The VENUS Study Wataru Mimura, Chieko Ishiguro, Megumi Maeda, Fumiko Murata, Haruhisa Fukuda
467 [GO] 2022―Nov―22 Real-world evidence of novel treatments for COVID-19 on mortality: a nationwide comparative cohort study of hospitalized patients in the 1st, 2nd, 3rd and 4th wave in the Netherlands M A Slim, B Appelman, H Peters-Sengers, D A Dongelmans, N F de Keizer, R P Schade, et al. (+5)
468 [GO] 2022―Nov―21 Post Intensive Care Syndrome (PICS) among survivors in a safety net hospital in South Bronx -a comparison of patients with and without COVID-19 Sebastian Ocrospoma Heraud, Virali Shah, Victor Perez-Gutierez, Mohannad Al-Khateeb, Sebastian Gandarillas Fraga, Afsheen Afzal, et al. (+8)
469 [GO] 2022―Nov―20 Strong neutralizing antibody responses to SARS-CoV-2 variants following a single vaccine dose in subjects with previous SARS-CoV-2 infection Nina Ekström, Anu Haveri, Anna Solastie, Camilla Virta, Pamela Österlund, Hanna Nohynek, et al. (+8)
470 [GO] 2022―Nov―11 Predictors of SARS-CoV-2 RNA from nasopharyngeal swabs and concordance with other compartments in non-hospitalized adults with mild to moderate COVID-19 Carlee Moser, Jonathan Z Li, Joseph J Eron, Evgenia Aga, Eric S Daar, David A Wohl, et al. (+11)
471 [GO] 2022―Nov―11 Persistence of neutralizing antibodies and clinical protection up to 12 months after SARS-CoV-2 infection in elderly R Collarino, C Vauloup-Fellous, A Allemang-Trivalle, L Mouna, E P Baudouin, H Keravec, et al. (+10)
472 [GO] 2022―Nov―10 Subgenomic RNA abundance relative to total viral RNA among SARS-CoV-2 variants Maxwell Su, Sara Ping, Phuong-Vi Nguyen, Alejandra Rojas, Laila Hussaini, Ludy Registre Carmola, et al. (+8)
473 [GO] 2022―Nov―08 A Systematic Review of COVID-19 Vaccine Antibody Responses in People Living with HIV Helen M Chun, Kyle Milligan, Elfriede Agyemang, Nathan Ford, Ajay Rangaraj, Shalini Desai, et al. (+3)
474 [GO] 2022―Nov―07 Global emergence of resistance to fluconazole and voriconazole in Candida parapsilosis in tertiary hospitals in Spain during the COVID-19 pandemic Nuria Trevijano-Contador, Alba Torres-Cano, Cristina Carballo-González, Mireia Puig-Asensio, María Teresa Martín-Gómez, Emilio Jiménez-Martínez, et al. (+30)
475 [GO] 2022―Nov―03 Lung abnormalities in SARS-CoV-2 infection: An analysis of paired computed tomography scans before and after infection. Katrine K Iversen, Andreas Ronit, Thomas S Kristensen, Shoaib Afzal, Jelena Jankovic, Anna Kalhauge, et al. (+4)
476 [GO] 2022―Nov―02 Risk factors for severe COVID-19 among HIV-infected and-uninfected individuals in South Africa, April 2020- March 2022 - data from sentinel surveillance Sibongile Walaza, Stefano Tempia, Anne von Gottberg, Nicole Wolter, Jinal N Bhiman, Amelia Buys, et al. (+14)
477 [GO] 2022―Oct―31 Correction to: Treating COVID-19 With Hydroxychloroquine (TEACH): A Multicenter, Double-Blind Randomized Controlled Trial in Hospitalized Patients
478 [GO] 2022―Oct―31 Genomic Investigation to Identify Sources of SARS-CoV-2 Infection Among Healthcare Personnel in an Acute Care Hospital Sarah E Sansom, Hannah Barbian, Mary K Hayden, Christine Fukuda, Nicholas M Moore, Lahari Thotapalli, et al. (+4)
479 [GO] 2022―Oct―31 Correction to: SARS-CoV-2 Surface Swabs in Locations With Public Access- Potential for Improved Source Control
480 [GO] 2022―Oct―27 Bebtelovimab for high-risk outpatients with early COVID-19 in a large US health system Scott Dryden-Peterson, Andy Kim, Mary-Ruth Joyce, Jennifer A Johnson, Arthur Y Kim, Lindsey R Baden, Ann E Woolley
481 [GO] 2022―Oct―22 Impact of the COVID-19 pandemic on the clinical features of pediatric RSV infection in Japan Shoko Ozeki, Jun-ichi Kawada, Daiki Yamashita, Chika Yasufuku, Takuya Akano, Masahiro Kato, et al. (+10)
482 [GO] 2022―Oct―22 Evaluation of SARS-CoV-2 nucleocapsid antigen in the blood as a diagnostic test for infection and infectious viral shedding Sujata Mathur, Michelle C Davidson, Khamal Anglin, Scott Lu, Sarah A Goldberg, Miguel Garcia-Knight, et al. (+21)
483 [GO] 2022―Oct―22 Comparison of SARS-CoV-2 viral loads in the nasal mucosa of patients infected with BA.1, BA.2 or BA.5 Omicron lineages Kyla Tozer, Calvin P Sjaarda, Emily Moslinger, Henry Wong, Samira Mubareka, Finlay Maguire, et al. (+4)
484 [GO] 2022―Oct―19 Prevalence and Factors Associated With Antigen Test Positivity Following SARS-CoV-2 Infection Among Health Care Workers in Los Angeles Paul C Adamson, Judith S Currier, Daniel Z Uslan, Omai B Garner
485 [GO] 2022―Oct―17 A multicenter comparison of prevalence and predictors of antimicrobial resistance in hospitalized patients before and during the SARS-CoV-2 pandemic Karri A Bauer, Laura A Puzniak, Kalvin C Yu, Kenneth P Klinker, Janet Watts, Pamela A Moise, et al. (+3)
486 [GO] 2022―Oct―17 Effect of SARS-CoV-2 vaccine booster on HIV reservoirs and immune markers M Ali Rai, Victoria Shi, Brooke D Kennedy, Jesse S Justement, Kathleen Gittens, Genevieve McCormack, et al. (+3)
487 [GO] 2022―Oct―10 Viral co-infections in hospitalised COVID-19 patients recruited to the ISARIC WHO CCP-UK study Elen Vink, Chris Davis, Alasdair MacLean, David Pascall, Sarah E McDonald, Rory Gunson, et al. (+6)
488 [GO] 2022―Oct―06 Host biomarkers reflect prognosis in patients presenting with moderate Covid-19 - a prospective cohort study Arjun Chandna, Raman Mahajan, Priyanka Gautam, Lazaro Mwandigha, Pragya Kumar, George M Varghese, et al. (+3)
489 [GO] 2022―Oct―06 Demographics and outcomes of initial phase of COVID-19 Medicines Delivery Units across 4 UK centres during peak B1.1.529 omicron epidemic: a service evaluation. M Brown, J Saund, A Qureshi, M Plowright, K Drury, J Gahir, et al. (+11)
490 [GO] 2022―Oct―06 Early outpatient treatment with remdesivir in patients at high risk for severe COVID-19: a prospective cohort study Sandra Rajme-López, Bernardo A Martinez-Guerra, Jessica Zalapa-Soto, Carla M Román-Montes, Karla M Tamez-Torres, María F González-Lara, et al. (+5)
491 [GO] 2022―Oct―06 Real-world Clinical Outcomes of Bebtelovimab and Sotrovimab Treatment of High-risk Persons With Coronavirus Disease 2019 During the Omicron Epoch Raymund R Razonable, Sidna M Tulledge-Scheitel, Sara N Hanson, Richard F Arndt, Leigh L Speicher, Teresa A Seville, et al. (+3)
492 [GO] 2022―Oct―05 Relative Risks of COVID-19-Associated Hospitalizations and Clinical Outcomes by Age and Race/Ethnicity-March 2020-March 2021 Catherine H Bozio, Kristen Butterfield, Stephanie A Irving, Gabriela Vazquez-Benitez, Toan C Ong, Kai Zheng, et al. (+4)
493 [GO] 2022―Oct―05 Misdiagnoses in the context of suspected pandemic influenza or COVID-19: A systematic review Lucy Bray, Katerina Meznikova, Daniel James, Razan Rislan, Rahul Shah, Pavan Mason, et al. (+4)
494 [GO] 2022―Oct―05 At-home Testing and Risk Factors for Acquisition of SARS-CoV-2 Infection in a Major US Metropolitan Area Ann E Woolley, Scott Dryden-Peterson, Andy Kim, Sarah Naz-McLean, Christina Kelly, Hannah H Laibinis, et al. (+9)
495 [GO] 2022―Oct―01 Discriminatory ability of gas chromatography-ion mobility spectrometry to identify patients hospitalised with COVID-19 and predict prognosis Joshua Nazareth, Daniel Pan, Jee Whang Kim, Jack Leach, James G Brosnan, Adam Ahmed, et al. (+10)
496 [GO] 2022―Oct―01 Evaluation of Bebtelovimab for Treatment of COVID-19 During the SARS-CoV-2 Omicron Variant Era Erin K McCreary, Kevin E Kip, Kevin Collins, Tami E Minnier, Graham M Snyder, Ashley Steiner, et al. (+12)
497 [GO] 2022―Sep―30 Predictors of SARS-CoV-2 seropositivity prior to COVID-19 vaccination among children 0-4 years and their household members in the SEARCh Study Maria Garcia Quesada, Marissa K Hetrich, Scott Zeger, Jayati Sharma, Yu Bin Na, Vic Veguilla, et al. (+19)
498 [GO] 2022―Sep―29 Population-based evaluation of post-acute COVID-19 chronic sequelae in patients who tested positive for SARS-CoV-2 Nicole H Goldhaber, W Scott Ogan, Andrew Greaves, Ming Tai-Seale, Amy Sitapati, Christopher A Longhurst, Lucy E Horton
499 [GO] 2022―Sep―27 Podcast 39: Marginalized communities and the disproportionate impacts of AIDS, COVID-19, and monkeypox - An interview with Gregg Gonsalves
500 [GO] 2022―Sep―27 mRNA vaccination decreases COVID-19-associated morbidity and mortality among organ transplant recipients: a contemporary cohort study Alexis Hope Lerner, Panos Arvanitis, Kendra Vieira, Elizabeth Jessica Klein, Dimitrios Farmakiotis
501 [GO] 2022―Sep―27 Successful Treatment of Delayed Localized Necrotizing Inflammatory Myositis after SARS-CoV-2 mRNA-1273 (“Moderna”) Vaccine: A Case Report Jennifer Chen Li, Jonathan Siglin, Michael S Marshall, Anat Stemmer-Rachamimov, Seth M Bloom, Kimberly G Blumenthal
502 [GO] 2022―Sep―23 Correlation of post-vaccination fever with specific antibody response to SARS-CoV-2 BNT162b2 booster and no significant influence of antipyretic medication Naoki Tani, Hideyuki Ikematsu, Takeyuki Goto, Kei Gondo, Takeru Inoue, Yuki Yanagihara, et al. (+9)
503 [GO] 2022―Sep―21 Prediction of Symptomatic SARS-CoV-2 infection by Quantitative Digital PCR Normalized to International Units Diego R Hijano, Zhengming Gu, Jessica Brazelton de Cardenas, Haiqing Zhu, Sri Suganda, Heather L Glasgow, et al. (+10)
504 [GO] 2022―Sep―20 Prolonged SARS-CoV-2 Delta Variant Shedding in a Patient with AIDS; Case Report and Review of the Literature Jillian L Peters, Amary Fall, Steven D Langerman, Margueritta El Asmar, Mari Nakazawa, Aishat Mustapha, et al. (+3)
505 [GO] 2022―Sep―12 Oral Polio Vaccine (OPV) to mitigate the risk of illness and mortality during the COVID-19 pandemic: A cluster-randomised trial in Guinea-Bissau Ane B Fisker, Justiniano S D Martins, Line M Nanque, Andreas M Jensen, Elsi J C Ca, Sebastian Nielsen, et al. (+2)
506 [GO] 2022―Sep―12 Risk of Long Covid in people infected with SARS-CoV-2 after two doses of a COVID-19 vaccine: community-based, matched cohort study Daniel Ayoubkhani, Matthew L Bosworth, Sasha King, Koen B Pouwels, Myer Glickman, Vahé Nafilyan, et al. (+4)
507 [GO] 2022―Sep―11 Correlation of SARS-CoV-2 Nasopharyngeal CT-values to Viremia and Mortality in Adults Hospitalised with Covid-19 Karl Hagman, Magnus Hedenstierna, Jacob Oesman, Emelie Arvidsson, Berit Hammas, Lena Grillner, et al. (+3)
508 [GO] 2022―Sep―11 Impact of a Pharmacist Managed Procalcitonin Program on COVID-19 Respiratory Tract Infection Outcomes and Healthcare Resource Utilization Andrew J FRATONI, Abigail K KOIS, Jessica L COLMERAUER, Kristin E LINDER, David P NICOLAU, Joseph L KUTI
509 [GO] 2022―Sep―11 COVID-19 vaccine effectiveness against progression to in-hospital mortality in Zambia, 2021-2022 Duncan Chanda, Jonas Z Hines, Megumi Itoh, Sombo Fwoloshi, Peter A Minchella, Khozya D Zyambo, et al. (+11)
510 [GO] 2022―Sep―07 Effectiveness of COVID-19 vaccines over time prior to Omicron emergence in Ontario, Canada: test-negative design study Hannah Chung, Peter C Austin, Kevin A Brown, Sarah A Buchan, Deshayne B Fell, Cindy Fong, et al. (+8)
511 [GO] 2022―Sep―07 Feasibility of At-Home Virological and Serological Testing for SARS-CoV-2 in Children Amina Ahmed, Whitney Rossman, Lauren C Lu, Connell O Dunn, Anna M Harris, Jennifer S Priem, et al. (+6)
512 [GO] 2022―Sep―02 High risk of secondary infections following thrombotic complications in patients with COVID-19 Marco Ripa, Laura Galli, Armando D’Angelo, Luca Apruzzi, Diego Palumbo, Corrado Campochiaro, et al. (+19)
513 [GO] 2022―Sep―02 Manufacturing Process of SER-109, a Purified Investigational Microbiome Therapeutic, Reduces Risk of Coronavirus Transmission from Donor Stool Christopher McChalicher, Ahmad Abdulaziz, S Steve Zhou, Mary Jane Lombardo, Brooke Hasson, John G Auniņš, et al. (+2)
514 [GO] 2022―Sep―01 Using a cloud-based machine-learning classification tree analysis to understand the demographic characteristics associated with COVID-19 booster vaccination among adults in the United States Lu Meng, Hannah E Fast, Ryan Saelee, Elizabeth Zell, Bhavini Patel Murthy, Neil Chandra Murthy, et al. (+5)
515 [GO] 2022―Aug―29 SARS-CoV-2 surface swabs in locations with public access - potential for improved source control Jacob PS Nielsen, Johannes R Madsen, Kamille Fogh, Emma H Mikkelsen, Emil Wolsk, Nikolai S Kirkby, et al. (+2)
516 [GO] 2022―Aug―25 Dying at Home Due to COVID-19 Jessie K Edwards, Wohl David Alain
517 [GO] 2022―Aug―25 Reduction in risk of death among patients admitted with COVID-19 between first and second epidemic waves in New York City Anthony Bowen, Jason Zucker, Yanhan Shen, Simian Huang, Qiheng Yan, Medini K Annavajhala, et al. (+4)
518 [GO] 2022―Aug―25 Surge in Incidence and COVID-19 Hospital Risk of Death, United States, September 2020 to March 2021 Bela Patel, Robert E Murphy, Siddharth Karanth, Salsawit Shiffaraw, Richard M Peters, Samuel F Hohmann, Raymond S Greenberg
519 [GO] 2022―Aug―25 Prevalence and Health Outcomes of Clostridioides difficile Infection during the COVID-19 Pandemic in a National Sample of United States Hospital Systems Kelly R Reveles, Alexa L Frei, Kelsey A Strey, Eric H Young
520 [GO] 2022―Aug―25 Detection of viral infection and bacterial co- and superinfection in COVID-19 patients presenting to the emergency department using the 29-mRNA host response classifier BVN-3 - a multicenter study Wolfgang Bauer, Sven Gläser, Dorina Thiemig, Katrin Wanner, Alexander Peric, Steffen Behrens, et al. (+9)
521 [GO] 2022―Aug―25 Description of Hospitalizations due to the SARS-CoV-2 Omicron Variant Based on Vaccination Status Matthew A Moffa, Nathan R Shively, Dustin R Carr, Derek N Bremmer, Carley Buchanan, Tamara L Trienski, et al. (+3)
522 [GO] 2022―Aug―24 MR-proADM Biomarker Predicts COVID-19 Clinical Outcomes: a US-based Cohort Study Natalie J Atallah, Vahe S Panossian, Christine J Atallah, Andrej Schwabe, Sascha Johannes, Jan Wiemer, Michael K Mansour
523 [GO] 2022―Aug―23 Sexually transmitted infection testing in the national Veterans Health Administration patient cohort during the COVID-19 pandemic Lauren A Beste, Shimrit Keddem, Joleen Borgerding, Elliott Lowy, Carolyn Gardella, Lorenzo McFarland, et al. (+7)
524 [GO] 2022―Aug―22 Efficacy of Approved versus Unapproved Vaccines for SARS-CoV-2 Infection in Randomised Blinded Clinical Trials Andrea Perez Navarro, Victoria Pilkington, Toby Pepperrell, Manya Mirchandani, Jacob Levi, Andrew Hill
525 [GO] 2022―Aug―20 Impact of innate immunity, endothelial damage, and metabolic biomarkers on COVID-19 severity and mortality Joseph M Rocco, Paola Laghetti, Mariantonietta Di Stefano, Irini Sereti, Ana Ortega-Villa, Jing Wang, et al. (+9)
526 [GO] 2022―Aug―17 Nucleocapsid antigenemia in patients receiving anti-CD20 therapy with protracted COVID-19 Eli Wilber, Anne Piantadosi, Ahmed Babiker, Kaleb McLendon, William O’Sick, Eric Fitts, et al. (+11)
527 [GO] 2022―Aug―17 Post Lung Transplantation Outcomes and Ex Vivo Histopathological Findings in Severe Post COVID-19 Pulmonary Disease - A Single Center Experience Hana Javaid, Masayuki Nigo, Bihong Zhao, Daniel Ocazionez Trujillo, Rodrigo Hasbun, Luis Ostrosky-Zeichner, et al. (+2)
528 [GO] 2022―Aug―16 Homologous and heterologous boosting of the ChAdOx1-S1-S COVID-19 vaccine with the SCB-2019 vaccine candidate: a randomized, controlled, phase 2 study Sue Ann Costa Clemens, Eveline Pipolo Milan, Eduardo Sprinz, José Cerbino Neto, Filippo Pacciarini, Ping Li, et al. (+4)
529 [GO] 2022―Aug―16 Immunogenicity of a three-dose primary series of mRNA COVID-19 vaccines in patients with lymphoid malignancies Amy C Sherman, Jennifer L Crombie, Chi An Cheng, Michaël Desjardins, Guohai Zhou, Omolola Ometoruwa, et al. (+13)
530 [GO] 2022―Aug―09 Correction to: An Analysis of SARS-CoV-2 Vaccine Reactogenicity: Variation by Type, Dose, and History, Severity, and Recency of Prior SARS-CoV-2 Infection
531 [GO] 2022―Aug―09 Impact of age and symptom development on SARS-CoV-2 transmission in households with children-Maryland, New York, and Utah, August 2020-October 2021 Kelsey M Sumner, Ruth A Karron, Melissa S Stockwell, Fatimah S Dawood, Joseph B Stanford, Alexandra Mellis, et al. (+19)
532 [GO] 2022―Aug―08 A Randomized Clinical Trial of Regdanvimab in High-Risk Patients with Mild-to-Moderate COVID-19 Jin Yong Kim, Oana Săndulescu, Liliana Lucia Preotescu, Norma E Rivera-Martínez, Marta Dobryanska, Victoria Birlutiu, et al. (+18)
533 [GO] 2022―Aug―06 Correction to: SARS-CoV-2 mRNA Vaccine Effectiveness in Health Care Workers by Dosing Interval and Time Since Vaccination: Test-Negative Design, British Columbia, Canada
534 [GO] 2022―Aug―05 Long COVID symptomatology after twelve months and its impact on quality of life according to initial COVID-19 disease severity Aurélie Fischer, Lu Zhang, Abir Elbéji, Paul Wilmes, Pauline Oustric, Therese Staub, et al. (+3)
535 [GO] 2022―Aug―03 Prevalence of medical contraindications to nirmatrelvir/ritonavir in a cohort of hospitalized and non-hospitalized patients with COVID-19 Sarah Lim, Christopher J Tignanelli, Nicolas Hoertel, David R Boulware, Michael G Usher
536 [GO] 2022―Aug―03 High-risk US international travelers seeking pretravel consultation during the COVID-19 pandemic Emily P Hyle, Mylinh H Le, Sowmya R Rao, Nora M Mulroy, Allison T Walker, Edward T Ryan, Regina C LaRocque
537 [GO] 2022―Jul―30 Applying lessons learned from COVID-19 therapeutic trials to improve future ALI/ARDS trials Qun Wu, Meghan E Pennini, Julie N Bergmann, Marina L Kozak, Kristen Herring, Kimberly L Sciarretta, Kimberly L Armstrong
538 [GO] 2022―Jul―29 Extended Remdesivir Infusion for Persistent COVID-19 Infection Mario A Martinez, Ting Yi Chen, Hosoon Choi, Munok Hwang, Dhammika Navarathna, Linhue Hao, et al. (+4)
539 [GO] 2022―Jul―28 Correction to: Risk Factors Associated With Hospitalization and Death in COVID-19 Breakthrough Infections
540 [GO] 2022―Jul―27 Correction to: 604. Impact of COVID-19 Pandemic on Telehealth Practices in Pediatric Infectious Diseases
541 [GO] 2022―Jul―26 Cognitive Impairment 13 Months After Hospitalization for COVID-19 Knut Stavem, Gunnar Einvik, Christofer Lundqvist
542 [GO] 2022―Jul―26 Sensitivity of the Elecsys Nucleocapsid Assay for the Detection of Preceding SARS-CoV-2 Infections Brian Grunau, Janessa Tom, Michael Asamoah-Boaheng, Sheila F O’Brien, Steven J Drews, Sadaf Sediqi, et al. (+3)
543 [GO] 2022―Jul―25 Adjunctive Recombinant Human Plasma Gelsolin for Severe COVID-19 Pneumonia Mark J DiNubile, Sandra Parra, Antoni Castro Salomó, Susan L Levinson
544 [GO] 2022―Jul―25 Aggregating human judgment probabilistic predictions of COVID-19 transmission, burden, and preventative measures Allison Codi, Damon Luk, David Braun, Juan Cambeiro, Tamay Besiroglu, Eva Chen, et al. (+3)
545 [GO] 2022―Jul―25 Escape of SARS-CoV-2 variant Omicron to mucosal immunity in vaccinated subjects Emanuela MARTINUZZI, Jacques BOUTROS, Nicolas GLAICHENHAUS, Charles Hugo MARQUETTE, Paul HOFMAN, Jonathan BENZAQUEN
546 [GO] 2022―Jul―22 Missed opportunity, the unseen driver for low COVID-19 vaccination rates in underserved patients Tania Campagnoli, Geetika Mohan, Nigist Taddese, Yaveen Santhiraj, Natasa Margeta, Saad Alvi, et al. (+4)
547 [GO] 2022―Jul―20 Examination of Common Coronavirus Antibodies in SARS-CoV-2-Infected and Uninfected Participants in a Household Transmission Investigation Megan M Stumpf, Brandi Freeman, Lisa Mills, Sandra Lester, Victoria T Chu, Hannah L Kirking, et al. (+2)
548 [GO] 2022―Jul―05 A More Accurate Measurement of the Burden of COVID-19 Hospitalizations Christina Vu, Eric S Kawaguchi, Cesar H Torres, Austin H Lee, Noah Wald-Dickler, Paul D Holtom, et al. (+3)
549 [GO] 2022―Jul―04 Prevalence of and factors associated with post-COVID-19 condition in the 12 months following the diagnosis of COVID-19 in adults followed in general practices in Germany Karel Kostev, Lee Smith, Ai Koyanagi, Louis Jacob
550 [GO] 2022―Jun―30 Risk Factors for Admission Within a Hospital-Based COVID-19 Home Monitoring Program Heather Sperring, Melissa Hofman, Heather E Hsu, Yian Xiao, Elizabeth A Keohane, Sara Lodi, et al. (+2)
551 [GO] 2022―Jun―28 An Analysis of SARS-CoV-2 Vaccine Reactogenicity: Variation by Type, Dose, and History, Severity, and Recency of Prior SARS-CoV-2 Infection Ann I Scher, Catherine M Berjohn, Celia Byrne, Rhonda E Colombo, Christopher J Colombo, Margaret Sanchez Edwards, et al. (+19)
552 [GO] 2022―Jun―24 Comparative COVID-19 Vaccine Effectiveness over Time in Veterans Florian B Mayr, Victor B Talisa, Obaid Shaikh, Saad B Omer, Adeel A Butt, Sachin Yende
553 [GO] 2022―Jun―23 Factors Associated with Hospitalization with Symptomatic COVID-19 Illness Among Pregnant Individuals: A Multi-Center Retrospective Cohort Study Carmen Sofia Arriola, De Kun Li, Flor Muñoz, Michael Daugherty, Caroline Doughty-Skierski, Sascha Ellington, et al. (+15)
554 [GO] 2022―Jun―23 Nationwide Implementation of Nonpharmaceutical Interventions During the Coronavirus Disease 2019 Pandemic Is Associated With Decreased Incidence of Pneumocystis jirovecii Pneumonia in Kidney Transplant Recipients Keun Hyung Park, Chan-Young Jung, Wonjeong Jeong, Gongmyung Lee, Jae Seok Yang, Chung Mo Nam, et al. (+2)
555 [GO] 2022―Jun―17 US County-level COVID-19 Vaccine Uptake and Rates of Omicron Cases and Deaths John M McLaughlin, Timothy L Wiemken, Farid Khan, Luis Jodar
556 [GO] 2022―Jun―15 Decreased Risk of COVID-19-Related Hospitalization Associated with Omicron Variant of SARS-CoV-2 Jessica P Ridgway, Samuel Tideman, Bill Wright, Ari Robicsek
557 [GO] 2022―Jun―10 Outcomes of Cytomegalovirus Viremia Treatment in Critically Ill Patients with COVID-19 Infection Scott Schoninger, Yanina Dubrovskaya, Kassandra Marsh, Diana Altshuler, Prithiv Prasad, Eddie Louie, et al. (+4)
558 [GO] 2022―Jun―07 Projected Effects of Disruptions to HIV Prevention Services During the COVID-19 Pandemic Among Black/African American Men Who Have Sex with Men in an Ending the HIV Epidemic Priority Jurisdiction Jennifer Labs, Amy S. Nunn, Philip A. Chan, S. Bessey, Carolyn J. Park, Brandon D. L. Marshall, et al. (+3)
559 [GO] 2022―Jun―07 COVID-19 patient reported symptoms using FLU-PRO Plus in a cohort study: associations with infecting genotype, vaccine history, and return-to-health Stephanie A. Richard, Nusrat J. Epsi, David A. Lindholm, Allison M. W. Malloy, Ryan C. Maves, Catherine M. Berjohn, et al. (+23)
560 [GO] 2022―Jun―07 Real-World Experience of Sotrovimab in High-Risk, Immunocompromised COVID-19 Patients Navina K. Birk, Saniya Jain, Louis Massoud, Diya Ramesh, Lea Monday, Bruce Muma, et al. (+3)
561 [GO] 2022―Jun―07 In-Hospital Mortality Among Hospitalized COVID-19 Patients in the United States: How did it change in 2021? Rena C. Moon, Ning A. Rosenthal
562 [GO] 2022―Jun―07 Efficacy and safety of intensified versus standard prophylactic anticoagulation therapy in patients with Covid-19: a systematic review and meta-analysis Nicola K Wills, Nikhil Nair, Kashyap Patel, Omaike Sikder, Marguerite Adriaanse, John Eikelboom, Sean Wasserman
563 [GO] 2022―Jun―07 Characterization of early-onset SARS-CoV-2 infection in immunocompromised patients who received tixagevimab-cilgavimab prophylaxis Eloy E. Ordaya, Elena Beam, Joseph D. Yao, Raymund R. Razonable, Paschalis Vergidis
564 [GO] 2022―Jun―06 The Politicization of Ivermectin Tweets during the COVID-19 Pandemic Marlon I. Diaz, John J. Hanna, Amy E. Hughes, Christoph U. Lehmann, Richard J. Medford
565 [GO] 2022―May―31 Genomic surveillance of SARS-CoV-2 in a university community: insights into tracking variants, transmission, and spread of Gamma (P.1) variant Ilinca I. Ciubotariu, Jack Dorman, Nicole M. Perry, Lev Gorenstein, Jobin J. Kattoor, Abebe A. Fola, et al. (+5)
566 [GO] 2022―May―31 Combination Therapy With Casirivimab/Imdevimab and Remdesivir for Protracted SARS-CoV-2 Infection in B-cell-Depleted Patients M Veronica Dioverti, David C Gaston, C Paul Morris, Carol Ann Huff, Tania Jain, Richard Jones, et al. (+5)
567 [GO] 2022―May―23 Corrigendum to: Do Stay at Home Orders and Cloth Face Coverings Control COVID-19 in New York City? Results From a SIER Model Based on Real-world Data Jian Li, Yuming Wang, Jing Wu, Jing-Wen Ai, Hao-Cheng Zhang, Michelle Gamber, et al. (+3)
568 [GO] 2022―May―20 Antibody level predicts the clinical course of breakthrough infection of COVID-19 caused by delta and omicron variants: a prospective cross-sectional study Min Hyung Kim, Yooju Nam, Nak-Hoon Son, Namwoo Heo, Bongyoung Kim, Eawha Kang, et al. (+6)
569 [GO] 2022―May―20 COVID-19 vaccine uptake and factors associated with being unvaccinated among lesbian, gay, bisexual, transgender, queer, and other sexual identities (LGBTQ+) New Yorkers Andrea Low, Connor Wright, Joey Platt, Christiana Chang, Joanne E. Mantell, Emily Romero, et al. (+5)
570 [GO] 2022―May―17 Ethnic differences in COVID-19 hospitalization and hospital outcomes in a multi-ethnic population in the Netherlands Didier Collard, Karien Stronks, Vanessa Harris, Liza Coyer, Kees Brinkman, Martijn Beudel, et al. (+8)
571 [GO] 2022―May―16 Clerkship in infectious diseases for medical students during covid-19 Edward Chávez-Cruzado, Jose Galvez-Olortegui, Anderson Vilchez-Chávez, Alex Castañeda-Sabogal
572 [GO] 2022―May―13 Transmission potential of the Omicron variant of SARS-CoV-2 in South Korea: From November 25, 2020 to January 8, 2022 Eunha Shim, Wongyeong Choi, Donghyok Kwon, Taeyoung Kim, Youngji Song
573 [GO] 2022―May―13 CalScope: Monitoring SARS-CoV-2 Seroprevalence from Vaccination and Prior Infection in Adults and Children in California May 2021- July 2021 Megha L. Mehrotra, Esther Lim, Katherine Lamba, Amanda Kamali, Kristina W. Lai, Erika Meza, et al. (+12)
574 [GO] 2022―May―11 Opaganib in COVID-19 pneumonia: Results of a randomized, placebo-controlled Phase 2a trial Kevin L. Winthrop, Alan W. Skolnick, Adnan M. Rafiq, Scott H. Beegle, Julian Suszanski, Guenther Koehne, et al. (+10)
575 [GO] 2022―May―11 Quantification and progress over time of specific antibodies against SARS-CoV-2 in breast milk of lactating women vaccinated with BNT162b2 Pfizer-BioNTech COVID-19 vaccine (LacCOVID) Erika Esteve-Palau, Araceli Gonzalez-Cuevas, M. Eugenia Guerrero, Clara Garcia-Terol, M. Carmen Alvarez, Geneva Garcia, et al. (+4)
576 [GO] 2022―May―09 “Effectiveness of COVID-19 Vaccines in Preventing Infection, Hospital Admission and Death: A Historical Cohort Study Using Iranian Registration Data During Vaccination program” Alireza Mirahmadizadeh, Alireza Heiran, Kamran Bagheri Lankarani, Mohammadreza Serati, Mohammad Habibi, Owrang Eilami, et al. (+2)
577 [GO] 2022―May―09 Clinical Features and Duration of Viral Shedding Individuals with SARS-CoV-2 Omicron Variant Infection Young R. Jang, Jeong-Min Kim, Jee E. Rhee, Dongju Kim, Nam-Joo Lee, Hyeokjin Lee, et al. (+3)
578 [GO] 2022―May―07 The protective effect of covid-19 vaccination on post-acute sequelae of covid-19 (pasc): a multicenter study from a large national health research network Sokratis N. Zisis, Jared C. Durieux, Christian Mouchati, Jamie A. Perez, Grace A. McComsey
579 [GO] 2022―May―07 Detection of SARS-CoV-2 by Canine Olfaction: A Pilot Study Maureen Maurer, Todd Seto, Claire Guest, Amendeep Somal, Catherine Julian
580 [GO] 2022―May―07 SARS-CoV-2 neutralization after mRNA vaccination and variant breakthrough infection Christian Gaebler, Justin DaSilva, Eva Bednarski, Frauke Muecksch, Fabian Schmidt, Yiska Weisblum, et al. (+8)
581 [GO] 2022―May―05 Risk of SARS-CoV-2 transmission through solid organ transplantation and outcomes of COVID-19 among recent transplant recipients Rebecca J. Free, Pallavi Annambhotla, Ricardo M. La Hoz, Lara Danziger-Isakov, Jefferson M. Jones, Lijuan Wang, et al. (+7)
582 [GO] 2022―May―05 COVID-19 vaccine dosage in children, adolescents, and young adults - is less more? Nicole H. Tobin, Otto O. Yang
583 [GO] 2022―May―05 COVID-19 Vaccine Hesitancy Among Healthcare Workers in Four Healthcare Systems in Atlanta Sheetal Kandiah, Onyinye Iheaku, Mirza Farrque, Jasmah Hanna, Kalisha Bonds Johnson, Zanthia Wiley, et al. (+5)
584 [GO] 2022―May―05 Procalcitonin Is Not a Reliable Biomarker of Bacterial Coinfection in People With Coronavirus Disease 2019 Undergoing Microbiological Investigation at the Time of Hospital Admission Katharine A Relph, Clark D Russell, Cameron J Fairfield, Lance Turtle, Thushan I de Silva, Matthew K Siggins, et al. (+362)
585 [GO] 2022―May―05 Initial SARS-CoV-2 viral load is associated with disease severity: a retrospective cohort study Dennis Souverein, Karlijn van Stralen, Steven van Lelyveld, Claudia van Gemeren, Milly Haverkort, Dominic Snijders, et al. (+9)
586 [GO] 2022―Apr―28 Unravelling the Treatment Effect of Baricitinib on Clinical Progression and Resource Utilization in Hospitalized COVID-19 Patients: Secondary Analysis of the Adaptive COVID-19 Treatment Randomized Trial-2 Jonathan Fintzi, Tyler Bonnett, Pablo Tebas, Vincent C. Marconi, Corri B. Levine, Hana M. El Sahly, et al. (+13)
587 [GO] 2022―Apr―28 Mission, Organization and Future Direction of the Serological Sciences Network for COVID-19 (SeroNet) Epidemiologic Cohort Studies Jane C Figueiredo, Fred R Hirsch, Lawrence H Kushi, Wendy N Nembhard, James M Crawford, Nicholas Mantis, et al. (+91)
588 [GO] 2022―Apr―21 Population-based assessment of contact tracing operations for COVID-19 in Pirkanmaa hospital district, Finland Juha Rannikko, Hanna Viskari, Simo Sirkeoja, Pekka Tamminen, Ville Kaila, Anni Ala-Mursula, et al. (+4)
589 [GO] 2022―Apr―19 The collapse of infectious disease diagnoses commonly due to communicable respiratory pathogens during the COVID-19 pandemic: A time series and hierarchical clustering analysis Ali Zhang, Matthew D. Surette, Kevin L. Schwartz, James I. Brooks, Dawn M.E. Bowdish, Roshanak Mahdavi, et al. (+5)
590 [GO] 2022―Apr―19 Bamlanivimab and etesevimab improve symptoms and associated outcomes in ambulatory patients at increased risk for severe COVID-19: results from the placebo-controlled double-blind Phase 3 BLAZE-1 trial Peter Chen, Gerhard Behre, Corey Hebert, Princy Kumar, Lisa Farmer Macpherson, Peita Louise Graham-Clarke, et al. (+6)
591 [GO] 2022―Apr―18 A systematic review of COVID-19 vaccine efficacy and effectiveness against SARS-CoV-2 infection and disease Melissa M Higdon, Brian Wahl, Carli B Jones, Joseph G Rosen, Shaun A Truelove, Anurima Baidya, et al. (+7)
592 [GO] 2022―Apr―15 SARS-CoV-2 mRNA vaccine effectiveness in healthcare workers by dosing interval and time since vaccination: test negative design, British Columbia, Canada Shiraz El Adam, Macy Zou, Shinhye Kim, Bonnie Henry, Mel Krajden, Danuta M Skowronski
593 [GO] 2022―Apr―14 Health care workers’ sick leave due to COVID-19 vaccination in context with SARS-CoV-2 infection and quarantine - a multicenter cross-sectional survey Stilla Bauernfeind, Gunnar Huppertz, Karolina Mueller, Florian Hitzenbichler, Loredana Hardmann, Sylvia Pemmerl, et al. (+12)
594 [GO] 2022―Apr―14 Outcomes of B-cell-depleted Patients with Coronavirus Disease 2019 Treated with Anti-spike Monoclonal Antibodies Zachary A. Yetmar, Ryan B. Khodadadi, Maria Teresa Seville, Lisa Brumble, John C. O’Horo, Ravindra Ganesh, Raymund R. Razonable
595 [GO] 2022―Apr―13 Longitudinal analysis of SARS-CoV-2 vaccine breakthrough infections reveal limited infectious virus shedding and restricted tissue distribution Ruian Ke, Pamela P. Martinez, Rebecca L. Smith, Laura L. Gibson, Chad J. Achenbach, Sally McFall, et al. (+37)
596 [GO] 2022―Apr―12 EFFECTIVENESS OF CASIRIVIMAB-IMDEVIMAB MONOCLONAL ANTIBODY TREATMENT AMONG HIGH-RISK PATIENTS WITH SARS-CoV-2 B.1.617.2 (COVID-19 DELTA VARIANT) INFECTION Mohanad MM. Al-Obaidi, Ahmet B. Gungor, Saman Nematollahi, Tirdad T. Zangeneh, Edward J. Bedrick, Katherine M. Johnson, et al. (+11)
597 [GO] 2022―Apr―12 Performance of a Triage Protocol for Monoclonal Antibodies in a Mixed Vaccinated and Unvaccinated Cohort of Covid-19 Patients Treated with Intravenous Infusion or Subcutaneous Injection Emily B. Rubin, Mofei Liu, Anita Giobbie-Hurder, Lauren A. Canha, C. Elizabeth Keleher, Keri M. Sullivan, Michael Dougan
598 [GO] 2022―Apr―10 Severe Acute Respiratory Syndrome Coronavirus 2 Antibody Seroprevalence in Decedents Undergoing Forensic Postmortem Examination: Feasibility for 
Real-Time Pandemic Surveillance Sally B Coburn, Yukari C Manabe, Oliver Laeyendecker, Susan G Sherman, Owen R Baker, Thomas C Quinn, et al. (+11)
599 [GO] 2022―Apr―08 Avoidance of Emergency Care in the Southeastern United States During the COVID-19 Pandemic Erin Gettler, Rebecca Stern, Bin Ni, Heather M Munro, Mark Steinwandel, David M Aronoff, et al. (+4)
600 [GO] 2022―Apr―07 Barriers to worldwide access for Paxlovid, a new treatment for COVID-19 Toby Pepperrelll, Leah Ellis, Junzheng Wang, Andrew Hill
601 [GO] 2022―Apr―05 Pathogen Species is Associated With Mortality in Nosocomial Bloodstream Infection in Patients with COVID-19 Juan Gago, D Filardo Thomas, Sarah Conderino, Samuel J Magaziner, Yanina Dubrovskaya, Kenneth Inglima, et al. (+9)
602 [GO] 2022―Apr―05 Rheumatic symptoms following COVID-19: a chronic post COVID-19 condition Dan Cui, Yeming Wang, Lixue Huang, Xiaoying Gu, Zhisheng Huang, Shengrui Mu, et al. (+2)
603 [GO] 2022―Apr―02 Vaccinated individuals with prior COVID-19 have likely lower risk of incident SARS-CoV-2 infection when compared to vaccinated individuals without prior infection N Kojima, A Roshani, A Baca, J D Klausner
604 [GO] 2022―Mar―29 Screening Large Population Health Databases for Potential COVID-19 Therapeutics: A Pharmacopeia-Wide Association Study (PWAS) of Commonly Prescribed Medications Derek R MacFadden, Kevin Brown, Sarah A Buchan, Hannah Chung, Rob Kozak, Jeffrey C Kwong, et al. (+3)
605 [GO] 2022―Mar―25 Population attributable fractions of underlying medical conditions for COVID-19 diagnosis and COVID-19 hospitalizations, ventilations, and deaths among adults in the United States Jennifer L Nguyen, Tamuno Alfred, Maya Reimbaeva, Deepa Malhotra, Farid Khan, David Swerdlow, Frederick J Angulo
606 [GO] 2022―Mar―25 Ibrutinib for Hospitalized Adults with Severe COVID-19 Infection: Results of the Randomized, Double-Blind, Placebo-Controlled iNSPIRE Study Steven E Coutre, Christopher Barnett, Olayemi Osiyemi, Daanish Hoda, Moti Ramgopal, Alexander C Fort, et al. (+6)
607 [GO] 2022―Mar―25 Singing Is a Risk Factor for SARS-CoV-2 Infection: A Case-control Study of Karaoke-related COVID-19 Outbreaks in Two Cities in Hokkaido, Japan, Linked by Whole Genome Analysis Manami Nakashita, Yuta Takagi, Hiroyuki Tanaka, Haruna Nakamura, Yusuke Serizawa, Tomohiko Ukai, et al. (+27)
608 [GO] 2022―Mar―25 SARS-CoV-2 humoral and cellular immune responses of patients with HIV after vaccination with BNT162b2 mRNA COVID-19 vaccine in the Tel-Aviv Medical Center Luba Tau, Dan Turner, Amos Adler, Rotem Marom, Svetlana Ahsanov, Natasha Matus, et al. (+8)
609 [GO] 2022―Mar―25 High and rapid increase in seroprevalence for SARS-CoV-2 in Conakry, Guinea: results from three successive cross-sectional surveys (ANRS COV16-ARIACOV) Abou Aissata Soumah, Mamadou Saliou Kalifa Diallo, Emilande Guichet, David Maman, Guillaume Thaurignac, Alpha Kabinet Keita, et al. (+9)
610 [GO] 2022―Mar―25 Temporal Variations in Seroprevalence of SARS-CoV-2 Infections by Race and Ethnicity in Arkansas Joshua L Kennedy, J Craig Forrest, Sean G Young, Benjamin Amick, Mark Williams, Laura James, et al. (+22)
611 [GO] 2022―Mar―18 Viral Load Among Vaccinated and Unvaccinated, Asymptomatic and Symptomatic Persons Infected with the SARS-CoV-2 Delta Variant Charlotte B Acharya, John Schrom, Anthea M Mitchell, David A Coil, Carina Marquez, Susana Rojas, et al. (+10)
612 [GO] 2022―Mar―16 Viral burden and clearance in asymptomatic COVID-19 Patients Avanka B Gunatilaka, Nicholas Marco, Graham H Read, Maggie Sweeney, Greg Regan, Cynthia Tsang, et al. (+9)
613 [GO] 2022―Mar―16 A Tale of Three Pandemics - SARS-CoV-2, HCV, and HIV in an Urban Emergency Department in Baltimore, Maryland Yu-Hsiang Hsieh, Richard E Rothman, Sunil S Solomon, Mark Anderson, Michael Stec, Oliver Laeyendecker, et al. (+9)
614 [GO] 2022―Mar―16 Confirmed SARS-CoV-2 reinfections after a second wave with predominance of Lambda in Lima and Callao, Peru Luis Pampa-Espinoza, Carlos Padilla-Rojas, Javier Silva-Valencia, Victor Jimenez-Vasquez, Iris Silva, Orson Mestanza, et al. (+15)
615 [GO] 2022―Mar―13 Clinical outcomes in hospitalized vaccine-breakthrough COVID-19 cases compared with contemporary unvaccinated hospitalized adults Marcelo Wolff, Margarita Gilabert, Rodrigo Hernández
616 [GO] 2022―Mar―10 COVID-19 Vaccines and SARS-CoV-2 Transmission in the Era of New Variants: A Review and Perspective Jasmine R Marcelin, Audrey Pettifor, Holly Janes, Elizabeth R Brown, James G Kublin, Kathryn E Stephenson
617 [GO] 2022―Mar―09 Increased risk of herpes zoster in adults ≥50 years old diagnosed with COVID-19 in the United States Amit Bhavsar, Germain Lonnet, Chengbin Wang, Konstantina Chatzikonstantinidou, Raunak Parikh, Yves Brabant, et al. (+4)
618 [GO] 2022―Mar―07 Risk factors associated with hospitalization and death in COVID-19 breakthrough infections Geehan Suleyman, Raef Fadel, Indira Brar, Rita Kassab, Rafa Khansa, Nicholas Sturla, et al. (+7)
619 [GO] 2022―Mar―07 New Onset Dementia Among Survivors of Pneumonia Associated with Severe Acute Respiratory Syndrome Coronavirus 2 Infection Adnan I Qureshi, William I Baskett, Wei Huang, S Hasan Naqvi, Chi-Ren Shyu
620 [GO] 2022―Mar―03 Coronavirus disease 2019 (COVID-19) associated pulmonary aspergillosis (CAPA): Re-framing the debate Cornelius J Clancy, M Hong Nguyen
621 [GO] 2022―Mar―03 Characteristics and Risk Factors for Mortality by COVID-19 Pandemic Waves in Fulton County, Georgia: A Cohort Study March 2020-February 2021 Nathaniel Chishinga, Neel R Gandhi, Udodirim N Onwubiko, Carson Telford, Juliana Prieto, Sasha Smith, et al. (+5)
622 [GO] 2022―Mar―02 Low Levels of Neutralizing Antibodies After Natural Infection With Severe Acute Respiratory Syndrome Coronavirus 2 in a Community-Based Serological Study Thomas W McDade, Amelia Sancilio, Richard D’Aquila, Brian Mustanski, Lauren A Vaught, Nina L Reiser, et al. (+6)
623 [GO] 2022―Feb―25 Long-term outcomes and recovery of patients who survived COVID-19: LUNG INJURY COVID-19 Study Gianna Vargas Centanaro, Myriam Calle Rubio, José Luis Álvarez-Sala Walther, Fernando Martinez-Sagasti, Andrea Albuja Hidalgo, Rafael Herranz Hernández, Juan Luis Rodríguez Hermosa
624 [GO] 2022―Feb―24 Serologic and cytokine signatures in children with multisystem inflammatory syndrome (MIS-C) and COVID-19 Stacey A Lapp, Joseph Abrams, Austin T Lu, Laila Hussaini, Carol M Kao, David A Hunstad, et al. (+23)
625 [GO] 2022―Feb―22 Corrigendum to: 204. Mucosal Cytokine Profiles in Children with COVID-19 Ana M Quintero, Shira H Cohen, Cameron Mertz, Rebecca M Glowinski, Sara Mertz, Fang Ye, et al. (+10)
626 [GO] 2022―Feb―21 Impact of Casirivimab-Imdevimab on SARS-CoV-2 delta variant nasopharyngeal virus load and Spike quasispecies Camille Vellas, Arnaud Del Bello, Géraldine Gaube, Pauline Tremeaux, Nicolas Jeanne, Noémie Ranger, et al. (+4)
627 [GO] 2022―Feb―20 Vaccination against SARS-CoV-2 is associated with a lower viral load and likelihood of systemic symptoms Carolyn T Bramante, Jennifer L Proper, David R Boulware, Amy Karger, Thomas Murray, Via Rao, et al. (+22)
628 [GO] 2022―Feb―18 Quantifying the Population-level Effect of the COVID-19 Mass Vaccination Campaign in Israel: a Modeling Study Ido Somekh, Wasiur R KhudaBukhsh, Elisabeth Dowling Root, Lital Keinan Boker, Grzegorz Rempala, Eric A F Simões, Eli Somekh
629 [GO] 2022―Feb―14 Coinfections in Patients with Cancer and COVID-19: A COVID-19 and Cancer Consortium (CCC19) Study Gowri Satyanarayana, Kyle T Enriquez, Tianyi Sun, Elizabeth J Klein, Maheen Abidi, Shailesh M Advani, et al. (+51)
630 [GO] 2022―Feb―14 Comparative efficacy of early Covid-19 monoclonal antibody therapies: a retrospective analysis Savanna San Filippo, Brynna Crovetto, John Bucek, Ronald G Nahass, Marc Milano, Luigi Brunetti
631 [GO] 2022―Feb―14 Assessment of Virological Contributions to COVID-19 Outcomes in a Longitudinal Cohort of Hospitalized Adults Lacy M Simons, Ramon Lorenzo-Redondo, Meg Gibson, Sarah L Kinch, Jacob P Vandervaart, Nina L Reiser, et al. (+12)
632 [GO] 2022―Feb―14 Prospective assessment of symptoms to evaluate asymptomatic SARS-CoV-2 infections in a cohort of healthcare workers Emilie Goguet, John H Powers, Cara H Olsen, David R Tribble, Julian Davies, Luca Illinik, et al. (+29)
633 [GO] 2022―Feb―13 Candidemia among COVID-19 patients in Turkey admitted to ICUs: A retrospective multicenter study Amir Arastehfar, Nevzat Ünal, Tuğrul Hoşbul, Muhammed Alper Özarslan, Ayşe Sultan Karakoyun, Furkan Polat, et al. (+9)
634 [GO] 2022―Feb―09 Community-Acquired Pneumonia in Canada During COVID-19 L A Mandell, G G Zhanel, C Rotstein, J Muscedere, M Loeb, J Johnstone
635 [GO] 2022―Feb―09 Characteristics of post-vaccination COVID-19 hospitalizations prior to booster vaccines Matthew A Moffa, Nathan R Shively, Thomas L Walsh
636 [GO] 2022―Feb―09 An outpatient management strategy using a Coronataxi digital early warning (CDEW) system reduces COVID-19 mortality Adeline Lim, Theresa Hippchen, Inga Unger, Oliver Heinze, Andreas Welker, Hans-Georg Kräusslich, et al. (+2)
637 [GO] 2022―Feb―09 Comparative Analysis of Mortality From Coronavirus Disease 2019 Across the European Union Countries and the Effects of Vaccine Coverage Panayiotis D Ziakas, Irene S Kourbeti, Eleftherios Mylonakis
638 [GO] 2022―Feb―09 Retraction to: Meta-analysis of Randomized Trials of Ivermectin to Treat SARS-CoV-2 Infection Andrew Hill, Anna Garratt, Jacob Levi, Jonathan Falconer, Leah Ellis, Kaitlyn McCann, et al. (+4)
639 [GO] 2022―Feb―09 Rapid Deployment of Multiple-Tactics to Address SARS-CoV-2 Vaccine Uptake in Healthcare Employees with a focus on Those Who Identify as Black, Indigenous, and People of Color (BIPOC) Dominic K Chan, Brittany D Alegria, Smitha R Chadaga, Lisa J Goren, Traci J Mikasa, Anna M Pearson, et al. (+3)
640 [GO] 2022―Feb―09 Association of non-alcoholic fatty liver disease with COVID-19 severity and pulmonary thrombosis: CovidFAT, a prospective, observational cohort study Nina Vrsaljko, Lara Samadan, Klaudija Viskovic, Armin Mehmedović, Jelena Budimir, Adriana Vince, Neven Papic
641 [GO] 2022―Feb―02 Small Towns, Big Cities: Rural and Urban Disparities among Hospitalized Patients with COVID-19 in the Central Savannah River Area Caroline A Hamilton, Deepak Ayyala, David Walsh, Christian Bramwell, Christopher Walker, Rita Wilson Dib, et al. (+6)
642 [GO] 2022―Feb―02 Efficacy and Safety of Regdanvimab (CT-P59): A Phase 2/3 Randomized, Double-Blind, Placebo-Controlled Trial in Outpatients with Mild-to-Moderate Coronavirus Disease 2019 Anca Streinu-Cercel, Oana Săndulescu, Liliana-Lucia Preotescu, Jin Yong Kim, Yeon-Sook Kim, Shinhye Cheon, et al. (+11)
643 [GO] 2022―Jan―31 Seroprevalence of SARS-CoV-2-specific antibodies in Australia following the first epidemic wave in 2020: a national survey Kaitlyn M Vette, Dorothy A Machalek, Heather F Gidding, Suellen Nicholson, Matthew V N O'Sullivan, John B Carlin, et al. (+16)
644 [GO] 2022―Jan―30 SARS-CoV-2 Seroprevalence and Reported COVID-19 Cases in U.S. Children, August 2020-May 2021 Alexia Couture, B Casey Lyons, Megha L Mehrotra, Lynn Sosa, Ngozi Ezike, Farah S Ahmed, et al. (+14)
645 [GO] 2022―Jan―28 Factors associated with SARS-COV-2 attack rates in aged care- a meta-analysis Mohana Kunasekaran, Ashley Quigley, Bayzidur Rahman, Abrar A Chughtai, David J Heslop, Christopher J Poulos, C Raina MacIntyre
646 [GO] 2022―Jan―28 Detection of the omicron variant virus with the Abbott BinaxNow SARS-CoV-2 Rapid Antigen Assay James Regan, James P Flynn, Manish C Choudhary, Rockib Uddin, Jacob Lemieux, Julie Boucau, et al. (+4)
647 [GO] 2022―Jan―22 Sustained Reduction in Urgent Care Antibiotic Prescribing During the COVID-19 pandemic: An Academic Medical Center’s Experience David Ha, Sharon Ong’uti, Amy Chang, Emily Mui, Ian Nelligan, Brooke Betts, et al. (+9)
648 [GO] 2022―Jan―21 Feasibility and Acceptability of Home-collected Samples for HIV Pre-exposure Prophylaxis (PrEP) and SARS-CoV-2 Laboratory Tests in San Francisco Primary Care Clinics Parya Saberi, Kristin Ming, Isha Shrestha, Hyman Scott, Brad Thorson, Albert Liu
649 [GO] 2022―Jan―20 Metrics for Phased Prevention of Coronavirus Disease 2019 Transmission for Institutions of Higher Education: 2022 and Beyond Neil Jay Sehgal
650 [GO] 2022―Jan―19 Outpatient Therapies for COVID-19: How do we choose? Todd C Lee, Andrew M Morris, Steven A Grover, Srinivas Murthy, Emily G McDonald
651 [GO] 2022―Jan―17 Ivermectin for COVID-19: Addressing Potential Bias and Medical Fraud Andrew Hill, Manya Mirchandani, Victoria Pilkington
652 [GO] 2022―Jan―17 Estimates of Presumed Population Immunity to SARS-CoV-2 by State in the United States, August 2021 Marie C D Stoner, Frederick J Angulo, Sarah Rhea, Linda Morris Brown, Jessica E Atwell, Jennifer L Nguyen, et al. (+3)
653 [GO] 2022―Jan―14 Adverse Effects and Antibody Titers in Response to the BNT162b2 mRNA COVID-19 Vaccine in a Prospective Study of Healthcare Workers Si’Ana A Coggins, Eric D Laing, Cara H Olsen, Emilie Goguet, Matthew Moser, Belinda M Jackson-Thompson, et al. (+25)
654 [GO] 2022―Jan―12 Monoclonal Antibody Therapy for COVID-19: A Public Health Perspective From Arkansas Atul Kothari, Elizabeth Woodland Borella, Michelle R Smith
655 [GO] 2022―Jan―12 Venerable but Vulnerable: When Centenarians Encounter Coronavirus Disease 2019 Juliette Dessemon, Christelle Elias, Laetitia Henaff, Mitra Saadatian-Elahi, Philippe Vanhems
656 [GO] 2022―Jan―06 Twelve-month Follow-up of Early COVID-19 Cases in the United States: Cellular and Humoral Immune Longevity Melisa M Shah, Mohammad Ata Ur Rasheed, Jennifer L Harcourt, Glen R Abedi, Megan M Stumpf, Hannah L Kirking, et al. (+14)
657 [GO] 2022―Jan―03 Assessment of COVID-19 intervention strategies in the Nordic countries using genomic epidemiology Sebastian Duchene, Leo Featherstone, Birgitte Freiesleben de Blasio, Edward C Holmes, Jon Bohlin, John H-O Pettersson
658 [GO] 2021―Dec―31 Short term safety of booster immunization with BNT162b2 mRNA COVID-19 vaccine in healthcare workers Yael Paran, Esther Saiag, Avishay Spitzer, Yoel Angel, Michal Yakubovsky, Hagit Padova, et al. (+6)
659 [GO] 2021―Dec―30 A small but significantly greater incidence of inflammatory heart disease identified after vaccination for SARS-CoV-2 (severe acute respiratory syndrome coronavirus 2) Kirk U Knowlton, Stacey Knight, Joseph B Muhlestein, Viet T Le, Benjamin D Horne, Heidi T May, et al. (+2)
660 [GO] 2021―Dec―28 Delay in the Effect of Restricting Community Mobility on the Spread of COVID-19 During the First Wave in the United States Shan He, Jooyoung Lee, Benjamin Langworthy, Junyi Xin, Peter James, Yang Yang, Molin Wang
661 [GO] 2021―Dec―27 Real-Life Effectiveness and Safety of Baricitinib as Adjunctive to Standard-of-Care Treatment in Hospitalized Patients With Severe Coronavirus Disease 2019 Nikolaos Tziolos, Emmanouil Karofylakis, Ioannis Grigoropoulos, Pinelopi Kazakou, Emmanouil Koullias, Athina Savva, et al. (+11)
662 [GO] 2021―Dec―25 Association Between SARS-CoV-2 RNAemia and Post-Acute Sequelae of COVID-19 Nikhil Ram-Mohan, David Kim, Angela J Rogers, Catherine A Blish, Kari C Nadeau, Andra L Blomkalns, Samuel Yang
663 [GO] 2021―Dec―23 Evaluating the impact of language concordance on COVID-19 contact tracing outcomes among Spanish-speaking adults in San Francisco between June and November 2020 Amity Eliaz, Alden H Blair, Yea-Hung Chen, Alicia Fernandez, Alexandra Ernst, Joy Mirjahangir, et al. (+4)
664 [GO] 2021―Dec―23 Adapting serosurveys for the SARS-CoV-2 vaccine era Nathan Duarte, Mercedes Yanes-Lane, Rahul K Arora, Niklas Bobrovitz, Michael Liu, Mariana G Bego, et al. (+9)
665 [GO] 2021―Dec―22 A dehumanizing experience with COVID-19 infection and hospitalization - An interview with Chris Stolarski
666 [GO] 2021―Dec―21 Corridengum to: Self-Rated Smell Ability Enables Highly Specific Predictors of COVID-19 Status: A Case-Control Study in Israel Noam Karni, Hadar Klein, Kim Asseo, Yuval Benjamini, Sarah Israel, Musa Nimri, et al. (+5)
667 [GO] 2021―Dec―21 Persistence, Magnitude and Patterns of Post-acute Symptoms and Quality of Life Following Onset of SARS-CoV-2 Infection: Cohort Description and Approaches for Measurement Michael J Peluso, J Daniel Kelly, Scott Lu, Sarah A Goldberg, Michelle C Davidson, Sujata Mathur, et al. (+41)
668 [GO] 2021―Dec―20 Estimation of Coronavirus Disease 2019 Hospitalization Costs From a Large Electronic Administrative Discharge Database, March 2020-July 2021 Sundar S Shrestha, Lyudmyla Kompaniyets, Scott D Grosse, Aaron M Harris, James Baggs, Kanta Sircar, Adi V Gundlapalli
669 [GO] 2021―Dec―17 Minimum manufacturing costs, national prices and estimated global availability of new repurposed therapies for COVID-19 Junzheng Wang, Jacob Levi, Leah Ellis, Andrew Hill
670 [GO] 2021―Dec―14 Clinical Considerations During Breakthrough Coronavirus Disease 2019 Infections in Vaccinated Individuals With Autoimmunity Joseph M Rocco, Luxin Pei, Frances Galindo, Elizabeth Laidlaw, Irini Sereti
671 [GO] 2021―Dec―11 Persistence of robust humoral immune response in COVID-19 convalescent individuals over twelve months after infection Kei Miyakawa, Sousuke Kubo, Sundararaj Stanleyraj Jeremiah, Hirofumi Go, Yutaro Yamaoka, Norihisa Ohtake, et al. (+14)
672 [GO] 2021―Dec―10 Aiming for Zero: Reducing Transmission of Coronavirus Disease 2019 in the D.C. Department of Corrections Mallory E Epting, Jacob A Pluznik, Samantha R Levano, Xinyi Hua, Isaac C H Fung, Beth Jordan, et al. (+11)
673 [GO] 2021―Dec―08 Circulation of Non- SARS-CoV-2 Respiratory Pathogens and Coinfection with SARS-CoV-2 Amid the COVID-19 Pandemic Katharine Uhteg, Adannaya Amadi, Michael Forman, Heba H Mostafa
674 [GO] 2021―Dec―08 Low versus High Dose Methylprednisolone in Adult Patients with COVID-19: Less is More Seema Joshi, Zachary Smith, Sana Soman, Saniya Jain, Atheel Yako, Marwa Hojeij, et al. (+7)
675 [GO] 2021―Dec―08 Anatomical site, viral RNA abundance, and time of sampling correlate with molecular detection of SARS-CoV-2 during infection F Julian Lantry, Nusrat Epsi, Simon Pollett, Mark P Simons, David A Lindholm, Rhonda E Colombo, et al. (+22)
676 [GO] 2021―Dec―07 US201 Study: A Phase 2, Randomized Proof-of-Concept Trial of Favipiravir for the Treatment of COVID-19 Robert W Finberg, Madiha Ashraf, Boris Julg, Folusakin Ayoade, Jai G Marathe, Nicolas C Issa, et al. (+4)
677 [GO] 2021―Dec―05 296. Description of Super-infections in Hospitalized Patients with COVID-19 Geena Kludjian, Stephanie Spivack, Stefania Gallucci, Laurie Kilpatrick, Aaron D Mishkin, Umadevi Sajjan, et al. (+3)
678 [GO] 2021―Dec―05 286. Infectious Complications and Antimicrobial Utilization in Hospitalized Patients with COVID-19 J Hunter Fraker, Vidhi Gandhi, Lan Duong, Jai Kumar, Princy N Kumar, Joseph G Timpone
679 [GO] 2021―Dec―05 293. Lung Cancer and Hematologic Malignancy ( HM) Patients Are Associated with the Highest Risk of Progressing to Severe Disease and Mortality in Cancer Patients with COVID-19 Anne-Marie Chaftari, Alexandre Malek, Hiba Dagher, Ying Jiang, Arnaud Bayle, Arvinder Bhinder, et al. (+10)
680 [GO] 2021―Dec―05 361. Aseptic Meningitis Associated to SARS Cov2 Infection and MIS-C: Pediatric Presentation of Covid-19 Mónica J Olguín Quintero, Sergio RenÉ Bonilla Pellegrini, Rodolfo N JimÉnez JuÁrez, María Citlalli Casillas Casillas
681 [GO] 2021―Dec―05 338. Multicenter Evaluation of Superinfection Occurrence and Impact on Clinical Outcomes in Patients with COVID-19 Taryn A Eubank, Katherine Perez, William L Musick, Kevin W Garey
682 [GO] 2021―Dec―05 337. SARS-CoV-2 Viral Load Does Not Predict Incident Venous Thromboembolism in COVID-19 Simon Pollett, Benjamin Wier, Stephanie A Richard, Anthony C Fries, Ryan C Maves, Ryan C Maves, et al. (+21)
683 [GO] 2021―Dec―05 313. Host Protein Biomarkers Predicting Severity of Lung Damage due to COVID-19 Isabell Kerschbaumer, Melissa Fazzari, Shana R Burstein, Aisha Furey, Amy S Fox, Adam M Cole, et al. (+3)
684 [GO] 2021―Dec―05 309. TB Quantiferon Testing Predicts Mortality in Patients with COVID-19 Mirza Z Baig, Siyun Liao, Margaret Powers-Fletcher, Moises A Huaman, Senu Apewokin
685 [GO] 2021―Dec―05 311. Impact of Non-alcoholic Fatty Liver Disease on Clinical Outcomes in Patients with COVID-19 Nina Vrsaljko, Lara Samadan, Jelena Budimir, Mirjana Balen Topic, Ivan Kurelac, Adriana Vince, Neven Papić
686 [GO] 2021―Dec―05 391. Small Towns, Big Cities: Rural and Urban Disparities Among Hospitalized Patients with COVID-19 Caroline Hamilton, Deepak Nag Ayyala, David Walsh, Christian-Jevon Bramwell, Christopher Walker, Rita Wilson Dib, et al. (+6)
687 [GO] 2021―Dec―05 306. Association of Antibiotic Use and Development Secondary Infection from Clostridium difficile, Multidrug-Resistant Bacteria, and Candida in Hospitalized Patients with History of COVID-19 Jessica K Costales, Helen Lee, Kathleen A Quan, Keith M Madey, Kurt McArthur, Shruti K Gohil, et al. (+3)
688 [GO] 2021―Dec―05 582. Risk Factors for Progression to Hospitalization in Adolescents Presenting with Mild or Moderate COVID-19 Melanie Dubois, Jeffrey Campbell, Gabriella S Lamb, Gabriella S Lamb, Mari M Nakamura
689 [GO] 2021―Dec―05 358. Early Cardiac Marker of Mortality in COVID-19 Douglas Salguero, Juliana Ferri-Guerra, Angel Porras, Marissa Donatelle, Everett Rogers, Lee Seiffer, et al. (+4)
690 [GO] 2021―Dec―05 349. Diagnostic Testing and Antibiotic Utilization in Patients with COVID-19 Lauren Groft, Iulia Opran, Yeabsera Tadesse, Hang Vo, Emily Heil, Emily Heil, et al. (+2)
691 [GO] 2021―Dec―05 457. High Levels of Serum Troponin I Indicate Higher Mortality Risk in Patients with COVID-19 Paula Ramirez, Daniela Parra-Tanoux, Ingrid G Bustos-Moya, Yuli Fuentes, Elsa Daniela Ibañez-Prada, Oriana Narváez - Ramírez, et al. (+6)
692 [GO] 2021―Dec―05 351. Antibiotic Management Decisions and Use of a Multiplex PCR Panel for Pneumonia Diagnosis Among Critically Ill Patients with COVID-19 Neda Bionghi, Donald E Dietz, Jason Zucker, Jason Zucker, Simian Huang, Susan Whittier, et al. (+4)
693 [GO] 2021―Dec―05 357. A Comparison of Chest CT Findings in Cancer and Non-Cancer Patients with COVID-19 Alexandre Malek, Hiba Dagher, Ray Y Hachem, Ying Jiang, Anne-Marie Chaftari, Issam I Raad
694 [GO] 2021―Dec―05 323. Distribution of Pathogens in Coinfections of Patients Admitted with COVID-19 Srilatha Neshangi, Budder Siddiqui, Sarah Tran, Phillip Zhang
695 [GO] 2021―Dec―05 356. The Role of Procalcitonin in Antimicrobial Stewardship Among Cancer Patients Admitted with COVID-19 Hiba Dagher, Anne-Marie Chaftari, Ray Y Hachem, Ying Jiang, Alexandre Malek, Natalie J Dailey Garnes, et al. (+3)
696 [GO] 2021―Dec―05 510. Reduced Mortality Rate in Critically Ill Patients with COVID-19 with the Implementation of a Treatment Protocol-Experience of a Tertiary Care Center in the Midwest During the Initial Surge of COVID-19 Ashlesha Kaushik, Sandeep Gupta, Jitendra Gupta
697 [GO] 2021―Dec―05 407. Minimum Manufacturing Costs, National Prices and Estimated Global Availability of New Repurposed Therapies for COVID-19 Junzheng Wang, Jacob Levi, Leah Ellis, Andrew Hill
698 [GO] 2021―Dec―05 334. Impact of Overall Dexamethasone Exposure on Development of Invasive Pulmonary Aspergillosis in Hospitalized Patients with COVID-19 Erik Skoglund, Amy Kum, Allison Mac, Mark Nguyen
699 [GO] 2021―Dec―05 501. Implementation and Outcomes of a Program to Coordinate and Administer Monoclonal Antibody Therapy to Long-Term Care Facility Residents with COVID-19 Andrew B Watkins, Lisa M Brand, Michelle Schwedhelm, Heather L Jensen, Brandon Scott, Dan K German, et al. (+4)
700 [GO] 2021―Dec―05 500. A Real-World Cohort Study of Bamlanivimab Versus Bamlanivimab-Etesevimab for Non-severe COVID-19 Lea Monday, George J Alangaden, Indira Brar, Ramesh Mayur
701 [GO] 2021―Dec―05 418. Low Frequency of Healthcare Worker Infections Following Occupational Exposures to COVID-19 Jessica Seidelman, Ibukunoluwa Akinboyo, Maya Rinehart, Matthew Stiegel, Rebekah W Moehring, Deverick J Anderson, et al. (+4)
702 [GO] 2021―Dec―05 417. COVID-19 Aerostudy: Evaluation of SARS-CoV-2 Virus in the Air of Patients Hospitalized with COVID-19 Hamed Hamza, Margaret Seitsema, Lorraine Conroy, Alfredo J Mena Lora, Eric Wenzler, Scott Borgetti, et al. (+8)
703 [GO] 2021―Dec―05 399. Epidemiology of Laboratory-identified Late-onset SARS-CoV-2 Positivity in Two Large, Urban, Acute-Care Hospitals: Implications for Surveillance of Hospital-Acquired COVID-19 William Trick, Michael Y Lin, Sharon F Welbel, Onfofre T Donceras, Huiyuan Zhang, Marion Tseng, Carlos Santos
704 [GO] 2021―Dec―05 441. The Effects of Race and Comorbidity Burden on Inflammatory Biomarkers Among Persons Hospitalized with COVID-19 Yetunde A Fatade, Lauren F Collins, Lauren F Collins, Zakaria Almuwaqqat, ZhenChao Chen, Mahadev Prasad, et al. (+2)
705 [GO] 2021―Dec―05 516. Evaluation of COVID-19 Monoclonal Antibody Therapies for the Treatment of Non-hospitalized Patients with COVID-19 Faiza Morado, Neha Nanda
706 [GO] 2021―Dec―05 438. Phenotypic Differences Between Distinct Immune Biomarker Clusters During the ‘Hyperinflammatory’ Middle-Phase of COVID-19 Paul W Blair, Joost Brandsma, Nusrat J Epsi, Stephanie A Richard, Deborah Striegel, Josh Chenoweth, et al. (+10)
707 [GO] 2021―Dec―05 542. Use of Bamlanivimab in Cancer Patients with Mild-to-Moderate COVID-19 Patricia Brock, Hiba Dagher, Adriana H Wechsler, Demis N Lipe, Patrick Chaftari, Anne-Marie Chaftari, et al. (+9)
708 [GO] 2021―Dec―05 548. Convalescent Plasma in Hospitalized Pediatric and Obstetric patients with COVID-19 Saki Ikeda, Eduardo Benzi, Lisa Hensch, Sridevi Devaraj, Shiu-Ki Rocky Hui, Manisha Gandhi, et al. (+3)
709 [GO] 2021―Dec―05 547. Risk Factors Associated with 30-Day Mortality in a Large Cohort of Patients who Received Remdesivir and Corticosteroids for Severe COVID-19 Kartik Gupta, Lea Monday, Milan Kaushik, George J Alangaden, Indira Brar
710 [GO] 2021―Dec―05 523. Use of Immune-Viral Dynamics Modeling to Understand Molnupiravir Drug Effect for COVID-19 Youfang Cao, Wei Gao, Ruthie Birger, Julie Stone
711 [GO] 2021―Dec―05 633. Preliminary Results from a Phase 1 Single Ascending-Dose Study Assessing Safety, Serum Viral Neutralizing Antibody Titers (sVNA), and Pharmacokinetic (PK) Profile of ADG20: an Extended Half-Life Monoclonal Antibody Being Developed for the Treatment and Prevention of Coronavirus Disease (COVID-19) Helen Paguntalan, Zoltán Magyarics, Lynn E Connolly, Ellie Hershberger, Kristin Narayan, Deepali Gupta, et al. (+5)
712 [GO] 2021―Dec―05 Variation in SARS-CoV-2 bioaerosol production in exhaled breath Renu Verma, Eugene Kim, Nicholas Degner, Katharine S Walter, Upinder Singh, Jason R Andrews
713 [GO] 2021―Dec―05 277. Low Rates of Bacterial Co-infection in Hospitalized Patients with COVID-19 Stephanie Spivack, Geena Kludjian, Stefania Gallucci, Laurie Kilpatrick, Aaron D Mishkin, Umadevi Sajjan, et al. (+3)
714 [GO] 2021―Dec―05 280. Burden of Hyperglycemia in Patients Receiving Dexamethasone for Severe COVID-19 Kirk B Fetters, Stephen Judge, Timothy Hatlen, Eric Daar
715 [GO] 2021―Dec―05 170. Reduction in Bloodborne Pathogen Splash Exposures After Implementation of Universal Masking and Eye Protection for COVID-19 Marci Drees, Tabe Mase, Jennifer Garvin, Kimberly Miller
716 [GO] 2021―Dec―05 947. Nocardiosis in Renal Transplant Recipients Linked to Decreased Utilization of Trimethoprim/Sulfamethoxazole During COVID-19 Terrence McSweeney, Jennifer Marvin, Elizabeth A Cohen, Vincent Do, Kristen Belfield, Sarthak Virmani, et al. (+4)
717 [GO] 2021―Dec―05 1089. Use of a Whole-Body Quantitative System Pharmacology Physiologically-Based Pharmacokinetic (QSP/PBPK) Model to Support Dose Selection of ADG20: an Extended Half-Life Monoclonal Antibody Being Developed for the Prevention of Coronavirus Disease (COVID-19) Scott A Van Wart, Evan D Tarbell, Kristin Narayan, Laura M Walker, Lynn E Connolly, Paul G Ambrose
718 [GO] 2021―Dec―05 1088. A Whole-Body Quantitative System Pharmacology Physiologically-Based Pharmacokinetic (QSP/PBPK) Model to Support Dose Selection of ADG20: an Extended Half-Life Monoclonal Antibody Being Developed for the Treatment of Coronavirus Disease (COVID-19) Evan D Tarbell, Scott A Van Wart, Dhaval K Shah, Laura M Walker, Andrew Santulli, Lynn E Connolly, et al. (+3)
719 [GO] 2021―Dec―05 1086. A Whole-Body Quantitative System Pharmacology Physiologically-Based Pharmacokinetic (QSP/PBPK) Model that a priori Predicts Intramuscular (IM) Pharmacokinetics of ADG20: an Extended Half-life Monoclonal Antibody Being Developed for the Treatment and Prevention of Coronavirus Disease (COVID-19) Scott A Van Wart, Evan D Tarbell, Donald E Mager, Dhaval K Shah, Lynn E Connolly, Paul G Ambrose
720 [GO] 2021―Dec―05 843. Targeted HIV Testing for Patients Hospitalized for COVID-19 Michael D Virata, Merceditas Villanueva, Janet Miceli
721 [GO] 2021―Dec―05 839. Examining the Effects of HIV Infection on Severity of Outcomes in Those with COVID-19 Melissa Parkinson, Rebecca Gerrity, Rachel Strength, Christian J Fuchs, Christopher Jackson, Dipen Kadaria, et al. (+3)
722 [GO] 2021―Dec―05 840. Clinical Characteristics of Patients Living with HIV Hospitalized for COVID-19 Nimra Chaudhry, Eris Cani, Tae Park, Cosmina Zeana, Paul Kelly, Haozhe Sun
723 [GO] 2021―Dec―05 81. SARS-CoV-2 RNAemia and Disease Severity in Pediatric Coronavirus Disease 2019 (COVID-19) Cameron Mertz, Rebecca M Glowinski, Sara Mertz, Colin L Peachey, Lauren Miller, Pablo J Sanchez, et al. (+7)
724 [GO] 2021―Dec―05 39. Anti-Spike Monoclonal Antibody Therapy for Kidney Transplant Recipients with COVID-19 Anna Hardesty, Elizabeth Klein, Kendra Vieira, Dimitrios Farmakiotis
725 [GO] 2021―Dec―05 36. Clinical Features of and Risk Factors for 30-day Readmission after an Initial Hospitalization with COVID-19 Elisa Akagi Fukushima, Claudia Villatoro Santos, Mamta Sharma, Susan M Szpunar, Louis Saravolatz, Ashish Bhargava
726 [GO] 2021―Dec―05 29. Sustained Recovery in Patients Admitted to Hospital With COVID-19 Kasper S Moestrup, Adrian G Zucco, Joanne Reekie, Cameron MacPherson, Sisse R Otrowski, Carsten Utoft Niemann, et al. (+2)
727 [GO] 2021―Dec―05 27. Co-infections and antimicrobial use in patients hospitalized with COVID-19 Prithiv Prasad, Ioannis Zacharioudakis, Jordan Poles, Yanina Dubrovskaya, Dinuli Delpachitra, Eduardo Iturrate, Sigridh Munoz-Gomez
728 [GO] 2021―Dec―05 204. Mucosal Cytokine Profiles in Children with COVID-19 Shira H Cohen, Cameron Mertz, Rebecca M Glowinski, Sara Mertz, Fang Ye, Zhaohui Xu, et al. (+9)
729 [GO] 2021―Dec―05 170. Antimicrobial Use Before and During COVID-19 - Data from 108 VA Facilities Matthew B Goetz, Matthew B Goetz, Tina M Willson, Vanessa W Stevens, Christopher J Graber, Michael Rubin
730 [GO] 2021―Dec―05 466. Symptom Profile of Hospitalized, Adult Patients with COVID-19 - Findings From COVID-Net Database Chun T Siu, Amogh Joshi
731 [GO] 2021―Dec―05 315. A Multi-center Study to Describe Obese Pediatric Patients with COVID-19 Across the United States Roukaya Al Hammoud, James Murphy, Gabriela P Del Bianco, Gloria Heresi, Michael L Chang
732 [GO] 2021―Dec―05 448. COVID-19 Acute Care at Home: A Substitution for Hospitalization in Patients with Mild Symptoms Joel A Kammeyer, Brian Perkins, Sara Seegert, Dave E Caris, Caitlyn M Hollingshead, Evan D Brochin, Benjamin H Russell
733 [GO] 2021―Dec―05 531. Risk Factors and Therapeutic Interventions Associated with Mortality in Veterans Diagnosed With SARS-CoV-2 Infection (or COVID-19) Admitted to a Large Academic Medical Center Elwyn Welch, Shazia Raheem, Andrew Hunter, Uma Ayyala, Venkata Bandi, Lavannya Pandit, Christina Kao
734 [GO] 2021―Dec―05 285. Outcomes and Antibiotic Use in Patients with COVID-19 Admitted to an Intensive Care Unit Megan Petteys, Leigh Ann Medaris, Julie E Williamson, Travis Denmeade, Rohit Soman, William E Anderson, et al. (+2)
735 [GO] 2021―Dec―05 403. Clinical Characteristics and Outcomes of Patients with COVID-19 Admitted to the Intensive Care Unit in the Dominican Republic Rita Alexandra Rojas-Fermin, Ann Sanchez, Anel E Guzman, Edwin Germosen, Cesar Matos, Alfredo J Mena Lora
736 [GO] 2021―Dec―05 959. Online CME Successful at Improving Knowledge, Competence and Confidence on Incorporating mAbs for COVID-19 Among a Global Audience Allison Armagan, Elaine Bell, Maria B Uravich, Shanthi Voorn
737 [GO] 2021―Dec―05 565. Risk of COVID-19 Among Healthcare Workers After Launch of Vaccination Campaign at an Academic Medical Center Bhagyashri D Navalkele, Jose Lucar, James B Brock, Jason Parham
738 [GO] 2021―Dec―05 344. Prevalence and Impact of Post-Acute Sequelae of COVID-19 Among People Experiencing Homelessness in King County, WA Between September 2020 - May 2021 Emily M Scott, Sarah N Cox, Julia H Rogers, Jessica Knaster Wasse, Helen Y Chu
739 [GO] 2021―Dec―05 953. Online Medical Education Improves Knowledge of Monoclonal Antibody Treatment for COVID-19 Among Physicians Allison Armagan, Maria B Uravich
740 [GO] 2021―Dec―05 291. Epidemiology of Candidemia Rates during COVID-19 and Comparison of Outcomes in Candidemia Between COVID-19 and Non-COVID-19 Patients Angela Beatriz Cruz, Jennifer LeRose, Kenisha J Evans, Monica Meyer, Teena Chopra, Teena Chopra
741 [GO] 2021―Dec―05 901. Integrated Community Health Screening for COVID-19 and HIV Promotes HIV Diagnoses and Linkage to Care Corey L Rosmarin-DeStefano, Eugene G Martin, Gratian Salaru, Barbara Tempalski, Diana Finkel, Eileen Scarinci
742 [GO] 2021―Dec―05 279. Clinical Characteristics of Critically Ill Patients with COVID-19 and Invasive Pulmonary Aspergillosis: A Case Series From Mexico City Patricia Galindo-Lopez, Benjamin Valente-Acosta, Francisco Moreno-Sanchez, Luis Espinosa-Aguilar, Irma Hoyo-Ulloa, Raquel Mendoza-Aguilar, et al. (+3)
743 [GO] 2021―Dec―05 189. Bacteremia among COVID-19 and Non-Covid-19 Patients Admitted in the ICU paraskeui chra, Evdokia Gavrielatou, prodromos Temperikidis, Michalis Tsimaras, eleni magira
744 [GO] 2021―Dec―05 336. COVID-19 and Pneumocystis jiroveci Pneumonia Christopher Saling, Sabirah N Kasule, Holenarasipur R Vikram
745 [GO] 2021―Dec―05 1212. COVID-19 and the Importance of Institutional Trust to Public Health Karin Kricorian, Katherine Kricorian
746 [GO] 2021―Dec―05 325. Empiric Antibiotics for COVID-19 and the Utility of Procalcitonin Adrienne D Desens, Kiya D Mohadjer, Jessica Thompson
747 [GO] 2021―Dec―05 326. Radiologic Findings of COVID-19 Associated Mucormycosis (CAM) from India Aswath Govindaraju, Deepti H Vijayakumar, Raghavendra Tirupathi, Jaffar A Al-Tawfiq, Ali A Rabaan
748 [GO] 2021―Dec―05 771. COVID-19 on the Line: A Significant Increase in CLABSI in Hospitalized Patients with COVID-19 at a Major Teaching Hospital Pishoy Haroun, Michael Ben-Aderet, Meghan Madhusudhan, Matthew J Almario, Ryan C Raypon, Sharon E Fawcett, Jonathan Grein
749 [GO] 2021―Dec―05 521. Predictors of Hospitalization Due to Coronavirus Disease 2019 (COVID-19) at a Veterans Affairs Medical Center Macy Ho, Sarah Le, Rajkumar J Sevak, Jamie G Chapman-Bueno, Stephen M Berman, Patricia Chun, Yong S Moon
750 [GO] 2021―Dec―05 388. Epidemiologic and Microbiologic Characteristics of Hospital-acquired Infections in Patients with COVID-19 at Intensive Care Unit, Mexico City Paulo Castañeda-Méndez, Maria Lorena Cabrera-Ruiz, Armando Barragán-Reyes, Esperanza Aleman Aguilar, Brenda Aceves Sanchez, Maria Fernanda Ruiz Salgado, et al. (+10)
751 [GO] 2021―Dec―05 1342. TOSCANA: The Observational Seroepidemiologic Study of COVID-19 at the United States Naval Academy Eugene Millar, Eric Laing, Adam Saperstein, Jitu Modi, Christopher Heaney, Jamie Fraser, et al. (+5)
752 [GO] 2021―Dec―05 1005. COVID-19 At-Home Capillary Blood Specimen Collection Pilot - Gaining Insight into Independent Self- Collection of Blood Specimens and COVID-19 Within the Veteran Population Tseli Mohammed, Jessica V Brewer, Mary E Pyatt, Juan P Romero Casas, Stacey Whitbourne, J Michael Gaziano, et al. (+2)
753 [GO] 2021―Dec―05 525. Atovaquone for Treatment of COVID-19 (Ataq COVID-19) Trial Mamta K Jain, Mamta K Jain, Hesham Sadek, James de Lemos, Darren mcGuire, Colby Ayers, et al. (+7)
754 [GO] 2021―Dec―05 190. Epidemiology of COVID-19 Breakthrough Infections in Dallas County, Texas, 2021 Suzanne Wada, Jared Wiegand, Mary Markarian, Victoria Hung, Christina Zhu, Megin Parayil, et al. (+3)
755 [GO] 2021―Dec―05 44. Impact of Nursing Home (NH) Universal Decolonization and COVID Prevention Training on COVID-19 Burden During the 2020-2021 Winter Surge in Orange County (OC), California (CA) Gabrielle Gussin, Raveena Singh, Shruti K Gohil, Raheeb Saavedra, Thomas Tjoa, Robert Pedroza, et al. (+10)
756 [GO] 2021―Dec―05 1204. Assessing Perceptions and Efficacy of COVID-19 Case and Contact Investigations - Dallas County, Texas, 2020 Jose Serrano, Harper R Clouston, Jared Wiegand, Kyoo Shim, Nathan Popper, Kayla Maaraoui, et al. (+5)
757 [GO] 2021―Dec―05 444. County-level COVID-19 Case Fatality Rate in Medicaid Expansion States Compared to Non-Expansion States Walid El-Nahal, Stephen Berry, Kevin Psoter, Kelly Gebo
758 [GO] 2021―Dec―05 43. SARS-CoV-2 Cycle threshold (Ct) values predict future COVID-19 cases Matthew Phillips, David Quintero, Susan Butler-Wu
759 [GO] 2021―Dec―05 187. Characterizing Household Clustering of COVID-19 Cases in Fulton County, Georgia, June 2020-April 2021 Carol Liu, Sasha Smith, Allison Chamberlain, Neel Gandhi, Fazle N Khan, Steve Williams, Sarita Shah
760 [GO] 2021―Dec―05 460. Disproportionalities in COVID-19 Clinical Drug Trials in the United States: A Systematic Literature Review Daniel B Chastain, Vishwa S Patel, Alexandria M Jefferson, Sharmon P Osae, Joeanna S Chastain, Andrés F Henao Martínez, et al. (+2)
761 [GO] 2021―Dec―05 627. CURE ID as a Tool for Curating and Analyzing Drugs Used in COVID-19 Clinical Trials Reema Charles, Parvesh Paul, Heather Stone, Serghei Gorobet, Belinda Nhundu, Katarzyna M Borkowski, et al. (+2)
762 [GO] 2021―Dec―05 343. RURAL-COVID-19 Trial: Retrospective Analysis of COVID-19 Coinfections in Hospitalized Urban and Rural Adults Caroline Hamilton, Heather Frazier, Jose A Vazquez
763 [GO] 2021―Dec―05 374. Need to Improve Minority Representation through COVID-19 Community Research Partnership Keerti Dantuluri, Whitney Rossman, Lauren C Lu, Connell O Dunn, Anna M Harris, Timothy Hetherington, et al. (+3)
764 [GO] 2021―Dec―05 588. Seroconversion Among Adults After Receiving At Least One Dose of a COVID-19 Vaccine: COVID-19 Community Research Partnership, Mid-Atlantic, Southeast and Southern United States, December 2020-May 2021 DeAnna J Friedman-Klabanoff, Ashley Tjaden, Michele Santacatterina, Iqra Munawar, John W Sanders, David M Herrington, et al. (+2)
765 [GO] 2021―Dec―05 1213. Vaccine Uptake Amongst Participants in the North Carolina COVID-19 Community Research Partnership Who Were Initially Receptive or Hesitant to Receive a COVID-19 Vaccine Iqra Munawar, Austin L Seals, John W Sanders, David M Herrington, Thomas F Wierzba
766 [GO] 2021―Dec―05 292. Antibiotic Use Is Increased in Patients with Acute Respiratory Distress Syndrome (ARDS) Requiring Extracorporeal Membrane Oxygenation (ECMO) due to COVID-19 Compared with Influenza J Alex Viehman, Christina K Thorngren, M Hong Nguyen, Palash Samanta, Cornelius J Clancy, Holt Murray, Ryan Rivosecchi
767 [GO] 2021―Dec―05 348. Characteristics and Outcomes in Hospitalized Patients with Covid-19 Complicated by Fungemia: A Single Center Retrospective Study Aleena Zahra, Bettina C Fries, Bettina C Fries, Sutthichai Sae-Tia
768 [GO] 2021―Dec―05 79. Children with COVID-19 Demonstrate Distinct Serum Cytokines Profiles According to Clinical Presentations Zhaohui Xu, Rebecca M Glowinski, Shira H Cohen, Cameron Mertz, Sara Mertz, Fang Ye, et al. (+3)
769 [GO] 2021―Dec―05 350. Joint Modeling of EHR and CXR Data to Predict COVID-19 Deterioration Emily Mu, Sarah Jabbour, Michael Sjoding, John Guttag, Jenna Wiens, Adrian Dalca
770 [GO] 2021―Dec―05 275. Clinical and Laboratory Predictors of Stroke Associated with COVID-19 Disease Valerie R Bromberg, Leigh Cressman, Pam C Tolomeo, Hatem Abdallah, Alexis Holmes, Jay Garcia, et al. (+7)
771 [GO] 2021―Dec―05 LB10. Impact of SARS-CoV-2 Delta Variant on the Spectrum of Pediatric COVID-19 Disease in Arkansas Jose R Romero, Donald E Warden, Michael Cima
772 [GO] 2021―Dec―05 328. Bacteremia in Patients Hospitalized with Covid-19 Disease, Risk Factors, Impact of immunomodulator Therapy, Role of Inflammatory Markers, Antibiotic Use, and Outcomes: A Single Center Retrospective Study Aleena Zahra, Bettina C Fries, Bettina C Fries
773 [GO] 2021―Dec―05 322. Risk Factors for COVID-19 Disease Severity Using Electronic-Health Records in a Real-World Cohort in the United States Shemra Rizzo, Ryan Gan, Devika Chawla, Kelly Zalocusky, Xin Chen, Yifeng Chia
774 [GO] 2021―Dec―05 571. Safety and Immunogenicity of INO-4800, a COVID-19 DNA Vaccine as a Primary Series and Booster Pablo Tebas, Joseph Agnes, Mary Giffear, Kimberly A Kraynyak, Elliott Blackwood, Dinah Amante, et al. (+39)
775 [GO] 2021―Dec―05 423. Implementation of a Hierarchy of Controls in a Mobile Health Unit to Safely Care for Inpatients with COVID-19 during Healthcare System Surge Paige Reason, Jerome A Leis, Claudia Cocco, Lynfa Stroud, Michelle Hladunewich, Debra Carew, et al. (+6)
776 [GO] 2021―Dec―05 364. Individualized Prognostics in COVID-19 Facilitated by Computer Recognition of Blood Leukocyte Subsets Claudia R Libertin, Prakash Kempaiah, Ravindra Durvasula, Ariel Rivas
777 [GO] 2021―Dec―05 318. Description of Patients Readmitted within 30 Days from COVID-19 Hospitalization Mahmoud Al-Saadi, Carlos Malvestutto, Mohammad Mahdee Sobhanie, Courtney Hebert, Nora Colburn, Mark Lustberg
778 [GO] 2021―Dec―05 459. COVID-19 Hospitalization and 30-Day Readmission: A Cohort Study of U.S. Hospitals Essy Mozaffari, Shuting Liang, Henry Morgan Stewart, Mark Thrun, Paul Hodgkins, Richard Haubrich
779 [GO] 2021―Dec―05 551. Remdesivir and Tocilizumab for the Treatment of Severe COVID-19 in a Community Hospital: A Retrospective Cohort Study Guillermo Rodriguez-Nava, Goar Egoryan, Daniela Patricia Trelles-Garcia, Maria Adriana Yanez-Bello, Qishuo Zhang, Chul Won Chung, et al. (+5)
780 [GO] 2021―Dec―05 432. An Outbreak of Coronavirus Disease, 2019 (COVID-19) in a Skilled Nursing Facility - California, 2021: Description, Mitigation, Challenges, and Opportunities Anastasia Maletz, Grace Kang, Raymond Y Chinn, John D Malone, Hosniyeh Bagheri, Margaret M Turner, et al. (+8)
781 [GO] 2021―Dec―05 LB5. PROVENT: Phase 3 Study of Efficacy and Safety of AZD7442 (Tixagevimab/Cilgavimab) for Pre-exposure Prophylaxis of COVID-19 in Adults Myron J Levin, Andrew Ustianowski, Stéphane De Wit, Odile Launay, Miles Avila, Seth Seegobin, et al. (+13)
782 [GO] 2021―Dec―05 494. Characteristics and Outcomes of COVID-19 in Hospitalized Native American Patients: A Single-Site Retrospective Analysis T Shaifer Jones, Myles Stone, Amy Nham, Nicole A Bratsch, Trevor N Thompson, Christopher Jentoft, Ryan M Close
783 [GO] 2021―Dec―05 340. Outcomes of COVID-19 in Hospitalized SOT Recipients: Experence in Colombia, South America Fernando Rosso, Eric Tafurt
784 [GO] 2021―Dec―05 1207. Coronavirus Disease, 2019 (COVID-19) in Long-Term Care Facilities (LTCF): One Large County’s Response, California 2020-2021 Raymond Y Chinn, Sayone Thihalolipavan, Jennifer Wheeler, Grace Kang, John D Malone, Eric McDonald
785 [GO] 2021―Dec―05 317. Invasive Fungal Infections in Critically-ill Patients with COVID-19 in Mexico City Eduardo S Bojorges-Aguilar, Carla M Roman-Montes, Areli Martinez-Gamboa, Andrea Rangel-Cordero, Paulette G Diaz-Lomeli, Eduardo Rivero-Sigarroa, et al. (+3)
786 [GO] 2021―Dec―05 321. Clinical Characteristics of Hospitalized HIV Patients with COVID-19 in Miami Folusakin Ayoade, Jose G Castro, Priscilla Valls, Tanya R Quiroz, Annette Amoros
787 [GO] 2021―Dec―05 1336. Outcomes of COVID-19 in Recent Kidney Transplants Recipients at a Large Transplant Center in Miami Maria A Mendoza, Ana Coro, Yoichiro Natori, Shweta Anjan, Giselle Guerra, Adela Mattiazzi, et al. (+5)
788 [GO] 2021―Dec―05 555. Utilization of Remdesivir for COVID-19 in the National Veterans Affairs Healthcare System Aisling Caffrey, J Xin Liao, Vrishali Lopes
789 [GO] 2021―Dec―05 524. Assessing the Safety of an Outpatient Remdesivir Infusion Program for Patients with Severe COVID-19 in the Setting of a Pandemic Surge Benjamin Gee, Anita Cheruvanky, Graciela Faiad, Aldon Li, Huan Pham, Earl Quijada, et al. (+2)
790 [GO] 2021―Dec―05 515. Evolution of Treatment Patterns for Patients Hospitalized with COVID-19 in the United States Kelly Zalocusky, Shemra Rizzo, Devika Chawla, Yifeng Chia, Tripthi Kamath, Larry Tsai
791 [GO] 2021―Dec―05 26. Risk of Post-COVID-19 Dyspnea and Interstitial Lung Disease (ILD) in a Real-World Cohort of Patients Hospitalized with COVID-19 in the United States Kelly Zalocusky, Devika Chawla, Margaret Neighbors, Shemra Rizzo, Larry Tsai
792 [GO] 2021―Dec―05 121. Mucormycosis and COVID-19 in the United States: a Real-World Evidence Analysis of Risk Factors and Survival Among Patients with Mucormycosis, with and without COVID-19 Preceding the Infection Kaylen Brzozowski
793 [GO] 2021―Dec―05 498. Baricitinib in Patients with Severe Pneumonia due to COVID-19 in Veracruz, Mexico Luis Del Carpio-Orantes, Sergio García-Méndez, Gustavo Miguel Zamudio-Severino, Jesús Salvador Sánchez-Díaz, Benito Navarrete-Espinosa, Miguel Ángel Rivera-Viñas, et al. (+20)
794 [GO] 2021―Dec―05 46. Racial and Ethnic Disparities in COVID-19 Incidence among Persons with HIV in a Multisite-Cohort Edward R Cachay, laura Bamford, Adrienne Shapiro, Bridget M Whitney, Darcy Wooten, Maile Karris, et al. (+12)
795 [GO] 2021―Dec―05 450. Type I Interferon Autoantibodies Are Detected in Those with Critical COVID-19, Including a Young Female Patient Debra Yee, Marana Tso, Elana Shaw, Lindsey B Rosen, Emily Samuels, Paul Bastard, et al. (+16)
796 [GO] 2021―Dec―05 411. Significance of a Known Epidemiological Link to a COVID-19 Index Case and Severity of COVID-19 Infection Christopher Kandel, Allison McGeer, Joshua Friedland, Altynay Shigayeva, Samira Mubareka
797 [GO] 2021―Dec―05 360. Evaluation of Cycle Threshold Values in Patients with Symptomatic COVID-19 Infection Danielle Dixon, Julieta Madrid-Morales, Jose Cadena-Zuluaga, Christopher R Frei
798 [GO] 2021―Dec―05 961. Experience, Lessons, and Strategies in Developing a High-Impact Real-Time Learning Network for Clinicians Caring for Patients with COVID-19 Infection Ravina Kullar, Payal K Patel, Marjorie Connolly, Coran Jallah, Gayle Levy, Varun Phadke, et al. (+6)
799 [GO] 2021―Dec―05 409. High Engagement in Social Distancing and Mask Wearing and Associations with Reduced COVID-19 Infection Among California College Students Lindsey Walicek, Annette Regan, Kelly L’Engle, Marie-Claude Couture
800 [GO] 2021―Dec―05 201. Comparison of Bloodstream Infections Between Hospitalized Patients with and without COVID-19 Infection During the First Wave of the COVID-19 Pandemic in a Community Hospital in South Bronx: An Observational Study Afsheen Afzal, Edgar Gomez, Victor Perez Guttierrez, Aye Myat Mon, Carolina Moreira Sarmiento, Amna Khalid, et al. (+12)
801 [GO] 2021―Dec―05 549. Monoclonal Antibody Therapy for COVID-19 Infection in Michigan: The Flint Experience Mariam Younas, Danielle Osterholzer, Brandon R Flues, Carlos Rios-Bedoya, Philip McDonald, Ghassan Bachuwa, et al. (+2)
802 [GO] 2021―Dec―05 402. COVID-19 Infection in Nepal: Epidemiological Analysis from April 2020 to March 2021 Hai V Le
803 [GO] 2021―Dec―05 467. COVID-19 Infection in Persons Living with HIV in a Network of Community Health Centers in New York Aisha S Khan, Christine A Kerr, Jenny Doyle, Sonia Punj, Julie Coleman, Iris Arzu, et al. (+3)
804 [GO] 2021―Dec―05 310. Cryptococcal Infection Following COVID-19 infection in Solid Organ Transplant Recipients: A Case Series Jeremey Walker, Peter Pappas, Lauren Nicholas Herrera, Cameron White, Anoma Nellore, Todd P McCarty
805 [GO] 2021―Dec―05 146. Intact Sense of Taste and Smell During COVID-19 Infection Is Associated with Absence of of SARS-CoV-2 Spike Protein Antibody Responses within 3 Months of Symptomatic Illness James M Wilson, Sheena Gillani, Robert Bencshop, Josh Poorbaugh, Ajay Nirula, Lin Zhang, et al. (+6)
806 [GO] 2021―Dec―05 181. Potential Benefit of Masking and other COVID-19 Infection Prevention Measures on Late-Onset Infections in the NICU Charlene Bultmann, Jaclyn Wiggins, Sagori Mukhopadhyay, Dustin Flannery, Mark Conaway, Miren Dhudasia, et al. (+18)
807 [GO] 2021―Dec―05 426. COVID-19 Infection Prevention Practices That Exceed CDC Guidance: Balancing Extra Caution Against Impediments to Care Shruti K Gohil, Edward Septimus, Kenneth Sands, Eunice J Blanchard, Julia Moody, Annabelle De St Maurice, et al. (+16)
808 [GO] 2021―Dec―05 41. Assessing Past vs Present COVID-19 Infection: A Survey of Criteria for Discontinuing Precautions in Asymptomatic Patients Shruti K Gohil, Annabelle De St Maurice, Deborah S Yokoe, Deborah S Yokoe, Stuart H Cohen, Francesca J Torriani, et al. (+7)
809 [GO] 2021―Dec―05 926. COVID-19 Infections After SARS-CoV-2 Vaccination in Solid Organ Transplant Recipients Kapil Saharia, Judy Streit, Susan E Beekmann, Philip M Polgreen, Matthew Kuehnert, Dorry Segev, et al. (+2)
810 [GO] 2021―Dec―05 331. Hospitalized COVID-19 infections in Infants < 1 Year of Age Christina Gagliardo, Eberechi I Nwaobasi-Iwuh, Niva Shah, Aparna Prasad, Neeraja Kairam, Stephanie Chiu, et al. (+4)
811 [GO] 2021―Dec―05 365. Assessing Provider Utilization of COVID-19 Inflammatory Marker Trends in Hospitalized Patients and Implications in Optimizing Value-Based Care During a Pandemic Praveen Subramanian, Lucy Stun, Nathan Bahr, Lewis Satterwhite, Maharshi Bhakta, Wissam El Atrouni, et al. (+2)
812 [GO] 2021―Dec―05 446. Prognostic Value of Absolute Lymphocyte Count for Disease Severity and Clinical Outcomes in Adult COVID-19 Inpatients Jianli Niu, Candice Sareli, Maria Deane, Aharon E Sareli
813 [GO] 2021―Dec―05 414. Observed Time Burden with Nursing Practices in an Emergency Room COVID-19 Isolation Zone at a University Affiliated Hospital in Korea Imyoung Choi, JaHyun Kang
814 [GO] 2021―Dec―05 559. A Nationwide Survey of COVID-19 Management in the Dominican Republic Over the Course of the Pandemic Alfredo J Mena Lora, Rita Alexandra Rojas-Fermin, David de Luna, Stephanie L Echeverria, Yori Roque, Ruben Calcano, et al. (+9)
815 [GO] 2021―Dec―05 973. Utilization of Project ECHO for COVID-19 Medical Knowledge and Best Practices for Health Professionals serving an Underserved Population Natalia Rodriguez, Melanie Goebel, Sheena Bhushan, Shital Patel
816 [GO] 2021―Dec―05 861. Impact of COVID-19 Mitigation Measures on PrEP Care at a Safety Net Health System in Atlanta Valeria D Cantos, Kate Ferencsik, Jennifer Prevot, Kelly Reyna, Gabriela Georgial, Karla I Galaviz, et al. (+5)
817 [GO] 2021―Dec―05 537. Implementation of a Workflow for COVID-19 Monoclonal Antibody Infusions at a Veterans Affairs Medical Center Pratish C Patel, Ayne Adenew, Angela McKnight, Kevin Jeng, Angelike P Liappis
818 [GO] 2021―Dec―05 522. Evaluation of Three COVID-19 Monoclonal Antibody Regimens in the Context of Rising B.1.526 Prevalence in New York City Hongkai Bao, Yi Guo, Kelsie Cowman, Victor Chen, Priya Nori, Priya Nori
819 [GO] 2021―Dec―05 558. Implementation and Outcomes of a COVID-19 Monoclonal Antibody Treatment Program in an Urban Safety-net Community Hospital Alfredo J Mena Lora, Stephanie L Echeverria, Fischer Herald, James McSweeney, Harshil Gumasana, Rodrigo M Burgos, Scott Borgetti
820 [GO] 2021―Dec―05 288. Clinical Variables Associated with COVID-19 Mortality and ICU Admission in a Public Safety-net Hospital in Chicago Ruben A Hernandez-Acosta, Juan Sarmiento, Palak Patel, Michael Hoffman, Katayoun Rezai
821 [GO] 2021―Dec―05 339. COVID-19 Mortality in a Private Hospital in Mexico City Maria Lorena Cabrera Ruiz, Paulo Castañeda-Méndez, Daniel Aguilar-Zapata, Javier Reyes Mar, Gonzalez Chon Octavio, Luis E Soto-Ramirez
822 [GO] 2021―Dec―05 443. Pre-vaccination Antibody Titers Against Seasonal Coronaviruses And Antibody Responses to the Pfizer-BioNTech BNT162b2 COVID-19 mRNA Vaccine in Healthcare Workers Eric Laing, Si’Ana Coggins, Kevin Schully, Emily Samuels, Emilie Goguet, Matthew Moser, et al. (+19)
823 [GO] 2021―Dec―05 572. Real-world Effectiveness of COVID-19 mRNA Vaccines against Hospitalizations and Deaths in a Retrospective Cohort Farhaan S Vahidy, Lauren Pischel, Mauricio E Tano, Alan Pan, Marc L Boom, Henry Sostman, et al. (+2)
824 [GO] 2021―Dec―05 25. Immunogenicity and Reactogenicity of COVID-19 mRNA Vaccines in Allogeneic Stem Cell Transplant Recipients Bruce P Bausk, Amy C Sherman, Michaël Desjardins, Natalie E Izaguirre, Chi-An Cheng, Megan Powell, et al. (+17)
825 [GO] 2021―Dec―05 586. Immunogenicity of COVID-19 mRNA Vaccines in Patients with Lymphoid Malignancies Natalie E Izaguirre, Amy C Sherman, Jennifer Crombie, Michaël Desjardins, Chi-An Cheng, Tal Gilboa, et al. (+9)
826 [GO] 2021―Dec―05 404. COVID-19 Normality Rate: Criteria for Optimal Time to Return to In-person Learning Carlos Starling, Jackson Machado-Pinto, Unaí Tupinambás, Estevão Urbano Silva, Bráulio R G M Couto
827 [GO] 2021―Dec―05 352. COVID-19 Not a Risk Factor of Alopecia Areata: Results of a National Cohort Study in South Korea Jeehyun Kim, Kwan Hong, Sujin Yum, Raquel Elizabeth Gomez Gomez, Byung Chul Chun
828 [GO] 2021―Dec―05 130. Effects of COVID-19 on a Complex Behavioral Intervention to Improve the Diagnosis and Management of UTI in Nursing Homes James H Ford, Sally Jolles, Dee Heller, Katie Selle, Daniela Uribe-Cano, Susan Nordman-Oliveira, et al. (+3)
829 [GO] 2021―Dec―05 753. Impact of COVID-19 on Healthcare Facility-Onset Clostridiodes difficile Infection Geehan Suleyman, Rafa Khansa, Ramesh Mayur, Indira Brar, Rachel Kenney
830 [GO] 2021―Dec―05 171. The Impact of COVID-19 on Healthcare-Associated Infections Meghan A Baker, Kenneth Sands, Susan S Huang, Ken Kleinman, Edward Septimus, Neha Varma, et al. (+16)
831 [GO] 2021―Dec―05 454. Impact of Covid-19 on Infectious Disease Fellows in the United States: A National Survey to Identify Targets for Intervention Shuba Balan, Shweta Anjan, Alison Ohringer, Jose Gonzales-Zamora, Deborah Jones Weiss, Michele I Morris, et al. (+3)
832 [GO] 2021―Dec―05 LB3. Baricitinib plus Standard of Care for Hospitalized Adults with COVID-19 on Invasive Mechanical Ventilation or Extracorporeal Membrane Oxygenation: Results of a Randomized, Placebo-Controlled Trial E Wesley Ely, Athimalaipet V Ramanan, Cynthia E Kartman, Stephanie de Bono, Ran Liao, Maria Lucia B Piruzeli, et al. (+4)
833 [GO] 2021―Dec―05 597. The Impact of COVID-19 on Outpatient Intravenous Antimicrobial Therapy (OPAT) in Physician Office Infusion Centers (POICs) Clifford P Martin, Robin H Dretler, Jorge R Bernett, Barry Statner, Thomas K Sleweon, Quyen Luu, et al. (+5)
834 [GO] 2021―Dec―05 415. A Whole Genome Sequencing Analysis of a Multi-unit Long-term Care Facility COVID-19 Outbreak Ling Yuan Kong, Leighanne Parkes, Yves Longtin, Christina Greenaway, Jerry Zaharatos, Vivian Loo, et al. (+5)
835 [GO] 2021―Dec―05 366. Abbott BinaxNOW Rapid Antigen Test Performance in Detecting SARS-CoV-2 Infections in a COVID-19 Outbreak Among Horse Racetrack Workers Krishna Surasi, Kristin J Cummings, Carl V Hanson, Mary Kate Morris, Maria Salas, David Seftel, et al. (+4)
836 [GO] 2021―Dec―05 425. Sustained Control and Prevention of COVID-19 Outbreaks in Detroit Skilled Nursing Facilities Seema Joshi, Abigail Manning, James Bivins, Samia Arshad, Amen Agbonze, Anita M Berger, et al. (+14)
837 [GO] 2021―Dec―05 188. Visualizing the Impact of a Wedding Leading to COVID-19 Outbreaks in Healthcare Settings, Washington State, July - August 2020 Audrey Brezak, Anna Unutzer, James W Lewis, Shauna Clark, Jessica Ferro, Siri Bliesner, et al. (+11)
838 [GO] 2021―Dec―05 433. Role of Community Vaccination Coverage in Controlling Future COVID-19 Outbreaks in Nursing Homes: A Modeling Study Brajendra K Singh, Joseph Walker, Prabasaj Paul, Sujan Reddy, John A Jernigan, John A Jernigan, Rachel Slayton
839 [GO] 2021―Dec―05 32. Host Immune-Protein Signature Combining TRAIL, IP-10 and CRP for Early and Accurate Prediction of Severe COVID-19 Outcome Alon Angel, Niv Samuel Mastboim, Oded Shaham, Tahel Ilan Ber, Roy Navon, Einav Simon, et al. (+23)
840 [GO] 2021―Dec―05 747. Association of Clostridiodes difficile Infection Incidence With Renewed Vigor in Infection Prevention Practices With the Onset of the COVID-19 Pandemic Ahmed A Khan, Sana Waqar
841 [GO] 2021―Dec―05 624. Perceptions of Telemedicine among Infectious Disease Outpatient Providers during the COVID-19 Pandemic Prishanya Pillai, Karen Carvajal, Angelina Winbush, Rohith Palli, Ted Louie
842 [GO] 2021―Dec―05 738. Comparison of Characteristics of US International Travelers Seeking Pretravel Health Consultations at US Global TravEpiNet Sites Before and During the COVID-19 Pandemic Mylinh H Le, Sowmya R Rao, Alison T Walker, Edward T Ryan, Regina C LaRocque, Emily P Hyle
843 [GO] 2021―Dec―05 465. Mental Health Treatment Disparities During the COVID-19 Pandemic Katherine Kricorian, Karin Kricorian
844 [GO] 2021―Dec―05 557. Trends in Remdesivir Treatment Over the Course of the COVID-19 Pandemic J Xin Liao, Vrishali Lopes, Aisling Caffrey
845 [GO] 2021―Dec―05 422. Sustainability of Improvements to Hand Hygiene Performance Throughout the COVID-19 Pandemic Victoria R Williams, Matthew Muller, Jeff Powis, Daniel R Ricciuto, Dominik Mertz, Kevin Katz, et al. (+6)
846 [GO] 2021―Dec―05 428. Assessing the Confidence, Knowledge and Preferences of Hospital Staff with Regards to Personal Protective Equipment (PPE) Practices During the COVID-19 Pandemic Rachel Brown, Sharon Markman, Amanda Brown, Rukhshan Mian, Vineet Arora, Craig Umscheid
847 [GO] 2021―Dec―05 469. The Mental Health Implications of Job Loss for Never-married Women During the COVID-19 Pandemic Katherine Kricorian
848 [GO] 2021―Dec―05 429. Infection Prevention During Use of a Warm Zone Model in Cohort Patient Care Locations during the COVID-19 Pandemic Joseph Sacht, Samantha Holton, Mylinh Yun, Jay Varkey
849 [GO] 2021―Dec―05 477. Increased Referrals for New PFAPA (Aphthous Stomatitis, Pharyngitis, Adenitis) Diagnosis During the COVID-19 Pandemic Bessey Geevarghese, Shan Sun, Ravi Jhaveri
850 [GO] 2021―Dec―05 295. SARS-CoV-2 Infection in a Referral Cancer Center in Mexico City During the First Year of the COVID-19 Pandemic Diana Vilar-Compte, Daniel De La Rosa Martinez, Alexandra Martín-Onraet, Carolina Pérez-Jiménez, Beda Islas-Muñoz, Pamela Alatorre-Fernández, et al. (+5)
851 [GO] 2021―Dec―05 1340. The Burden of Influenza and Rhinovirus Among Hospitalized Adults Post the COVID-19 Pandemic Olivia D Reese, Ashley Tippett, Laila Hussaini, Luis Salazar, Megan Taylor, Caroline Ciric, et al. (+16)
852 [GO] 2021―Dec―05 1175. Influenza Vaccine Hesitancy in Hospitalized Children, Before and During the COVID-19 Pandemic Marisa Orbea, Jose Dominguez, Rachel Cunningham, C Mary Healy, Julie A Boom, Claire Bocchini
853 [GO] 2021―Dec―05 152. Use of Antimicrobials among Suspected COVID-19 Patients at Selected 12 Hospitals in Bangladesh: Findings from the First Wave of COVID-19 Pandemic Syeda Mah-E-Muneer, Md Zakiul Hassan, Md Abdullah Al Jubayer Biswas, Zubair Akhtar, Pritimoy Das, Fahmida Rahman, et al. (+2)
854 [GO] 2021―Dec―05 163. MIC Shifts in Response to Increased Antibiotic Utilization During COVID-19 Pandemic Jonathan Byrd, Neena Thomas-Gosain, Jane V Eason, Jessica Bennett, Jarred Bowden
855 [GO] 2021―Dec―05 160. Urgent Care Prescriber Perspectives on Antibiotic Prescribing During the COVID-19 Pandemic Brooke Betts, David R Ha, Marisa Holubar, Marisa Holubar, Maja Artandi, Sharon Onguti, Ian Nelligan
856 [GO] 2021―Dec―05 16. An Ambulatory Quality Improvement Initiative to Optimize Influenza Vaccination Amongst Adults Living with HIV During the COVID-19 Pandemic Deborah A Kahal, Christopher James, Brian Wharton, Sherine Eaddy, Elizabeth Gaines, Karen Henry, et al. (+2)
857 [GO] 2021―Dec―05 161. The Agency for Healthcare Research and Quality (AHRQ) Safety Program for Improving Antibiotic Use: Antibiotic Stewardship Intervention in 389 United States Ambulatory Practices during the COVID-19 Pandemic Sara C Keller, Tania M Caballero, Pranita Tamma, Pranita Tamma, Melissa A Miller, Prashila Dullabh, et al. (+7)
858 [GO] 2021―Dec―05 183. Decrease in Invasive Pneumococcal Disease in 7 United States Children’s Hospitals during the COVID-19 Pandemic Adriana Sarmiento Clemente, Sheldon L Kaplan, William J Barson, Philana L Lin, Jose R Romero, John S Bradley, et al. (+4)
859 [GO] 2021―Dec―05 152. Sharp Decline in Rates of Community Respiratory Viral Infections Among NIH Clinical Center Patients During the COVID-19 Pandemic Michele Woolbert, Ninet Sinaii, Christine Spalding, David K Henderson, Tara N Palmore
860 [GO] 2021―Dec―05 1129. Outpatient Prescribing During the COVID-19 Pandemic Ganga Moorthy, Congwen Zhao, Michael J Smith
861 [GO] 2021―Dec―05 867. Telehealth and HIV Care During the COVID-19 Pandemic Smitha Gudipati, Monica Lee, Indira Brar, Norman Markowitz
862 [GO] 2021―Dec―05 874. Impact of Telehealth in HIV Ambulatory Clinic during COVID-19 Pandemic Impact of Telehealth in HIV Ambulatory Clinic during COVID-19 Pandemic Sandhya Nagarakanti, Eliahu Bishburg, Donna George, Kristen Ehlers
863 [GO] 2021―Dec―05 174. Increase in Candida auris cases in New Jersey healthcare facilities during the COVID-19 pandemic - 2017-2020 Reed Magleby, Gabriel Innes, Diya Cherian, Jessica Arias, Jason Mehr, Kaitlin Forsberg, et al. (+2)
864 [GO] 2021―Dec―05 1441. Significant Decrease in the Incidence Rate of Common Outpatient Upper Respiratory Tract Infection Diagnoses per Clinic Visit in the First Respiratory Season of October 2020 to March 2021 During the Covid-19 Pandemic. A Report From an Outpatient Antimicrobial Stewardship Program at a community hospital in Brooklyn Jilan M Shah, Olga Badem, Zeyar Thet, Thinzar Wai, Karthik Seetharam, Olawale Akande, et al. (+5)
865 [GO] 2021―Dec―05 758. Increased Prevalence of Clostridioides difficile Infection During the COVID-19 Pandemic Among Hospitalized Veterans in South Texas, USA Eric H Young, Erica Beck, Delvina Ford, Julieta Madrid-Morales, Ann Hoffman, Jose Cadena-Zuluaga, et al. (+2)
866 [GO] 2021―Dec―05 476. A Global Survey of Countermeasures Against the COVID-19 Pandemic Among Solid Organ Transplant Centers Aasith Villavicencio, Mohammed Raja, Deepali Kumar, Deepali Kumar, Lara Danziger-Isakov, Lara Danziger-Isakov, et al. (+5)
867 [GO] 2021―Dec―05 12. Modeled Impact of the COVID-19 Pandemic and Associated Reduced Adult Vaccinations on Herpes Zoster in the United States Elizabeth M La, Desmond Curran, Ahmed Salem, David Singer, Nicolas Lecrenier, Sara Poston
868 [GO] 2021―Dec―05 1123. Appropriateness of Antibiotic Prescribing Through the COVID-19 Pandemic and Associated Telehealth Visits Bethany A Wattles, James A Stahl, Kahir S Jawad, Yana Feygin, Maiying Kong, Navjyot Vidwan, et al. (+2)
869 [GO] 2021―Dec―05 779. COVID-19 Pandemic and Catheter-associated Urinary Tract Infection Trends Geehan Suleyman, Rita Kassab, Smitha Gudipati, Ramesh Mayur, Indira Brar
870 [GO] 2021―Dec―05 385. SARS-CoV-2 Infections Among Military Personnel Deployed on the USNS COMFORT to New York City During the COVID-19 Pandemic and One-Year Follow-Up Elizabeth Cooper, Tida Lee, Eric Laing, Andrew Ritter, Melissa Lee, Matthew Baker, et al. (+11)
871 [GO] 2021―Dec―05 774. Outbreak of Central-Line-Associated Bloodstream Infections (CLABSI) amid the COVID-19 Pandemic Associated with Changes in Central Line Dressing Care Accompanying Changes in Nursing Education, Nursing Documentation, and Dressing Supply Kits Ahad Azeem, Irene L Newquist, Lesley L Royal, Kimberly S Hemrick, Zachary A Creech, Shiv A Patel, et al. (+4)
872 [GO] 2021―Dec―05 154. Antibiotic Use During Three Separate Waves of the COVID-19 Pandemic at a Large Academic Medical Center in Detroit, MI Deepika Sivakumar, Shelbye R Herbin, Raymond Yost, Marco R Scipione
873 [GO] 2021―Dec―05 48. Time Between Viral Loads for Suppressed and Non-Suppressed People with HIV During the COVID-19 Pandemic Compared to Pre-Pandemic Walid El-Nahal, Nicola Shen, Catherine Lesko, Anthony Fojo, Bryan Lau, Jeanne Keruly, et al. (+5)
874 [GO] 2021―Dec―05 410. The Importance of Personal Protective Equipment Education Opportunities and Messages of Encouragement at the Workplace to Reduce Burnout: Cross-sectional Survey After the First Wave of the COVID-19 Pandemic in Japan Takahiro Matsuo, Fumika Taki, Daiki Kobayashi, Torahiko Jinta, Chiharu Suzuki, Akiko Ayabe, et al. (+5)
875 [GO] 2021―Dec―05 1199. Decreased Human Respiratory Syncytial Virus Activity during the COVID-19 Pandemic in Japan: An Ecological Time-Series Analysis, 2014 through 2020 Keita Wagatsuma, Iain S Koolhof, Reiko Saito
876 [GO] 2021―Dec―05 1209. The Evolving Nature of Syndromic Surveillance During the COVID-19 Pandemic in Massachusetts Sarah J Willis, Karen Eberhardt, Liisa Randall, Alfred DeMaria, Catherine M Brown, Lawrence C Madoff, et al. (+4)
877 [GO] 2021―Dec―05 804. Infection Control and Clinical Support in Long-Term Care Homes During the COVID-19 Pandemic in North Toronto: A Quasi-Experimental Study Maria M Magaz, Jaclyn O’Brien, Victoria R Williams, Christina Chan, Adrienne Chan, Natasha Salt, Jerome A Leis
878 [GO] 2021―Dec―05 341. Evaluation of Antimicrobial Use and Prescribing Patterns During the COVID-19 Pandemic in Patients Receiving Tocilizumab Barbara Barsoum, Kai-Ming Chang, Nicole Mulvey, Henry Donaghy, Thien-Ly Doan
879 [GO] 2021―Dec―05 34. Stemming the Rise in Antibiotic Prescription for Community Acquired Respiratory Infections (ARI) During COVID-19 Pandemic in Singapore General Hospital (SGH) Shena Yun Chun Lim, Peijun Yvonne Zhou, Daphne Yah Chieh Yii, Kai Chee Hung, Lai Wei Lee, Yi Xin Liew, et al. (+9)
880 [GO] 2021―Dec―05 707. Hospital-Onset Clostridioides difficile Infection Rates During COVID-19 Pandemic in the ICU Patients Evdokia Gavrielatou, prodromos Temperikidis, Michalis Tsimaras, eleni magira
881 [GO] 2021―Dec―05 1179. PCV13 Pediatric Routine Schedule Completion and Adherence Before and During the COVID-19 Pandemic in the US Liping Huang, Jennifer L Nguyen, Johnna Perdrizet, Tamuno Alfred, Adriano Arguedas
882 [GO] 2021―Dec―05 101. PCV13 Pediatric Vaccination Disparity and Impact Due to COVID-19 Pandemic in the US Liping Huang, Jennifer L Nguyen, Johnna Perdrizet, Tamuno Alfred, Adriano Arguedas
883 [GO] 2021―Dec―05 970. Medical Student Engagement with the COVID-19 Pandemic Is Increased Through Participation in a Preclinical Elective Kaelyn C Cummins, Katherine Naeger, Prathit A Kulkarni
884 [GO] 2021―Dec―05 169. The Resurgence of Candida auris in California during the Novel Coronavirus (COVID-19) Pandemic, May 2020-May 2021 Tisha Mitsunaga, Diana Holden, Ellora Karmarkar, Idamae Kennedy, Teresa Nelson, Vikram Haridass, et al. (+24)
885 [GO] 2021―Dec―05 1339. Impact of COVID-19 Pandemic on Activity of Other Respiratory Viral Pathogen and Norovirus Lauren DiBiase, Emily Sickbert-Bennett, David J Weber, David J Weber, Melissa B Miller
886 [GO] 2021―Dec―05 47. Impact of COVID-19 Pandemic on an Emergency Department Opt-out HIV Screening Program: An Interrupted Time Series Analysis Jianli Niu, Paula Eckardt
887 [GO] 2021―Dec―05 162. The Impact of the COVID-19 Pandemic on Antibiotic Prescribing in Pediatric Primary Care Lauren Dutcher, Yun Li, Giyoung Lee, Robert Grundmeier, Keith W Hamilton, Jeffrey Gerber
888 [GO] 2021―Dec―05 408. Impact of the COVID-19 Pandemic on Antimicrobial Use and Resistance in the United States and the Dominican Republic Alfredo J Mena Lora, Rita Alexandra Rojas-Fermin, Stephanie L Echeverria, Katia Castro, Anel E Guzman, Scott Borgetti, Susan C Bleasdale
889 [GO] 2021―Dec―05 964. Impact of the COVID-19 Pandemic on Bedside Medical Education: A Mixed-Methods Study Eva Clark, Jennifer Freytag, Sylvia J Hysong, Bich Dang, Thomas P Giordano, Prathit A Kulkarni
890 [GO] 2021―Dec―05 660. Effect of the COVID-19 Pandemic on Blood Culture Contamination Rates and Quality Improvement Processes Alexander G Hosse
891 [GO] 2021―Dec―05 770. Impact of COVID-19 Pandemic on Central Line-associated Bloodstream Infections in Metropolitan Detroit Geehan Suleyman, Nicholas sturla, Smitha Gudipati, Indira Brar, Ramesh Mayur
892 [GO] 2021―Dec―05 886. The Impact of the COVID-19 Pandemic on Clinical Follow-Up, Monitoring and Regimen Discontinuation for People Living with HIV in the US Gerald Pierone, Jennifer S Fusco, Laurence Brunet, Cassidy Henegar, Jean A van Wyk, Supriya Sarkar, et al. (+4)
893 [GO] 2021―Dec―05 896. Examining the Impact of the COVID-19 Pandemic on Delivery of HIV Care and Prevention Services Among Patients in a Ryan White Clinic Michelle Zhang, Sharlay Butler, Jason Kennedy, Molly McKune, Ghady Haidar, Deborah McMahon
894 [GO] 2021―Dec―05 492. Impact of the COVID-19 Pandemic on Diabetes Surrogate Markers in a Population of People Living with HIV Tyler Maxwell, Esther Kanner, Nubriel Hernandez, Suzanne Molino, Jessica E Yager, Shannon Ramdeen, Roopali Sharma
895 [GO] 2021―Dec―05 172. Impact of COVID-19 Pandemic on Healthcare-associated Infections (HAIs) in a Large Network of Hospitals Sonali D Advani, Sonali D Advani, Emily Sickbert-Bennett, Elizabeth Dodds Ashley, Andrea Cromer, Yuliya Lokhnygina, et al. (+5)
896 [GO] 2021―Dec―05 1338. Before and After: The Impact of the COVID-19 Pandemic on Influenza-Like Illness Trends in PAIVED Rhonda E Colombo, Stephanie A Richard, Christina Schofield, Limone Collins, Anuradha Ganesan, Casey Geaney, et al. (+16)
897 [GO] 2021―Dec―05 1188. The Effect Of The COVID-19 Pandemic On Influenza-Related Hospitalization, Intensive Care Admission And Mortality In Canadian Children Helen E Groves, Jesse Papenburg, Kayur Mehta, Julie A Bettinger, Manish Sadarangani, Scott Halperin, Shaun Morris
898 [GO] 2021―Dec―05 193. Impact of COVID-19 Pandemic on Pulmonary Tuberculosis Evaluations and Diagnosis at a Large Safety Net Hospital in Los Angeles, California Aditya J Jones, Edward C Jones-Lopez, Susan Bulter-Wu, Melissa L Wilson, John Rodman, Christian Voyageur, Brenda E Jones
899 [GO] 2021―Dec―05 706. Effect of the Covid-19 Pandemic on Rates of Recurrent Clostridiodes difficile Infection in the Veterans Affairs System Dimitri M Drekonja, Jane Zhang, Andrew R Reinink, Ruth Anway, Sean Nugent, Aasma Shaukat
900 [GO] 2021―Dec―05 845. Impact of the COVID-19 Pandemic on Routine HIV Screening in an Emergency Department Elizabeth A Aguilera, Gilhen Rodriguez, Gabriela P Del Bianco, Gloria Heresi, James Murphy, Samuel Prater
901 [GO] 2021―Dec―05 811. Impact of the COVID-19 Pandemic on Surgical Volume and Surgical Site Infections (SSI) in a Large Network of Community Hospitals Erin Gettler, Jessica Seidelman, Becky A Smith, Deverick J Anderson
902 [GO] 2021―Dec―05 604. Impact of COVID-19 Pandemic on Telehealth Practices in Pediatric Infectious Diseases Sindhu Mohandas, Daniel Olson, Sergio Fanella, Amin Hakim, Claudia Gaviria-Agudelo, Sabah Kalyoussef
903 [GO] 2021―Dec―05 1407. The Latent Tuberculosis Infection Cascade of Care during the COVID-19 Pandemic Response in a Mid-Sized US City Trevor M Stantliff, Lauren Houshel, Rinki Goswami, Serenity Millow, Gabrielle Cook, Robin Knapmeyer, et al. (+3)
904 [GO] 2021―Dec―05 452. Correlation of Charleston Comorbidity Index Score as the COVID-19 Pandemic Surged Throughout HCA Healthcare Facilities and Patient Outcomes Irene Riestra Guiance, Ernesto Robalino Gonzaga, Isabel Riestra, Steven Char, Minh Q Ho
905 [GO] 2021―Dec―05 19. Delivery of Flu Immunizations to Healthcare Workers During COVID-19 Pandemic Using a Multidisciplinary Flu Team Approach in a Tertiary Center in the Middle East Lyssette Cardona, Shafii Mohammed, Samah Nour, Mu’ed Alkhalaileh
906 [GO] 2021―Dec―05 420. Emergency Nurses’ Experiences over 1 Year of the COVID-19 Pandemic: A Qualitative Study Ki Rog Lee, JaHyun Kang
907 [GO] 2021―Dec―05 165. Decreased Antimicrobial Consumption and Decreased Rates of Multi-drug Resistant Organisms Following Onset of the COVID-19 Pandemic: Experience from an Australian Tertiary Hospital Michael Moso, Kelly Cairns, Trisha Peel, Nenad Macesic
908 [GO] 2021―Dec―05 149. Impact of Stewardship on Antibiotic Utilization Rates During the COVID-19 Pandemic: Successes and Challenges in a Regional Hospital Ana Macias, Jennifer Elgin, Donna Duerson, Cirle A Warren
909 [GO] 2021―Dec―05 11. People Living with HIV During the COVID-19 Pandemic: Who Did (or Did Not) Receive Annual Influenza Vaccination? Deborah A Kahal, Brian Wharton, Christopher James, Richard Caplan, Bincsik K Arlene
910 [GO] 2021―Dec―05 974. The Use of Social Media for Medical Education During the COVID-19 Pandemic; A Vision to the Future Maria Jose Reyes Fentanes, Paula Amescua Guerra, Armelle Perez Cortes Villalobos
911 [GO] 2021―Dec―05 327. Assessment of Bacterial Co-infection Rates and Antibiotic Exposure in COVID-19 Patients Adam J Luetkemeyer, Nick Bennett, Laura Aragon, Jeannette Ploetz, Sarah E Boyd
912 [GO] 2021―Dec―05 304. Impact of Antibiotic Prophylaxis Prior to Treatment with Steroids and Tocilizumab in COVID-19 Patients Francisco Javier Membrillo de Novales, Miriam Estébanez Muñoz, Tatiana Mata Forte, Germán Ramírez-Olivencia, María Isabel Zamora Cintas, María Simón Sacristán, et al. (+3)
913 [GO] 2021―Dec―05 330. Evaluating the Relationship Between Comorbidity Treatment Status and In-hospital Mortality Among COVID-19 Patients Cristy Davenport, Sharmon P Osae, Geren Thomas, Henry N Young, Andrés F Henao Martínez, Carlos Franco-Paredes, Daniel B Chastain
914 [GO] 2021―Dec―05 455. Diagnostic Value of Hematological Parameters in Different Stages of the Disease in Covid-19 Patients Ruhma Ali, Aditya Patel, Kok Hoe Chan, Jihad Slim
915 [GO] 2021―Dec―05 504. Case SEries: Nasal Antimicrobial Photodisinfection (APDT) as Treatment Protocol for Asymptomatic and Early Stage COVID-19 Patients Jack Kolenda, Josepmaria Argemi
916 [GO] 2021―Dec―05 307. Predictors of Respiratory Bacterial Co-Infection in Hospitalized COVID-19 Patients Erica E Reed, Austin Bolker, Kelci E Coe, Jessica M Smith, Kurt Stevenson, Shu-Hua Wang
917 [GO] 2021―Dec―05 1335. High Serum Levels of Interleukin-10 as a Predictor Factor of In-Hospital Mortality in COVID-19 Patients Salome Gomez-Duque, Enrique Gamboa-Silva, Ingrid G Bustos-Moya, Yuli Fuentes, Julian Lozada-Arciniegas, Elsa Daniela Ibañez-Prada, et al. (+9)
918 [GO] 2021―Dec―05 LB2. Safety and Efficacy of Combination SARS-CoV-2 Monoclonal Neutralizing Antibodies (mAb) BRII-196 and BRII-198 in Non-Hospitalized COVID-19 Patients Teresa H Evering, Mark Giganti, Kara W Chew, Michael Hughes, Carlee Moser, David Alain Wohl, et al. (+12)
919 [GO] 2021―Dec―05 299. D-dimer as an ICU Admission Risk Predictor in COVID-19 Patients, A Prospective Study Oriana Narváez - Ramírez, Lina Morales-Cely, Ingrid G Bustos-Moya, Yuli Viviana Fuentes-Barreiro, Julian Lozada-Arciniegas, Elsa Daniela Ibañez-Prada, et al. (+7)
920 [GO] 2021―Dec―05 138. Tele-COVID Rounds and Tele-Stewardship Surveillance Reduces Antibiotic Use in COVID-19 Patients Admitted to 17 Small Community Hospitals John J Veillette, Stephanie C Shealy, Stephanie Gelman, Edward A Stenehjem, Steven K Throneberry, Michael Pirozzi, et al. (+5)
921 [GO] 2021―Dec―05 282. Risk Factors for Mortality in Severe COVID-19 Patients Admitted to the Intensive Care Unit: A Retrospective Single-Center Study in Saudi Arabia Sherif Khattab, Souad AlMuthree, Mohamed Bakry, Noha Ibraheem, Omar Alghamdi, Mahassen Khalifa, et al. (+2)
922 [GO] 2021―Dec―05 284. Antibiotic Prescribing Trends in Hospitalized Influenza Versus COVID-19 Patients at a Community-Based Health System Aileen Martinez, Lyssette Cardona, Nina Ricci
923 [GO] 2021―Dec―05 303. Evaluation of Antimicrobial Utilization and the Incidence of Bacterial Pneumonia Co-infection in Non-ICU COVID-19 Patients at an Urban Academic Medical Center Sara Groome, Claudine El-Beyrouty, Meghan Mitchell
924 [GO] 2021―Dec―05 435. Outcomes for E484K Mutation Negative COVID-19 Patients Cohorted with E484K Mutation Positive COVID-19 Patients: A Retrospective Cohort Study Fahad Buskandar, Amber L Linkneheld-Struk, Victoria R Williams, Adrienne Chan, Lorraine Maze Dit Mieusement, Natasha Salt, Jerome A Leis
925 [GO] 2021―Dec―05 312. Clinical Attributes and Risk Factors for In- Hospital Mortality among Covid-19 Patients in a Community Hospital Setting: A Propensity Matched Analysis Karthik Seetharam, Premila Bhat, Kelash Kumar, Thinzar Wai, Vamsi Yenugadhati, Bhargav Desai, et al. (+27)
926 [GO] 2021―Dec―05 802. Corynebacterium striatum Outbreak Among Ventilated COVID-19 Patients in an Acute Care Hospital - California, 2021 Janice J Kim, Nancy E Turner, Emily Holman, Linda Lefrak, Fady A Youssef, Patrizia Richardson, et al. (+4)
927 [GO] 2021―Dec―05 395. Early Predictors of Intensive Care Unit Admission among COVID-19 Patients in Qatar Safae Abuyousef, Shaikha Alnaimi, Nabil E Omar, Reem Elajez, Eman Zeyad Ibrahim Elmekaty, Eiman Abdelfattah-Arafa, et al. (+14)
928 [GO] 2021―Dec―05 298. Examining the Relationship Between Excess Weight and In-Hospital Mortality in COVID-19 Patients in Southwest Georgia, U.S Austin C Dykes, Daniel B Chastain, Geren Thomas, Henry N Young, Andrés F Henao Martínez, Carlos Franco-Paredes, Sharmon P Osae
929 [GO] 2021―Dec―05 406. Incidence of Community and Hospital Acquired Infections in Critically Ill COVID-19 Patients in the Dominican Republic Rita Alexandra Rojas-Fermin, Anel E Guzman, Ann Sanchez, Edwin Germosen, Cesar Matos, Alfredo J Mena Lora
930 [GO] 2021―Dec―05 281. Prevalence of Influenza Co-infection in a Real-world Cohort of COVID-19 Patients in the U.S Devika Chawla, Xin Chen, Klaus Kuhlbusch, Kelly Zalocusky, Shemra Rizzo
931 [GO] 2021―Dec―05 33. Evaluation of Rural-Urban Differences in Hospitalization and Mortality Rates for US COVID-19 Patients in the United States Alfred (Jerrod) Anzalone, Ronald Horswell, San Chu, Brian Hendricks, Jeremy Harper, William Beasley, et al. (+4)
932 [GO] 2021―Dec―05 440. Detection of COVID-19 Patients Requiring Escalation to ICU Status Using a Naïve Bayes Classifier William R Barnett, Chad Jaenke, Zachary Holtzapple, James Williams, Nithin Kesireddy, Waleed Khokher, Ragheb Assaly
933 [GO] 2021―Dec―05 405. A Qualitative Study Based on a Case Series of Obstetric COVID-19 Patients to Determine Risks in Management Associated with Severity in a Government Hospital in the Philippines Sheila Patrice D Funelas-Santos, Judith P Peralta
934 [GO] 2021―Dec―05 536. Clinical Outcomes of Hospitalized COVID-19 Patients Treated with Remdesivir-NEAT ID 909REM Study François Raffi, Nadir Arber, Casper Rokx, Lambert Assoumou, Pallav L Shah, Nathalie De Castro, et al. (+13)
935 [GO] 2021―Dec―05 319. Presepsin as a Prognostic Biomarker for Mortality in COVID-19 Patients vs Community-Adquired Pneumonia (CAP) Patients Lina Morales-Cely, Laura A Bravo-Castelo, Ingrid G Bustos-Moya, Yuli Fuentes, Julian Lozada-Arciniegas, Elsa Daniela Ibañez-Prada, et al. (+7)
936 [GO] 2021―Dec―05 287. Characteristics and Outcomes of COVID-19 Patients with Candidemia at a Community Hospital in Chicago Oluwadamilola A Adeyemi, Gregg Gonzaga, Sean Cariño, Steve B Kalish
937 [GO] 2021―Dec―05 463. Factors of Social Determinants of Health Associated with Length of Stay in COVID-19 Patients with Multimorbidity in Southwest Georgia, United States Sahand Golpayegany, Sharmon P Osae, Geren Thomas, Henry N Young, Andrés F Henao Martínez, Carlos Franco-Paredes, Daniel B Chastain
938 [GO] 2021―Dec―05 431. SARS-CoV-2 Environmental Contamination in Hospitalized COVID-19 Patients’ Rooms Bobby G Warren, Alicia Nelson, Aaron Barrett, Bechtler S Addison, Amanda M Graves, Sarah S Lewis, et al. (+5)
939 [GO] 2021―Dec―05 445. COVID-19 Pharmacotherapy Was Not Associated with Mortality in a Community Teaching System Eric Urnoski, Thomas Butler
940 [GO] 2021―Dec―05 527. Lower Risk of ICU Admission with Remdesivir in Patients Hospitalized with COVID-19 Pneumonia Sarah Lim, Pamela Schreiner, Alan Lifson, Erica Bye, Kathryn Como-Sabetti, Ruth Lynfield, Ruth Lynfield
941 [GO] 2021―Dec―05 545. A Retrospective Review of 30-day Mortalities in Solid-Organ Transplant Recipients (SOT) versus Non-Transplant Patients (NTP) Receiving Remdesivir (REM) and Dexamethasone (DEX) for COVID-19 Pneumonia Krina Vyas, Kevin L Epps, Nan Zhang, Sadia Shah, Matthew Soto-Arenall, Lisa Brumble, Claudia R Libertin
942 [GO] 2021―Dec―05 367. Role of Conventional Biomarker for Prediction of Chest CT-confirmed COVID-19 Pneumonia Monprach Harnphadungkit, Taweegrit Siripongboonsitti
943 [GO] 2021―Dec―05 342. Secondary Infections following Tocilizumab for Treatment of COVID-19 Pneumonia Adam Warner, Mujahed Abbas, Benjamin S Avner, Thomas E Flynn, Todd A Walroth, Brett W Jagger
944 [GO] 2021―Dec―05 518. Model-informed Dose Selection of Dual Toll-like Receptor 7/8 Inhibitor Enpatoran (M5049) for the Treatment of COVID-19 Pneumonia Lena Klopp-Schulze, Jamie Shaw, Jennifer Dong, Akash Khandelwal, Elizabeth Adams, Dongzi Yu, Kosalaram Goteti
945 [GO] 2021―Dec―05 562. Tocilizumab Use in the Second Trimester Pregnant Patients with Severe Covid-19 Pneumonia and their Maternal and Fetal Outcomes: Two Case Reports Fatima iqbal, Shiema A Ahmed, Kamran Mushtaq, Faraj S Howady, Fatima Rustom, Muna Almaslamani
946 [GO] 2021―Dec―05 470. Relapsing COVID-19 Pneumonia in Patients Receiving Rituximab Therapy Jolie Gallagher, Kevin H Hall, Benjamin Albrecht
947 [GO] 2021―Dec―05 345. Dermatological Manifestations in Patients with COVID-19 Pneumonia in Veracruz, Mexico Luis Del Carpio-Orantes, Sergio García-Méndez, Jesús Salvador Sánchez-Díaz, Andrés aguilar-silva, Elisa Estefania Aparicio-Sánchez, Sonia Cruz-Albarrán, et al. (+13)
948 [GO] 2021―Dec―05 563. Experience of a Private Hospital in the Treatment of COVID-19 Pneumonia in Veracruz, Mexico Luis Del Carpio-Orantes, Luis Alberto Márquez-Rodriguez, José Luis García-Pérez, Christian Alberto Rodríguez-Santos, Carlos Yahir Llaven-Velázquez, Eduardo Gutiérrez-Martínez, et al. (+6)
949 [GO] 2021―Dec―05 308. Secondary Infections in Patients Requiring Extracorporeal Membrane Oxygenation (ECMO) for Severe Acute Respiratory Distress Syndrome (ARDS) due to COVID-19 Pneumonia (PNA) Ryan Rivosecchi, J Alex Viehman, Christina K Thorngren, Ryan K Shields, Fernanda P Silveira, Fernanda P Silveira, et al. (+6)
950 [GO] 2021―Dec―05 31. Development a Novel Score (SAD-60) for Predicting Mortality in Hospitalised Patients with COVID-19 Pneumonia: A Multicenter Retrospective Study of 1013 Patients Serkan Surme, Hatice Kubra Karanalbant, Gulsah Tuncer, Osman Bayramlar, Betul Copur, Esra Zerdali, et al. (+9)
951 [GO] 2021―Dec―05 Safety and Efficacy of Tocilizumab 4 or 8 mg/kg in Hospitalized Patients With Moderate to Severe COVID-19 Pneumonia: A Randomized Clinical Trial Princy N Kumar, Jules Hernández-Sánchez, Sandra Nagel, Yuning Feng, Fang Cai, Joseph Rabin, et al. (+11)
952 [GO] 2021―Dec―05 302. Using Antiphospholipid Antibody Presence as an Additional Biomarker to Identify COVID-19 Positive Patients with High Risk for Thrombosis Jennifer R Hewlett, Jing Du, M Sung Lee, Gavin McLeod, Herbert Archer
953 [GO] 2021―Dec―05 544. Using Active Surveillance to Identify Monoclonal Antibody Candidates Among COVID-19 Positive Veterans, Atlanta VA Healthcare System Alexander T Paras, Kathryn E DeSilva, Nora T Oliver, Lauren H Epstein, Nadine M Harris, Emily J Cartwright, Abeer Moanna
954 [GO] 2021―Dec―05 394. Descriptive Evaluation of Epidemiology and Microbiology of Patients with COVID-19 Pre/post Implementation of Corticosteroids as Standard of Care Goran Flajc, Ahmed Zaki
955 [GO] 2021―Dec―05 538. The Role of N-acetylcysteine on Post Covid-19 Pulmonary Fibrosis Bernard Demot, Kristin Ivan Mark Hizon
956 [GO] 2021―Dec―05 955. Trends in Top COVID-19 Questions Among a National Audience of Primary Care Clinicians Aylin Madore, Margaret Oliverio, Steven Nock
957 [GO] 2021―Dec―05 493. Incidence and Characterization of Chronic Active COVID Among Patients Infected with the Novel Coronavirus (COVID-19) Receiving B-cell Depleting Therapies (BCDTs) Jacob Kartes, Emily S Spivak, Hannah Imlay
958 [GO] 2021―Dec―05 80. The Utility of Cultures for Isolated Fevers in Patients with Influenza or COVID-19 Receiving Extracorporeal Membrane Oxygenation Joseph E Marcus, Valerie Sams, Michal Sobieszcyk, Alice E Barsoumian
959 [GO] 2021―Dec―05 LB4. Casirivimab and Imdevimab for Treatment of Hospitalized Patients With COVID-19 Receiving Low Flow or No Supplemental Oxygen Eleftherios Mylonakis, Selin Somersan-Karakaya, Sumathi Sivapalasingam, Shazia Ali, Yiping Sun, Rafia Bhore, et al. (+26)
960 [GO] 2021―Dec―05 499. Rapid and Sustained Decline in CXCL-10 (IP-10) Annotates Clinical Outcomes Following TNF-α Antagonist Therapy in Hospitalized Patients with Severe and Critical COVID-19 Respiratory Failure Courtney Schroeder, Hilal Hachem, Amandeep Godara, Daniel Fein, Hashim Mann, Christian Lawlor, et al. (+6)
961 [GO] 2021―Dec―05 424. The Impact of COVID-19 Response on Infection Prevention Programs and Practices in Southeastern United States Sonali D Advani, Sonali D Advani, Andrea Cromer, Brittain A Wood, Esther Baker, Kathryn L Crawford, et al. (+9)
962 [GO] 2021―Dec―05 485. Pediatrics Institutional COVID-19 Review Prakash Karna, Lauren Farrand, Uzma Hasan
963 [GO] 2021―Dec―05 461. Classical Antigen Presenting Cell Activation Correlates with T Cell Immunity and COVID-19 Severity Zhongyan Lu, Jarina Pena-DaMata, Katherine Pohida, Camille Lake, Nusrat J Epsi, Stephanie A Richard, et al. (+9)
964 [GO] 2021―Dec―05 437. Longitudinal Plasma Cytokine Profiles Differentiating COVID-19 Severity Groups Amanda M Green, Aisha Souquette, Mona Agrawal, Joshua Wolf, Joshua Wolf, Aditya Gaur, et al. (+5)
965 [GO] 2021―Dec―05 40. Lenzilumab Efficacy and Safety in Newly Hospitalized COVID-19 Subjects: Results From a Phase 3 Randomized Double-Blind Placebo-Controlled Trial Zelalem Temesgem, Charles Burger, Jason Baker, Christopher Polk, Claudia R Libertin, Colleen F Kelley, et al. (+9)
966 [GO] 2021―Dec―05 208. Comparison of Bloodstream Infections in Hospitalized Patients Before and During the COVID-19 Surge in a Community Hospital in the South Bronx: An Observational Study Afsheen Afzal, Edgar Gomez, Victor Perez Guttierrez, Aye Myat Mon, Carolina Moreira Sarmiento, Amna Khalid, et al. (+12)
967 [GO] 2021―Dec―05 35. Health-related quality of life in COVID-19 survivors after 12 months, a prospective cohort study Sebastiaan Siegerink, Marië Nijpels, Sander Albers, Frédérique Jurgens, Felix K Pettai, Laura Samwel, et al. (+5)
968 [GO] 2021―Dec―05 456. The Racial Divide: A Follow Up Study on Racial Disparity Amongst COVID-19 Survivors in an Urban Community in New Jersey Christopher Millet, Humberto Jimenez, Emily Racoosin, George Horani, Yezin Shamoon, Spandana Narvaneni, et al. (+11)
969 [GO] 2021―Dec―05 436. U-shaped-aggressiveness of SARS-CoV-2: Period Between Initial Symptoms and Clinical Progression to COVID-19 Suspicion. A Population-Based Cohort Study Bruno G Buitano, Dan Morgenstern, Juan Talavera, Andrea Zaldívar, Mercedes Martínez
970 [GO] 2021―Dec―05 512. Does Time From COVID-19 Symptom Onset to Administration of Anti-spike Protein Monoclonal Antibody Predict Response? Savanna SanFilippo, Brynna Crovetto, Marc Milano, John Bucek, Ronald G Nahass, Luigi Brunetti
971 [GO] 2021―Dec―05 294. Surveillance for Potential Post-Acute COVID-19 Syndrome Medical Complications in the Emergency Department (ED) - A Retrospective Longitudinal Study of ED Patients Who Had Evidence of SARS-CoV-2 Infection Versus Those Who Did Not Isabel Lake, Richard C Wang, Richard E Rothman, Oliver Laeyendecker, Reinaldo Fernandez, Gaby Dashler, et al. (+2)
972 [GO] 2021―Dec―05 145. SARS-CoV-2 (COVID-19) Testing Experience within a Military Treatment Facility Sara Robinson, Wesley R Campbell, Yuliya Johnson, Michael Backlund, Daniel Brooks
973 [GO] 2021―Dec―05 416. Diagnostic Yield of Serial COVID-19 Testing in Hospitalized Patients Jeremy Li, Charles Frenette, Vivian Loo
974 [GO] 2021―Dec―05 386. A Systematic Review of COVID-19 Transmission Dynamics and Clinical Response on Cruise Ships Globally Between January and October 2020 Kathryn Willebrand, Lauren Pischel, Amyn A Malik, Samuel Jenness, Saad Omer
975 [GO] 2021―Dec―05 430. Strategies for Prevention of COVID-19 Transmission in Hospitals Wooyoung Jang, Bongyoung Kim, Eu Suk Kim, Kyoung-Ho Song, Song Mi Moon, Myung Jin Lee, et al. (+5)
976 [GO] 2021―Dec―05 502. Early COVID-19 Treatment with SARS-CoV-2 Neutralizing Antibody Sotrovimab Anil K Gupta, Yaneicy Gonzalez Rojas, Erick Juarez, Manuel Crespo Casal, Jaynier Moya, Diego Rodrigues Falci, et al. (+16)
977 [GO] 2021―Dec―05 529. Systematic Review and Meta-Analysis of Ivermectin Safety Profile in COVID-19 Trials Hannah Wentzel, Junzheng Wang, Abbienaya Dayanamby, Victoria Pilkington, Jacob Levi, Andrew Hill, Leah Ellis
978 [GO] 2021―Dec―05 346. Head to Toe Imaging of Complications and Sequelae of COVID- 19 and COVID-19 Vaccination Deepti H Vijayakumar, Deepali Saxena, Rajesh V Helavar, Raghavendra Tirupathi
979 [GO] 2021―Dec―05 590. Persisting COVID-19 vaccination hesitancy in the South Bronx Danelly Gomez D' Aza, Masood A Shariff, Israel Duran Santibanez, Raquel Horowitz, Hina Asad, Dennis Mensah, et al. (+4)
980 [GO] 2021―Dec―05 587. An Intervention to Improve COVID-19 Vaccination Rates Among Inpatients at a Veterans Affairs Hospital Ayako Fujita, Tiffany Goolsby, Krista Powell, Emily J Cartwright
981 [GO] 2021―Dec―05 573. Digital Patient/Caregiver Education: A Tool to Improve COVID-19 Vaccination Rates and Confidence Among the Public Amy Larkin, Allison Armagan
982 [GO] 2021―Dec―05 566. Impact of a Culturally Sensitive Multilingual Community Outreach Model on COVID-19 Vaccinations at an Urban Safety-net Community Hospital Alfredo J Mena Lora, Stephanie L Echeverria, Ella Li, Miguel Morales, Rita Esquiliano, Genessa Schultz, et al. (+4)
983 [GO] 2021―Dec―05 584. Phase 1 Placebo-Controlled Trial of COVI-VAC™, an Intranasal, Live Attenuated COVID-19 Vaccine Sybil Tasker, Daryl Bendel, Melissa Bevan, Steffen Mueller, Anna Kushnir, Brandon Londt, J Robert Coleman
984 [GO] 2021―Dec―05 495. Evaluation of Antigen Testing for Detection of COVID-19 Vaccine Breakthrough Cases in Long-Term Care Meghan Linder, Sarah Humphrey-King, Rebecca Pierce, Sheri L Hearn, Melissa Sutton, Shane Sevey, et al. (+3)
985 [GO] 2021―Dec―05 186. Characteristics of COVID-19 Vaccine Breakthrough Cases in Minnesota, 2021 Stephanie Meyer, Amy Saupe, Aaron Bieringer, Corinne Holtzman, Luke Magnuson, Erica Bye, et al. (+6)
986 [GO] 2021―Dec―05 98. COVID-19 Vaccine Breakthrough Hospitalizations and Deaths in the Veterans Health Administration Gina Oda, Aditya Sharma, Cynthia A Lucero-Obusan, Patricia Schirmer, Mark Holodniy, Connor W Edson, Ramin Khaksar
987 [GO] 2021―Dec―05 569. Characterization of COVID-19 Vaccine Breakthrough Infections in Metropolitan Detroit Nicholas sturla, Rita Kassab, Rafa Khansa, Thomas Chevalier, David Allard, Robert Tibbetts, et al. (+2)
988 [GO] 2021―Dec―05 1010. Cross-Species Translation of Correlates of Protection for COVID-19 Vaccine Candidates Using Quantitative Tools Anna Largajolli, Nele Plock, Bhargava Kandala, Akshita Chawla, Seth H Robey, Kenny Watson, et al. (+5)
989 [GO] 2021―Dec―05 576. Determinants of COVID-19 Vaccine Hesitancy: A Cross-Sectional Study in 3 Communities in the United States and Lebanon Mohamad Yasmin, Mohamad Ali Tfaily, Rebecca P Emery, Habiba Hassouna, Rita Obeid, Mudita Bhugra, et al. (+2)
990 [GO] 2021―Dec―05 574. High Acceptance and Rapid Implementation of COVID-19 Vaccine in a Public HIV Clinic in Northern California: An Initial Analysis of Social Determinants Jennifer Lin, Frank Oi-Shan Wong, Christopher Thibodeaux, Moon Choi-McInturff, Aracely Tamayo, Vivian Levy
991 [GO] 2021―Dec―05 585. Safety of Pfizer-BioNtech COVID-19 Vaccine in Healthcare Workers, Singapore Kai-Qian Kam, Chee Fu Yung, Chia Yin Chong, Jia hui Li, Karen Donceras Nadua, Natalie W Tan, Koh Cheng Thoon
992 [GO] 2021―Dec―05 439. Corowa-kun: Impact of a COVID-19 Vaccine Information Chatbot on Vaccine Hesitancy, Japan 2021 Takaaki Kobayashi, Yuka Nishina, Hana Tomoi, Ko Harada, Eiyu Matsumoto, Kanako Inaba, et al. (+8)
993 [GO] 2021―Dec―05 335. Staphylococcus aureus Bacteremia as a Potential and Severe Complication from Intramuscular COVID-19 Vaccine Injection Miguel Sebastian Pedromingo Kus
994 [GO] 2021―Dec―05 581. COVID-19 Vaccine Perceptions in Adults from Greater Nashville Tennessee Kailee N Fernandez, Danielle A Rankin, Harrison L Howe, Sean M Bloos, Seifein Salib, Rana Talj, et al. (+8)
995 [GO] 2021―Dec―05 577. COVI-VAC™, a Live Attenuated COVID-19 Vaccine, Provides Single Dose Protection Against Heterologous Challenge with SARS-CoV-2 Beta (B.1.351) in the Syrian Golden Hamster Model Anna Kushnir, Steffen Mueller, Sybil Tasker, J Robert Coleman
996 [GO] 2021―Dec―05 1196. A Multi-faceted, Iterative Program to Increase COVID-19 Vaccine Uptake in a Midwestern HIV Clinic Sara H Bares, Rachelle Carr, Samantha L Jones, Nichole N Regan, Valentina Orduna, Daniel W Cramer, et al. (+2)
997 [GO] 2021―Dec―05 567. Reasons for Deferral of COVID-19 Vaccines Among Arab American Healthcare Professionals Living in the United States Anita Shallal, Evi Abada, Rami Musallam, Omar Fehmi, Linda Kaljee, Ziad Fehmi, et al. (+7)
998 [GO] 2021―Dec―05 490. Uptake and Perceptions of COVID-19 Vaccines Among US Pregnant Women Annette Regan, Pallavi Aytha Swathi, Marcianna Nosek, Ning Yan Gu
999 [GO] 2021―Dec―05 570. Prioritized Access to COVID-19 Vaccines Among Vulnerable Communities Increases Vaccination Rates Leonor Fernandez, Ashley O'Donoghue, Peter Shorett, Jonathan Blair, Lawrence Markson, Tenzin Dechen, et al. (+2)
1000 [GO] 2021―Dec―05 580. Hesitancy in Uptake and Recommendation of COVID-19 Vaccines by US Healthcare Workers Steven S Spires, Rebecca Rayburn-Reeves, Elizabeth Dodds Ashley, Jenna Clark, Avani P Desai, Jan Lindemans
1001 [GO] 2021―Dec―05 475. The Utility of Community-Academic Partnerships in Promoting the Equitable Delivery of COVID-19 Vaccines in Black Communities Jacinda Abdul-Mutakabbir, Samuel Casey, Veatrice Jews, Andrea King, Kelvin Simmons, Bridgette Peteet, et al. (+3)
1002 [GO] 2021―Dec―05 24. Longitudinal Assessment of Immune Responses to COVID-19 Vaccines in Solid Organ Transplant Recipients Megan Powell, Amy C Sherman, Julia Klopfer, Michaël Desjardins, Chi-An Cheng, Yasmeen Senussi, et al. (+13)
1003 [GO] 2021―Dec―05 178. Comparing the Incidence of Multidrug Resistant Bacteremia, Fungemia and Hospital-acquired Clostridioides difficile Infection in COVID-19 Versus Non-COVID-19 Patients: a Single Hospital, One-year Observational Study in New York City Chia-Yu Chiu, Amara Sarwal, Michael Widjaja, Addi Feinstein
1004 [GO] 2021―Dec―05 45. COVID-19 Vulnerability and Data Reporting in Africa: Reflections from Cameroon Seth D Judson, Kevin Njabo, Judith Torimiro
1005 [GO] 2021―Dec―05 1034. FebriDx use in Immunocompromised Patients in a Real-World Hospital Setting during the second (COVID-19) wave in Italy Filippo Lagi, Alessandro Bartoloni, Catalina Suarez-Cuervo
1006 [GO] 2021―Dec―05 541. Comparing Patients with Severe COVID-19 Who Improve to the Point of Discharge Following an Abbreviated Course (< 5 Days) of Remdesivir (RDV) Versus a Standard Course (≥5 Days) Huan Pham, Qiaoling Chen, Aldon Li, Adam Baghban, Anita Cheruvanky, Graciela Faiad
1007 [GO] 2021―Dec―05 173. Deciphering COVID-19-Associated Effects on Hospital MRSA Transmission and Social Networks Gregory Madden, Matthew Bielskas, Methun Kamruzzaman, Parantapa Bhattacharya, Bryan Lewis, Eili Klein, et al. (+2)
1008 [GO] 2021―Dec―05 324. COVID-19-Associated Pulmonary Aspergillosis (CAPA) at Veterans Affairs (VA) Hospitals in Southern California and Arizona Michelle Fang, Phuong Khanh Nguyen, Tony T Chau, Ashley Doan, Andrew S Varker, Marshall T Renna, et al. (+8)
1009 [GO] 2021―Dec―05 333. Comparing COVID-19-related Morbidity and Mortality between Patients with and without Substance Use Disorder: A Retrospective Cohort Study Angela McLaughlin, Rebecca Burns, Morgan Ryan, Sabrina A Assoumou
1010 [GO] 2021―Dec―05 38. Remdesivir Treatment in Patients Hospitalized with COVID-19: A Comparative Analysis of In-Hospital All-Cause Mortality Essy Mozaffari, Aastha Chandak, Zhiji Zhang, Shuting Liang, Mark Thrun, Robert L Gottlieb, et al. (+6)
1011 [GO] 2021―Dec―05 320. Differentiating Dengue from COVID-19: A Diagnostic Challenge in the Tropical Regions of the Americas Fernando Rosso, Olga Lucia agudelo Rojas
1012 [GO] 2021―Dec―05 353. New-Onset Diabetes as an Acute Complication of COVID-19: A National Population Cohort Analysis Kwan Hong, Jeehyun Kim, Sujin Yum, Raquel Elizabeth Gómez Gómez, Byung Chul Chun
1013 [GO] 2021―Dec―05 LB1. Remdesivir for the Treatment of High-Risk Non-Hospitalized Individuals With COVID-19: A Randomized, Double-Blind, Placebo-Controlled Trial Joshua A Hill, Roger Paredes, Carlos Vaca, Jorge Mera, Brandon J Webb, Gilberto Perez, et al. (+16)
1014 [GO] 2021―Dec―05 514. Anti-SARS-CoV-2 Monoclonal Antibodies for Early COVID-19: A Real World Experience Katherine Belden, Bryan Hess, Caroline Brugger, Rachel Carr, Todd Braun, Joseph L DeRose, John Zurlo
1015 [GO] 2021―Dec―05 468. Delayed Mortality Among Solid Organ Transplant Recipients Hospitalized for Covid-19: An International Multicenter Study Madeleine R Heldman, Olivia S Kates, Robert M Rakita, Erika D Lease, Ajit P Limaye, Cynthia E Fisher
1016 [GO] 2021―Dec―05 950. The Challenge of Fellowship Interviews During COVID-19: An Online Post-interview Survey Rattanaporn Mahatanan, Maxwell Vergo, Richard A Zuckerman
1017 [GO] 2021―Dec―05 1409. Pulmonary Non-tuberculous Mycobacterium Infection (PNTMI) and COVID-19: Characterization of the National COVID Collaborative Cohort (N3C) Carlos E Figueroa Castro, William Hersh
1018 [GO] 2021―Dec―05 546. Therapeutic Effect of Regdanvimab in Patients with Mild to Moderate COVID-19: Day 28 Results from a Multicentre, Randomised, Controlled Pivotal Trial Michael G Ison, Jin Yong Kim, Oana Sandulescu, Liliana-Lucia Preotescu, Norma Erendira Rivera Martinez, Marta Dobryanska, et al. (+17)
1019 [GO] 2021―Dec―05 314. Six-Month Post-Acute Sequelae of COVID-19: High Self-Reported Morbidity among Women and Younger Adults Ashish Bhargava, Wei Zhao, Mamta Sharma, Susan M Szpunar, Louis Saravolatz
1020 [GO] 2021―Dec―05 22. International Multicenter Study Comparing Cancer to Non-Cancer Patients with COVID-19: Impact of Risk Factors and Treatment Modalities on Outcome Ray Y Hachem, Anne-Marie Chaftari, Nigo Masayuki, Nelson Hamerschlak, Hiba Dagher, Ying Jiang, et al. (+28)
1021 [GO] 2021―Dec―05 526. Implementation of Use of Monoclonal Antibody Therapy in a Large Academic Center for the Outpatient Treatment of Covid-19: Impact on 30 Day Hospitalization Rates, ED Visits and Death Azra Bhimani, Vinay Srinivasan, Stacey Weinstein, Nathan Clemons, Quanna Batiste, Shangxin Yang, et al. (+2)
1022 [GO] 2021―Dec―05 1191. Pediatric Long Haul Post COVID-19: Is New Jersey’s Experience Different? Aakriti Bhargava, Lauren Farrand, Stephen Zieniewicz, Dennis J Brenner, Timothy S Yeh, Uzma Hasan
1023 [GO] 2021―Dec―05 497. Moderate Versus High Dose Corticosteroids in Adult Patients with Severe COVID-19: Less Is More Seema Joshi, Sana Soman, Saniya Jain, Atheel Yako, Marwa Hojeij, Louis Massoud, et al. (+5)
1024 [GO] 2021―Dec―05 1326. Possible Predictors of Coinfection in COVID-19: Making a Difficult Diagnosis Christopher J Lehmann, Rohan N Shah, Mengqi Zhu, Natasha N Pettit, Jessica Ridgway, Renslow Sherer
1025 [GO] 2021―Dec―05 561. Phase 3 Trial of Fostamatinib for the Treatment of COVID-19: Repurposing an Immunomodulatory Drug Previously Approved for Immune Thrombocytopenia Ziad Mallat, Suzana Margareth Lobo, Anuj Malik, Sandra Tong
1026 [GO] 2021―Dec―05 506. Outpatient Bamlanivimab, Casirivimab and Imdevimab for COVID-19: Single Center Feasibility Analysis Vahini Chundi, Jennifer J Wenner, Christopher Scheib, Yatin Patel, Cynthia snider, Jeffrey C Hatcher, Douglas B McQuaid
1027 [GO] 2021―Dec―05 442. Sex-Related Differences in Mortality from COVID-19: Survival Analysis of Patients from an Urban Hospital Mamta Sharma, Susan M Szpunar, Ashish Bhargava, Leonard B Johnson, Louis Saravolatz
1028 [GO] 2021―Dec―05 305. Cholecystitis as a Possible Immunologic Consequence of COVID-19; Case Series from a Large Healthcare System Anna Jacobs, Christopher Polk, Mindy Sampson, Banks Kooken, Thomas Ludden, Catherine Passaretti, et al. (+2)
1029 [GO] 2021―Dec―05 451. Is Antibody to Nucleocapsid More Prevalent in Individuals with Severe COVID-19? Hemang Patel, Ashish Bhargava, Daniel Lebovic, Tiziano Scarabelli, Meredith M Coyle, Natali Salaytah, Louis Saravolatz
1030 [GO] 2021―Dec―05 535. Comparison of Outcomes in Patients Positive for Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection After Monoclonal Antibody Therapy (MAT) with Bamlamivimab or Casirivimab-Imdevimab Courtney Nichols, Mark Lustberg, Mohammad Mahdee Sobhanie, Joy Lehman, Erica E Reed, Nicholas E Kman, et al. (+5)
1031 [GO] 2021―Dec―05 553. Outcomes in Patients Positive for Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection After Treatment with Monoclonal Antibody Therapy (MAT) in the Outpatient Setting Courtney Nichols, Mark Lustberg, Mohammad Mahdee Sobhanie, Joy Lehman, Erica E Reed, Nicholas E Kman, et al. (+5)
1032 [GO] 2021―Dec―05 401. Natural History of Shedding and Household Transmission of Severe Acute Respiratory Syndrome Coronavirus 2 Using Intensive High-Resolution Sampling Jonathan Altamirano, Prasanthi Govindarajan, Andra Blomkalns, Sean Leary, India Robinson, Leanne Chun, et al. (+11)
1033 [GO] 2021―Dec―05 784. Efficiency of Quaternary Ammonium Disinfectants against SARS-CoV-2 and Coronavirus 229E Charles P Gerba
1034 [GO] 2021―Dec―05 472. Clinical Outcomes of Solid Organ Transplant Recipients with Severe Acute Respiratory Syndrome Coronavirus 2: 2021 Update Deeksha Jandhyala, Jessica Lewis, Ruth Adekunle
1035 [GO] 2021―Dec―05 Letter to the Editor: Response to ‘Overlooked Shortcomings of Observational Studies of Interventions in Coronavirus Disease 2019: An Illustrated Review for the Clinician‘ by Tleyjeh et al Martin Wolkewitz, Oksana Martinuka
1036 [GO] 2021―Dec―05 508. Title Favipiravir for the Treatment of Coronavirus Disease 2019; A Propensity Score Matched Cohort Study Rand A Alattar, Shiema A Ahmed, Tasneem Abdallah, Rashid Kazman, Aseelah N Qadmour, Tawheeda Ibrahim, et al. (+19)
1037 [GO] 2021―Dec―05 564. SARS-CoV-2 Ferritin Nanoparticle Vaccines Elicit Broad SARS Coronavirus Immunogenicity M G Joyce, Wei-Hung Chen, Rajeshwer Sankhala, Agnes Hajduczki, Paul Thomas, Elizabeth Martinez, et al. (+3)
1038 [GO] 2021―Dec―05 1347. Comparison Between SARS-Cov-2, non-SARS-Cov-2 Coronavirus, Influenza and RSV Infections Among Solid Organ Transplant Recipients Maria A Mendoza, Motoa Gabriel, Mohammed Raja, Shweta Anjan, Anmary A Fernandez, Steve Courel, et al. (+13)
1039 [GO] 2021―Dec―05 412. Estimating the Impact of School Classroom Sizes on the Probability of Severe Acute Respiratory Syndrome Coronavirus-2 Infectivity or Exposure Sanya J Thomas, Rebecca R Young, Ibukunoluwa Akinboyo, Michael J Smith, Tara Buckley, Sarah S Lewis
1040 [GO] 2021―Dec―05 519. Risk Factor Analysis for Hospital Admission Following Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) Monoclonal Antibody Treatment Lana Abusalem, Cole Wood, Juan Carlos Rico Crescencio, Ryan K Dare
1041 [GO] 2021―Dec―05 1331. Seasonality of Common Human Coronaviruses in the United States, 2014-2021 Melisa Shah, Amber K Haynes, Rebecca M Dahl, Krista Kniss, Benjamin Silk, Marie E Killerby
1042 [GO] 2021―Dec―05 539. Impact of Corticosteroids when Combined with Tocilizumab or Remdesivir for the Treatment of Severe SARS-CoV-2 Michael Rosati, Nikunj M Vyas, Cindy Hou
1043 [GO] 2021―Dec―05 278. Immunocompromised Patients with Prolonged Viral Shedding of SARS-COV-2 Jessica Tarabay, Ahmed Babiker, Max W Adelman, Victoria D Stittleburg, Jay Varkey, Stephanie M Pouch, et al. (+2)
1044 [GO] 2021―Dec―05 387. Predictors of Seropositivity to SARS-CoV-2 Among Workforce Members at a Large Urban Medical Center Evelyn A Flores, Deborah Kupferwasser, Prudencio Merino, Donna Phan Tran, Honghu Liu, Yilan Huang, et al. (+8)
1045 [GO] 2021―Dec―05 347. SARS-CoV-2 and Acute Otitis Media in Children: A Case Series Holly M Frost, Thresia Sebastian, Amy Keith, Melanie Kurtz, Samuel R Dominguez, Samuel R Dominguez, et al. (+2)
1046 [GO] 2021―Dec―05 821. Changes in Cleaning Practices and Non-conventional Personal Protective Equipment Use due to SARS-CoV-2 and Association with Increases in Multi-drug Resistant Organism Cases Medora L Witwer, Susan E Kline, Patricia Ferrieri, Samantha Saunders, Ginette Dobbins, Kari Gand, Alison Galdys
1047 [GO] 2021―Dec―05 396. Disparities in SARS-CoV-2 Antibody Prevalence: Findings from a Citywide Serosurvey in Holyoke, Massachusetts, November 2020-January 2021 Wilfredo Matias, Isabel Fulcher, Cody Nolan, Yodeline Guillaume, Jack Zhu, Francisco Molano, et al. (+11)
1048 [GO] 2021―Dec―05 674. Evaluation of the Access Bio CareStart™ Rapid SARS-CoV-2 Antigen Test in Asymptomatic Individuals Tested at a Community Mass-testing Program in Western Massachusetts Wilfredo Matias, Sara suliman, Isabel Fulcher, Francisco Molano, Shannon Collins, Elizabeth Uceta, et al. (+12)
1049 [GO] 2021―Dec―05 297. Infectious Complications Associated with Tocilizumab Use in Patients Infected with SARS-CoV-2 at a Mid-Atlantic Hospital Consortium Kristen R Kent, Nellie Darling, Xue Geng, Gavin Clark, Marybeth Kazanas, Princy N Kumar, Joseph G Timpone
1050 [GO] 2021―Dec―05 189. Potential Tiger-to-Human Transmission of SARS-CoV-2 at a Tennessee Zoo: A One Health Approach to Outbreak Investigation Heather N Grome, Becky Meyer, Erin Read, Martha Buchanan, Andrew C Cushing, Kara J Levinson, et al. (+10)
1051 [GO] 2021―Dec―05 533. Protocol for and Efficacy of Monoclonal Antibody (mAb) Treatment of SARS-CoV-2 at a VA Medical Center Phuong Khanh Nguyen, Thomas D Dieringer, Adela Greeley, Suny Kun, Feliza Calub, My-Phuong Pham, et al. (+4)
1052 [GO] 2021―Dec―05 375. High Laboratory-confirmed SARS-CoV-2 Attack Rate in Lima Health Care Personnel During August 2020-March 2021 Suggests Role for Improved Infection Control Matthew Westercamp, Giselle Soto, Rachel Smith, Eduardo Azziz-Baumgartner, Susan Bollinger, Roger Castillo, et al. (+10)
1053 [GO] 2021―Dec―05 373. Household transmission of SARS-CoV-2 B.1.1.7 lineage -2 U.S. States, 2021 Raymond Soto, Christoper Hsu, Meagan Chuey, Marisa Donnelly, Victoria T Chu, Noah G Schwartz, et al. (+11)
1054 [GO] 2021―Dec―05 390. Can Testing the Environment for SARS-CoV-2 Be a Signal for Staff Infections in Nursing Homes (NHs)? Gabrielle Gussin, Raveena Singh, Izabela Coimbra Ibraim, Raheeb Saavedra, Thomas Tjoa, Micaila Curtis, et al. (+2)
1055 [GO] 2021―Dec―05 568. Comparison of Humoral Immune Response to the SARS-CoV-2 BNT162b2 Vaccine Between Solid Organ Transplant Recipients and Healthy Controls Ahmad Yanis, Zaid Haddadin, Andrew Speaker, Danya Waqfi, Rana Talj, Danielle A Rankin, et al. (+8)
1056 [GO] 2021―Dec―05 376. Sensitivity and Specificity of the WHO Probable SARS-CoV-2 Case Definition Among Symptomatic Healthcare Personnel Han Nguyen, Sarah Weber, Yachana Kataria, Manisha Cole, Elizabeth Duffy, Elizabeth Ragan, et al. (+8)
1057 [GO] 2021―Dec―05 505. Impact of Remdesivir on SARS-CoV-2 Clearance in a Real-Life Setting: A Matched-Cohort Study Vincenzo Spagnuolo, Marta Voarino, Marco Tonelli, Laura Galli, Andrea Poli, Elena Bruzzesi, et al. (+10)
1058 [GO] 2021―Dec―05 464. Structural Vulnerability among Patients with HIV and SARS-CoV-2 Coinfection: Descriptive Case Series from the U.S. Midwest Natasha E Hongsermeier-Graves, Rohan Khazanchi, Nada Fadul
1059 [GO] 2021―Dec―05 290. Persistence of Long COVID in SARS-CoV-2 Confirmed Cases One-Year Post Infection Harrison L Howe, Danielle A Rankin, Sean M Bloos, Kailee N Fernandez, Seifein Salib, Rana Talj, et al. (+7)
1060 [GO] 2021―Dec―05 834. Characterization of Heavily Treatment Experienced HIV-1 Infected Clinical Trial Participants Infected with SARS-CoV-2 COVID 19: Fostemsavir BRIGHTE Phase 3 Clinical Trial Shiven Chabria, Stephane De Wit, Amy Pierce, Bronagh M Shepherd, Michael Warwick-Sanders, Fangfang Du, et al. (+3)
1061 [GO] 2021―Dec―05 678. Rapid Molecular SARS-CoV-2 Detection by Abbott ID NOW Is Reliable in Pediatric Patients Catherine Murphy, Emily Sheboy Scarcello, Sheila M Nolan
1062 [GO] 2021―Dec―05 419. SARS-CoV-2 Environmental Surface Contamination of Healthcare Staff Common Areas Helen L Zhang, Brendan Kelly, Michael Z David, Ebbing Lautenbach, Elizabeth Huang, Selamawit Bekele, et al. (+5)
1063 [GO] 2021―Dec―05 556. Ruxolitinib for the Management of Severe Pneumonia Caused by SARS-CoV-2. Exploring the Combination with dexamethasone Aaron Molina, Alejandro Olmedo-Reneaum, Maria Del Rocio Reyes-Paniagua, Mariana Molina
1064 [GO] 2021―Dec―05 511. Treatment with Molnupiravir in the MOVe-In and MOVe-Out Clinical Trials Results in an Increase in Transition Mutations Across the SARS-CoV-2 Genome Julie Strizki, Jay Grobler, Ying Zhang, Jiejun Du, Shunbing Zhao, Diane Levitan, et al. (+3)
1065 [GO] 2021―Dec―05 377. SARS-CoV-2 Genomic Surveillance Reveals Little Spread Between a Large University Campus and the Surrounding Community Andrew Valesano, William Fitzsimmons, Christopher Blair, Robert Woods, Julie Gilbert, Dawn Rudnik, et al. (+4)
1066 [GO] 2021―Dec―05 LB8. Lower SARS-CoV-2 IgG and Pseudovirus Neutralization Titers Post-mRNA Vaccination among People Living with HIV Matthew A Spinelli, Michael J Peluso, Kara Lynch, Cassandra Yun, David V Glidden, Timothy J Henrich, et al. (+2)
1067 [GO] 2021―Dec―05 491. Persistence of SARS-CoV-2 Iinfection in Immunocompromised Children Susan Dolan, Jean Mulcahy Levy, Angela Moss, Kelly Pearce, Molly Butler, Samuel R Dominguez, et al. (+5)
1068 [GO] 2021―Dec―05 42. Outbreak of SARS-CoV-2 in Hospitalized Hemodialysis Patients: an Epidemiologic and Genomic Investigation Charles E Marvil, Anne Piantadosi, Aaron Preston, Andrew Webster, Jeannette Guarner, Kari L Love, et al. (+6)
1069 [GO] 2021―Dec―05 589. Oral Tablet Vaccination Induces Heightened Cross-Reactive CD8 T Cell Responses to SARS-COV-2 in Humans Susan Johnson, Clarissa Martinez, Mario Cortese, Josefina Martinez, Shaily Garg, Nadine Peinovich, et al. (+2)
1070 [GO] 2021―Dec―05 283. Population-Based Co-infection of Carbapenem-Resistant Organisms and SARS-CoV-2 in Massachusetts Ashley Geoghegan, Jessica Leaf, Monina Klevens, Scott Troppy
1071 [GO] 2021―Dec―05 380. Environmental Contamination with SARS-CoV-2 in Nursing Homes Lona Mody, Kristen Gibson, Liza Bautista, Karen Neeb, Ana Montoya, Grace Jenq, et al. (+7)
1072 [GO] 2021―Dec―05 487. Experience with Remdesivir for Treatment of SARS-CoV-2 in Patients with Liver Cirrhosis Patricia Saunders-Hao, Sumeet Jain, Bruce Hirsch, Pranisha Gautam-Goyal
1073 [GO] 2021―Dec―05 453. Neutralizing Antibody Responses to SARS-CoV-2 in Professional Soccer Players Jorge Pagura, Clovis Arns de Cunha, Roberto Nishimura, Sergio Wey, André Pedrinelli, Sergio Cimerman, et al. (+6)
1074 [GO] 2021―Dec―05 397. Impact of School Opening Model on Cases of SARS-CoV-2 in Surrounding Communities: A Nationwide, Retrospective Cohort Study Westyn Branch-Elliman, Zeynep Ertem, Elissa Perkins, Polly van den Berg, Isabella Epshtein, Nathorn Chaiyakunapruk, et al. (+3)
1075 [GO] 2021―Dec―05 447. An Ordinal Scale Assessing SARS-CoV-2 Infected Patient Outcomes Using Electronic Health Records Maryam Khodaverdi, Bradley S Price, Susan L Santangelo, Alfred (Jerrod) Anzalone, Wesley Kimble, J Zachary Porterfield, et al. (+6)
1076 [GO] 2021―Dec―05 554. Clinical Impact of Monoclonal Antibody Therapy with SARS-CoV-2 Infection Inderjit Mann, Melinda Monteforte, Roderick Go
1077 [GO] 2021―Dec―05 513. Use of Antimicrobial Stewardship Program in Operationalizing Monoclonal Antibody Therapy in SARS-CoV-2 Infection Jessica Abrantes-Figueiredo, Stephanie Nalewyko, Dora E Wiskirchen
1078 [GO] 2021―Dec―05 316. Use of (1-3)-β-D-Glucan Assay for Diagnosis of Candidemia in Patients Hospitalized with SARS-CoV-2 Infection Yesha Malik, Amy Dupper, Jaclyn Cusumano, Dhruv Patel, Kathryn Twyman, Deena Altman, et al. (+2)
1079 [GO] 2021―Dec―05 301. Detection of Pneumococcal Pneumonia During SARS-CoV-2 Infection Anne Watkins, Devyn Yolda-Carr, Isabel M Ott, Maura Nakahata, Adam Moore, M Catherine Muenker, et al. (+14)
1080 [GO] 2021―Dec―05 147. Defining the Optimal Serial Testing Interval and Features for Identifying Patients with Early SARS-CoV-2 Infection Sanjat Kanjilal
1081 [GO] 2021―Dec―05 144. Clinical Validation and Performance of a T-cell Immunosequencing Assay to Identify Past SARS-CoV-2 Infection Sudeb C Dalai, Jennifer N Dines, Thomas M Snyder, Rachel M Gittelman, Tera Eerkes, Pashmi Vaney, et al. (+16)
1082 [GO] 2021―Dec―05 483. Disease Severity and Clinical Manifestations of SARS-CoV-2 Infection Among Infants Over the First Year of the Pandemic in Canada Pierre-Philippe Piché-Renaud, Luc Panetta, Daniel Farrar, Charlotte Moore Hepburn, Olivier Drouin, Fatima Kakkar, Shaun Morris
1083 [GO] 2021―Dec―05 931. Epidemiology and Clinical Outcomes of SARS-CoV-2 Infection Among Pediatric Solid Organ Transplant Recipients: A Single-Center Case Experience Jesus Sotelo, Esra Akkoyun, Giselle S Chery, Amal Aqul, Dev M Desai, Paul K Sue, Alyssa Power
1084 [GO] 2021―Dec―05 126. Magnitude and Dynamics of the T-Cell Response to SARS-CoV-2 Infection and Vaccination Thomas M Snyder, Rachel M Gittelman, Mark Klinger, Damon H May, Edward J Osborne, Ruth Taniguchi, et al. (+38)
1085 [GO] 2021―Dec―05 486. Characteristics Associated with SARS-CoV-2 Infection in Children F Curtis Sudbury, Amanda Williams, Michelle Kwon, Leah Musser, Patrick Gavigan, Jessica E Ericson
1086 [GO] 2021―Dec―05 462. Differences in the Humoral Response to SARS-CoV-2 Infection in Children vs. Adult Girlande Mentor, Olivier Drouin, Silvie Valois, Suzanne Taillefer, Christian Renaud, Fatima Kakkar
1087 [GO] 2021―Dec―05 1334. Outcomes Among Influenza and SARS-CoV-2 Infection in Hospitalized Adults Age ≥ 50 Years and with Underlying Chronic Obstructive Pulmonary Disease (COPD) or Congestive Heart Failure (CHF) Megan Taylor, Ashley Tippett, Laila Hussaini, Luis Salazar, Caroline Ciric, Olivia Reese, et al. (+16)
1088 [GO] 2021―Dec―05 481. SARS-CoV-2 Infection in Hospitalized Children: An Elevated Body Mass Index is a Marker of Increased Risk of Acute Respiratory Failure Catherine Foster, Shelley Kumar, Elizabeth Tocco, Galit Holzmann-Pazgal, Judith R Campbell, Lucila Marquez, Ankhi Dutta
1089 [GO] 2021―Dec―05 276. SARS-CoV-2 Infection in Solid Organ Transplant Candidates and Recipients at Texas Children’s Hospital: A Retrospective Review Leanne Petters, Flor M Munoz, Claire Bocchini, Elizabeth A Moulton, Daniel Ruderfer
1090 [GO] 2021―Dec―05 34. Long-term clinical outcomes following SARS-CoV-2 infection include persistent symptoms and cardiovascular disease beyond 3 months post-infection Stephanie A Richard, Simon Pollett, Nusrat J Epsi, Ryan C Maves, Ryan C Maves, Gregory Utz, et al. (+20)
1091 [GO] 2021―Dec―05 49. Effects of Maternal SARS-CoV-2 Infection on Neonatal Discharge Planning and Care: Exacerbation of Racial and Ethnic Healthcare Disparities Jennifer Jubulis, Amanda Goddard, Sarah Dibrigida, Carol A McCarthy
1092 [GO] 2021―Dec―05 530. Bamlanivimab (BAM) for SARS-CoV-2 Infection: Rates and Risk Factors for Hospitalization after Monoclonal Antibody Administration in a High-Risk Population John M Curtin, Varea H Costello, Benjamin L Custer, Jason M Blaylock, Catherine F Decker, Roseanne Ressner, et al. (+5)
1093 [GO] 2021―Dec―05 575. Local Experience of Breakthrough SARS-CoV-2 Infections After Full Vaccination Ahmed A Khan, Gayla Havener, Donald Graham, Brian Miller, Gail O'Neill, Vidya Sundareshan
1094 [GO] 2021―Dec―05 378. Descriptive Analysis of SARS-CoV-2 Infections Among Health System and University Employees Jessica Seidelman, Ibukunoluwa Akinboyo, Maya Rinehart, Rebekah W Moehring, Deverick J Anderson, Kristen Said, et al. (+4)
1095 [GO] 2021―Dec―05 479. Real-world Evaluation of SARS-CoV-2 Monoclonal Antibodies in Solid Organ Transplant Recipients Kristen Zeitler, Nicholas Piccicacco, Lyndsey Bowman, Jose Montero, Margarita Cancio, Sally Houston, Kami Kim
1096 [GO] 2021―Dec―05 532. Establishing a SARS-CoV-2 Monoclonal Antibody Infusion Clinic: Early Trends in Outcomes and Disparities Allison J Hare, Judith M Rivera McPhaul, Patrick Cargan, Pablo Tebas, Kathleen Degnan, Jillian T Baron, Keith W Hamilton
1097 [GO] 2021―Dec―05 421. Effect of SARs-Cov-2 mRNA Vaccination in Healthcare Workers with Household COVID Exposure Laura Selby, Richard Starlin
1098 [GO] 2021―Dec―05 458. A Machine Learning Approach Identifies Distinct Early-Symptom Cluster Phenotypes Which Correlate with Severe SARS-CoV-2 Outcomes Nusrat J Epsi, John H Powers, David A Lindholm, David A Lindholm, Alison Helfrich, Nikhil Huprikar, et al. (+16)
1099 [GO] 2021―Dec―05 610. Tele-ID Consult Services at Academic Medical Centers: Experience and Outcomes During the SARS-CoV-2 Pandemic Aryn M Andrzejewski, Rima Abdel-Massih, Rima Abdel-Massih, John Mellors, Nupur Gupta
1100 [GO] 2021―Dec―05 1141. Effect of the SARS-CoV-2 Pandemic on Staphylococcus aureus Colonization in Healthy Children Jonathon C McNeil, Marritta Joseph, Lauren Sommer, Anthony R Flores, Anthony R Flores
1101 [GO] 2021―Dec―05 221. Evaluation of Rates of Culture Positive Blood Stream Pathogens Prior to and During the SARS-CoV-2 Pandemic: A Multicenter Evaluation Laura A Puzniak, Karri A Bauer, Kalvin Yu, Pamela Moise, Vikas Gupta
1102 [GO] 2021―Dec―05 156. Evaluation of Trends in Antimicrobial Use and Proportion of Culture Positive Gram-Negative/Gram-Positive Pathogens Comparing Prior to and During the SARS-CoV-2 Pandemic: A Multicenter Evaluation Laura A Puzniak, Karri A Bauer, Kalvin Yu, Vikas Gupta
1103 [GO] 2021―Dec―05 363. Characteristics of Envelope and Nuclear Gene Expression Patterns in Asymptomatic SARS-CoV-2 Patients: A Single Center Retrospective Observational Study Keiko Mizuno, Takayuki Komatu, Daisuke Usuda, Shiori Hocchi, Karin Ashizawa, Takashi Aoki, et al. (+4)
1104 [GO] 2021―Dec―05 370. Examining the Relationship Between SARS-CoV-2 PCR Cycle Threshold, Disease Severity and Epidemiologic Trends Jessica Penney, Amanda Jung, Benjamin Koethe, Shira Doron
1105 [GO] 2021―Dec―05 359. Clinical implications of SARS-CoV-2 PCR presumptive positive results Takeru Yamamoto, Masako Mizusawa
1106 [GO] 2021―Dec―05 354. SARS-CoV-2 Viral Viability Culture and Sequencing from Immunocompromised Patients with Persistently Positive SARS-CoV-2 PCR Results Abby Sung, Adam Bailey, Meghan Wallace, Henry B Stewart, David McDonald, Candace R Miller, et al. (+10)
1107 [GO] 2021―Dec―05 507. Impact of Baricitinib on Outcomes in Patients Treated with Remdesivir and Dexamethasone for SARS-CoV-2 Pneumonia: A Retrospective Cohort Study Lauren Dea, Hal Piwonka, Learned Gonzales, Shubha Kerkar, Xolani Mdluli, Yisu Kim
1108 [GO] 2021―Dec―05 28. Utilizing the Charleston Comorbidity Index as an Independent Predictor for Outcomes in SARS-Cov-2 Positive Patients Irene Riestra Guiance, Steven Char, Ernesto Robalino Gonzaga, Isabel Riestra, Minh Q Ho
1109 [GO] 2021―Dec―05 398. Multicenter Evaluation of Outcomes of SARS-CoV-2 Positive Patients Treated at Rural vs Urban Hospitals in the United States Karri A Bauer, Kalvin Yu, Vikas Gupta, Laura A Puzniak
1110 [GO] 2021―Dec―05 482. SARS-CoV-2 Prevalence in Feces of Very Young Children, A Longitudinal Study Lydia M Nashed, Jyoti Mani, Sahel Hazrati, Tiana Richards, Naya Nerikar, Shreeya Ravi, et al. (+4)
1111 [GO] 2021―Dec―05 389. Demographic and Clinical Characteristics of Suspect SARS-CoV-2 Reinfection Cases in Los Angeles County from March 10 to June 1, 2021: A Cross-sectional Study of Case Interview Data Joseph Thompson, Laureen Masai, Nageena Khalid, Katie Chun, Diana Khuu, Nouran Mahmoud Alkhoudairy, Jennifer B Griffin
1112 [GO] 2021―Dec―05 393. Characteristics of SARS-CoV-2 RNA Viral Loads among Nursing Home Residents and Staff with Repeat Positive Tests ≥ 90 Days After Initial Infection: 5 US Jurisdictions, July 2020-March 2021 W Wyatt Wilson, Kelly M Hatfield, Stacy Tressler, Cara Bicking Kinsey, Renee Zell, Channyn Williams, et al. (+16)
1113 [GO] 2021―Dec―05 372. Detection of SARS-CoV-2 RNAemia in Deceased Tissue Donors Melissa Greenwald, Eduard Grebe, Valerie Green, Alyce Linthurst Jones, Philip Williamson, Michael Busch, Matthew Kuehnert
1114 [GO] 2021―Dec―05 489. SARS-CoV-2 Seroprevalence and Antibody Response Among Pregnant People in Seattle, WA Sylvia LaCourse, Alisa Kachikis, Kelsey L Kinderknecht, Romeo R Galang, Lauren B Zapata, Krissy M Yamamoto, et al. (+4)
1115 [GO] 2021―Dec―05 371. Estimating SARS-CoV-2 Seroprevalence from Spent Blood Samples, January-March 2021 Daniel Graciaa, Hans Verkerke, Jeannette Guarner, Ana Maria Moldoveanu, Narayana Cheedarla, Connie Arthur, et al. (+6)
1116 [GO] 2021―Dec―05 148. Single-amplicon, Multiplex Real-time RT-PCR with Tiled Probes to Detect SARS-CoV-2 spike Mutations Associated with Variants of Concern Maxwell Su, Katherine S Immergluck, Samuel Stampfer, Anuradha Rao, Leda Bassitt, Vi Nguyen, et al. (+8)
1117 [GO] 2021―Dec―05 583. SARS-CoV-2 Spike Protein S1/S2 Antibodies after Vaccination with Sinopharm in Peruvian Physicians Maria Lopera, Romina Vera, Carlos Tapia, Carlos Cabrera, Jose Gonzales-Zamora, jorge Alave
1118 [GO] 2021―Dec―05 383. Feasibility of Specimen Self-collection in Young Children Undergoing SARS-CoV-2 Surveillance for In-person Learning Jonathan Altamirano, Grace Tam, Marcela Lopez, India Robinson, Leanne Chun, Nuzhat Shaikh, et al. (+11)
1119 [GO] 2021―Dec―05 384. SARS-CoV-2 Surveillance Testing Patterns among Hospitalized Pediatric Patients in a Single Academic Medical Center Areej Bukhari, Jessica Seidelman, Becky A Smith, Sarah S Lewis, Michael J Smith, Rebekah W Moehring, et al. (+2)
1120 [GO] 2021―Dec―05 400. Impact of SARS-CoV-2 Test-based Strategy to Reduce Quarantine Days Among Asymptomatic Healthcare Workers After Household Exposure Bhagyashri D Navalkele, Jose Lucar, James B Brock, Jason Parham
1121 [GO] 2021―Dec―05 379. Abstract For Comparison of Mandatory vs Non-Mandatory Compliance Rates For SARS-CoV-2 Testing in Grades K-12 Jennifer Veltman, Philip Papayanis, Alex Dubov
1122 [GO] 2021―Dec―05 362. Saliva as a Reliable Sample Type for Mass SARS-CoV-2 Testing Strategies Anne Wyllie, Chantal B Vogels, Orchid M Allicock, Anne Watkins, Mary Petrone, Devyn Yolda-Carr, et al. (+8)
1123 [GO] 2021―Dec―05 369. Alternative Workflow for SARS-CoV-2 Testing Using a Heat Lysis Protocol for Respiratory Specimens Meghna Yadav, Tiffany Martinez, Isabel Regoli, Osvaldo Hernandez, Phuong Le, Heather Carolan, et al. (+2)
1124 [GO] 2021―Dec―05 LB9. Longitudinal antibody dynamics in children infected with SARS-CoV-2 through 6 months post-infection Lauren E Gentles, Leanne P Kehoe, Katharine D Crawford, Kirsten Lacombe, Jane Dickerson, Joanna H Yuan, et al. (+7)
1125 [GO] 2021―Dec―05 509. Clinical Characteristics and Outcomes in Patients Infected with SARS-CoV-2 Treated with Remdesivir, Tocilizumab, and/or Dexamethasone at a Mid-Atlantic Hospital Consortium Nellie Darling, Kristen R Kent, Gavin Clark, Xue Geng, Marybeth Kazanas, Princy N Kumar, Joseph G Timpone
1126 [GO] 2021―Dec―05 1172. SARS-CoV-2 Vaccine Hesitancy in Caregivers of Hospitalized Children Marisa Orbea, Rachel Cunningham, C Mary Healy, Julie A Boom, Claire Bocchini
1127 [GO] 2021―Dec―05 520. Pharmacokinetic and Safety Phase 1 Study and Microneutralization Assay Results with BRII-196/BRII-198, a Novel Antibody Cocktail Active Against a Wide Range of SARS-CoV-2 Variants David A Margolis, Fujie Zhang, Xiaohua Hao, Yanyan Li, Mingming Wang, Chunming Li, et al. (+4)
1128 [GO] 2021―Dec―05 578. INO-4800 DNA Vaccine Induces Neutralizing Antibodies and T cell Activity Against Global SARS-CoV-2 Variants Viviane M Andrade, Aaron Christensen-Quick, Joseph Agnes, Jared Tur, Charles C Reed, Richa Kalia, et al. (+18)
1129 [GO] 2021―Dec―05 543. Molnupiravir Maintains Antiviral Activity Against SARS-CoV-2 Variants In Vitro and in Early Clinical Studies Jay Grobler, Julie Strizki, Nicholas Murgolo, Wei Gao, Youfang Cao, Ying Zhang, et al. (+7)
1130 [GO] 2021―Dec―05 149. Extraction-free RT-PCR to Detect SARS-CoV-2 Variants of Concern Brian L Harry, Yue Qiu, Ling Lu, Mara Couto-Rodriguez, Dorottya Nagy-Szakal, Niamh B O’Hara, Shi-Long Lu
1131 [GO] 2021―Dec―05 LB7. Ad26.COV2.S-Elicted Neutralizing Activities Against SARS-CoV-2 Variants of Concern in Phase 1/2a and Phase 3 Clinical Trials Mathieu Le Gars, Jerald Sadoff, Mandy Jongeneelen, Dirk Heerwegh, Georgi Shukarev, Carla Truyers, et al. (+8)
1132 [GO] 2021―Dec―05 368. Performance Characteristics of Sequencing Assays for Identification of the SARS-CoV-2 Viral Genome Danny Antaki, Mara Couto-Rodriguez, Tong Liu, Kristin Butcher, Esteban Toro, Bryan Höglund, et al. (+6)
1133 [GO] 2021―Dec―05 355. A Novel Likelihood-Based Model to Estimate SARS-CoV-2 Viral Titer from Next-Generation Sequencing Data Heather L Wells, Joseph Barrows, Mara Couto-Rodriguez, Xavier O Jirau Serrano, Marilyne Debieu, Karen Wessel, et al. (+5)
1134 [GO] 2021―Dec―05 131. Antiviral NL-CVX1 Efficiently Blocks Infection of SARS-CoV-2 Viral Variants of Concern (VOC) Wen Su, Matthew Walker, Maria Rebelo, Cong Tang, Ana R Coelho, Laurie Tatalick, et al. (+7)
1135 [GO] 2021―Dec―05 37. Allogeneic, Off-the-Shelf, SARS-CoV-2-specific T Cells Demonstrate Reactivity Against Emerging Variant Strains Spyridoula Vasileiou, Manik Kuvalekar, Aster Workineh, Ayumi Watanabe, Yovana Velazquez, Suhasini Lulla, et al. (+7)
1136 [GO] 2021―Dec―05 503. In vitro Evaluation of Sitagliptin-HIV-1 Trans-activator Transcription Peptide Nano-formula for Antiviral Activity Against SARS-CoV-2: Drug Repurposing Approach Khalid Eljaaly, Hani Asfour, Tarek Ibrahim, Osama Ahmed, Nabil Alhakamy, Usama Fahmy, et al. (+6)
1137 [GO] 2021―Dec―05 30. SARS-CoV2 Reinfections in a University Teaching Hospital Una Sutton, Judi Lynch, Niamh Fitzgerald, Guerrino Macori, Séamus Fanning, Jérôme Fennell
1138 [GO] 2021―Dec―05 951. Virtually the Same: Our Experience Teaching Abx Before and During the Pandemic Katherine R Schafer, E Shen, Timothy R Peters
1139 [GO] 2021―Dec―05 116. Impact of an Antimicrobial Stewardship Program in the First Year of Pandemic 2020 in a Large,Academic, Public Network Hospitals in Bogotá,Colombia Carlos A Solorzano Ramos, Erika A Ruiz Palma, Gerardo A Muñeton Lopez, Camilo Gomez Rodriguez, Elena V Castro Solarte, Elkin V Lemos Luengas
1140 [GO] 2021―Dec―05 106. Pandemic Pinch: The Impact of COVID Response on Antimicrobial Stewardship Program (ASP) Resource Allocation Elizabeth Dodds Ashley, April Dyer, Travis M Jones, Melissa D Johnson, Angelina Davis, Katherine R Foy, et al. (+10)
1141 [GO] 2021―Dec―05 LB6. Asymptomatic Infection and Duration of Viral Shedding in Symptomatic Breakthrough Infections in a Phase 3 Study of AZD1222 (ChAdOx1 nCoV-19) Magdalena Sobieszczyk, Ann R Falsey, Merlin L Robb, Hong-Van Tieu, Julie McElrath, Lawrence Corey, et al. (+7)
1142 [GO] 2021―Dec―01 Trends in clinical severity of hospitalized patients with COVID-19, Premier Hospital Dataset, April 2020 - April 2021 Geoffrey P Whitfield, Aaron M Harris, Sameer S Kadri, Sara Warner, Sapna Bamrah Morris, Jennifer E Giovanni, et al. (+7)
1143 [GO] 2021―Dec―01 Allergists Can Safely Evaluate and Re-vaccinate Individuals with Immediate Allergic Reactions to mRNA COVID-19 Vaccines Matthew Greenhawt, Elissa M Abrams, Marcus Shaker
1144 [GO] 2021―Dec―01 Corrigendum to: Temporal Changes in the Risk of Superspreading Events of Coronavirus Disease 2019 Jun-Sik Lim, Eunbi Noh, Eunha Shim, Sukhyun Ryu
1145 [GO] 2021―Nov―18 High Mortality During the Second Wave of the Coronavirus Disease 2019 (COVID-19) Pandemic in Uganda: Experience From a National Referral COVID-19 Treatment Unit Felix Bongomin, Brian Fleischer, Ronald Olum, Barbra Natukunda, Sarah Kiguli, Pauline Byakika-Kibwika, et al. (+2)
1146 [GO] 2021―Nov―18 Lower SARS-CoV-2 viral shedding following COVID-19 vaccination among healthcare workers in Los Angeles, California Paul C Adamson, Michael A Pfeffer, Valerie A Arboleda, Omai B Garner, Annabelle de St. Maurice, Benjamin von Bredow, et al. (+3)
1147 [GO] 2021―Nov―18 COVID-19-associated Invasive Fungal Infection John W Baddley, George R Thompson, Sharon C-A Chen, P Lewis White, Melissa D Johnson, M Hong Nguyen, et al. (+6)
1148 [GO] 2021―Nov―18 The Impact of Coronavirus Disease 2019 on Medical Trainee Career Decisions Jennifer L Hsu, Erin M Bonura, Dana M Blyth, David A Lindholm, Heather C Yun, Alice E Barsoumian
1149 [GO] 2021―Nov―18 SARS-CoV-2 Genomic Surveillance Reveals Little Spread From a Large University Campus to the Surrounding Community Andrew L Valesano, William J Fitzsimmons, Christopher N Blair, Robert J Woods, Julie Gilbert, Dawn Rudnik, et al. (+7)
1150 [GO] 2021―Nov―11 COVID-19 outcomes among U.S. Military Health System beneficiaries include complications across multiple organ systems and substantial functional impairment Stephanie A Richard, Simon D Pollett, Charlotte A Lanteri, Eugene V Millar, Anthony C Fries, Ryan C Maves, et al. (+24)
1151 [GO] 2021―Nov―10 A call for caution in the immunocompromised: COVID-19 associated with mortality in a vaccinated lung transplant recipient John I Hogan, Camille N Kotton
1152 [GO] 2021―Nov―06 COVID-19 associated mucormycosis in France: a rare but deadly complication François Danion, Valérie Letscher-Bru, Juliette Guitard, Karine Sitbon, Sarah Dellière, Adela Angoulvant, et al. (+11)
1153 [GO] 2021―Nov―06 In depth characterization of vaccine breakthrough infections with SARS-CoV-2 among healthcare workers of a Dutch academic medical center Lidewij W Rümke, Femke C Groenveld, Yvonne M G van Os, Patrique Praest, Anniek A N Tanja, Dorien T C M de Jong, et al. (+11)
1154 [GO] 2021―Nov―04 Bamlanivimab efficacy in older and high BMI outpatients with Covid-19 selected for treatment in a lottery-based allocation process Emily B Rubin, Jonathan A Boiarsky, Lauren A Canha, Anita Giobbie-Hurder, Mofei Liu, Matthew J Townsend, Michael Dougan
1155 [GO] 2021―Oct―31 The impact of COVID-19 on outpatient antibiotic prescriptions in Ontario, Canada; An interrupted time series analysis Taito Kitano, Kevin A Brown, Nick Daneman, Derek R MacFadden, Bradley J Langford, Valerie Leung, et al. (+9)
1156 [GO] 2021―Oct―20 A multidimensional cross-sectional analysis of COVID-19 seroprevalence among a police officer cohort: The PoliCOV-19 study Parham Sendi, Rossella Baldan, Marc Thierstein, Nadja Widmer, Peter Gowland, Brigitta Gahl, et al. (+10)
1157 [GO] 2021―Oct―19 Socioeconomic Disparities in SARS-CoV-2 Serological Testing and Positivity in New York City Wil Lieberman-Cribbin, Marta Galanti, Jeffrey Shaman
1158 [GO] 2021―Oct―10 SARS-CoV-2 blood RNA load predicts outcome in critically ill COVID-19 patients Fabian Heinrich, Michael F Nentwich, Eric Bibiza-Freiwald, Dominik Nörz, Kevin Roedl, Martin Christner, et al. (+7)
1159 [GO] 2021―Oct―10 Performance of the inFLUenza Patient-Reported Outcome Plus (FLU-PRO Plus©) instrument in patients with COVID-19 Stephanie A Richard, Nusrat Epsi, Simon Pollett, David A Lindholm, Allison M W Malloy, Ryan Maves, et al. (+20)
1160 [GO] 2021―Oct―10 Feasibility of SARS-CoV-2 Antibody Testing in Remote Outpatient Trials Sarah M Lofgren, Elizabeth C Okafor, Alanna A Colette, Katelyn A Pastick, Caleb P Skipper, Matthew F Pullen, et al. (+11)
1161 [GO] 2021―Oct―09 Real-world Assessment of 2,879 COVID-19 Patients Treated with Monoclonal Antibody Therapy: A Propensity Score-Matched Cohort Study Megan H Cooper, Paul A Christensen, Eric Salazar, Katherine K Perez, Edward A Graviss, Duc Nguyen, et al. (+3)
1162 [GO] 2021―Oct―07 Graded Administration of Second Dose of Moderna and Pfizer-BioNTech COVID-19 mRNA Vaccine in Patients with Hypersensitivity to First Dose Linh-An C Tuong, Peter Capucilli, Mary Staicu, Allison Ramsey, Edward E Walsh, S Shahzad Mustafa
1163 [GO] 2021―Oct―05 Acceptability, usability and performance of lateral flow immunoassay tests for SARS-CoV-2 antibodies: REACT-2 study of self-testing in non-healthcare key workers Bethan Davies, Marzieh Araghi, Maya Moshe, He Gao, Kimberly Bennet, Jordan Jenkins, et al. (+8)
1164 [GO] 2021―Oct―04 Feasibility and Acceptability of community COVID-19 Testing Strategies (FACTS) in a University setting Jennifer A Hirst, Mary Logan, Thomas R Fanshawe, Lazaro Mwandigha, Marta Wanat, Charles Vicary, et al. (+10)
1165 [GO] 2021―Sep―28 Clinical management of hospitalized COVID-19 patients in the United States Essy Mozaffari, Aastha Chandak, Zhiji Zhang, Shuting Liang, Julie Gayle, Mark Thrun, et al. (+7)
1166 [GO] 2021―Sep―25 Performance of self-collected anterior nasal swabs and saliva specimens for detection of SARS-COV-2 during symptomatic and asymptomatic periods Carlos G Grijalva, Melissa Rolfes, Yuwei Zhu, James Chappell, Natasha Halasa, Ahra Kim, et al. (+3)
1167 [GO] 2021―Sep―24 Prime-boost vaccination with BNT162b2 induces high neutralizing activity against SARS-CoV-2 variants in naïve and COVID-19 convalescent individuals Joanna Luczkowiak, Nuria Labiod, Gonzalo Rivas, Marta Rolo, Fátima Lasala, Jaime Lora-Tamayo, et al. (+5)
1168 [GO] 2021―Sep―23 Visit trends and factors associated with telemedicine uptake among persons with HIV during the COVID-19 pandemic Brian R Wood, Kristine F Lan, Yuan Tao, Eric Y Mose, Erin Aas, Jehan Z Budak, et al. (+2)
1169 [GO] 2021―Sep―18 Application of a Serial Antigen Based Testing Strategy for SARS-CoV-2 and Student Adherence in a University Setting, Wisconsin - October-November 2020 John Paul Bigouette, Laura Ford, Ian Pray, Kimberly Langolf, Juliana Kahrs, Tara Zochert, et al. (+5)
1170 [GO] 2021―Sep―17 COVID-19 vaccine impact on rates of SARS-CoV-2 cases and post vaccination strain sequences among healthcare workers at an urban academic medical center: a prospective cohort study Tara C Bouton, Sara Lodi, Jacquelyn Turcinovic, Beau Schaeffer, Sarah E Weber, Emily Quinn, et al. (+12)
1171 [GO] 2021―Sep―17 SARS-CoV-2 Epidemiology on a Public University Campus in Washington State Ana A Weil, Sarah L Sohlberg, Jessica A O'Hanlon, Amanda M Casto, Anne W Emanuels, Natalie K Lo, et al. (+30)
1172 [GO] 2021―Sep―09 “Conquering COVID: How Global Vaccine Inequality Risks Prolonging the Pandemic Richard L Oehler, Vivian R Vega
1173 [GO] 2021―Sep―07 A high frequency of Candida auris blood stream infections in COVID-19 patients admitted to intensive care units, North-western India: A case control study Ekadashi Rajni, Ashutosh Singh, Bansidhar Tarai, Kusum Jain, Ravi Shankar, Kalpana Pawar, et al. (+2)
1174 [GO] 2021―Sep―06 Clinical and Pregnancy Outcomes of COVID-19 Among Hospitalized Pregnant Women in the United States Christina M Ackerman, Jennifer L Nguyen, Swapna Ambati, Maya Reimbaeva, Birol Emir, Javier Cabrera, et al. (+4)
1175 [GO] 2021―Sep―06 High completion of COVID-19 vaccination among healthcare workers despite initial self-reported vaccine reluctance Vivek Jain, Sarah B Doernberg, Marisa Holubar, Beatrice Huang, Jenna Bollyky, Hannah Sample, et al. (+5)
1176 [GO] 2021―Sep―02 Ivermectin should not be recommended to treat SARS-CoV-2 infection A G Boven, C Kenyon, R Colebunders
1177 [GO] 2021―Aug―31 Sex and gender differences in testing, hospital admission, clinical presentation, and drivers of severe outcomes from COVID-19 Eileen P Scully, Grant Schumock, Martina Fu, Guido Massaccesi, John Muschelli, Joshua Betz, et al. (+8)
1178 [GO] 2021―Aug―31 Association between SARS-CoV-2 cycle threshold values and clinical outcomes in patients with COVID-19 A systematic review and meta-analysis Vishal P Shah, Wigdan H Farah, James C Hill, Leslie C Hassett, Matthew J Binnicker, Joseph D Yao, M Hassan Murad
1179 [GO] 2021―Aug―21 Experience of Treating COVID-19 With Remdesivir and Convalescent Plasma in a Resource-Limited Setting: A Prospective, Observational Study Janak Koirala, Pradip Gyanwali, Robert B Gerzoff, Saroj Bhattarai, Bipin Nepal, Rekha Manandhar, et al. (+96)
1180 [GO] 2021―Aug―18 Cross-neutralizing activity against SARS-CoV-2 variants in COVID-19 patients: Comparison of four waves of the pandemic in Japan Koichi Furukawa, Lidya Handayani Tjan, Silvia Sutandhio, Yukiya Kurahashi, Sachiyo Iwata, Yoshiki Tohma, et al. (+9)
1181 [GO] 2021―Aug―14 Letter to the editor - Viral RNA Shedding and Transmission Potential of Asymptomatic and Pauci-symptomatic COVID-19 Patients Ajay Gupta, Sonia Jain, Vipul Gupta
1182 [GO] 2021―Aug―13 Demographic disparities in clinical outcomes of COVID-19: data from a statewide cohort in South Carolina Xueying Yang, Jiajia Zhang, Shujie Chen, Bankole Olatosi, Larisa Bruner, Abdoulaye Diedhiou, et al. (+4)
1183 [GO] 2021―Aug―10 Predictive Value of an Age-Based Modification of the National Early Warning System in Hospitalized Patients with COVID-19 Ryan C Maves, Stephanie A Richard, David A Lindholm, Nusrat Epsi, Derek T Larson, Christian Conlon, et al. (+10)
1184 [GO] 2021―Aug―10 Cross-reactive antibody response to mRNA SARS-CoV-2 vaccine after recent COVID-19-specific monoclonal antibody therapy Stacey Schultz-Cherry, Maureen A McGargill, Paul G Thomas, Jeremie H Estepp, Aditya H Gaur, E Kaitlynn Allen, et al. (+8)
1185 [GO] 2021―Aug―09 Nonpharmaceutical Interventions Remain Essential to Reducing COVID-19 Burden Even in a Well-Vaccinated Society: A Modeling Study Tomás M León, Jason Vargo, Erica S Pan, Seema Jain, Priya B Shete
1186 [GO] 2021―Aug―09 Addressing and Inspiring Vaccine Confidence in Black, Indigenous, and People of Color (BIPOC) during the COVID-19 Pandemic Jasmine R Marcelin, Talia H Swartz, Fidelia Bernice, Vladimir Berthaud, Robbie Christian, Christopher da Costa, et al. (+13)
1187 [GO] 2021―Aug―09 Expression of Concern: “Meta-analysis of Randomized Trials of Ivermectin to Treat SARS-CoV-2 Infection” Andrew Hill, Anna Garratt, Jacob Levi, Jonathan Falconer, Leah Ellis, Kaitlyn McCann, et al. (+4)
1188 [GO] 2021―Aug―06 The Association of Human Leukocyte Antigen and COVID-19 in Southern China Xueping Yu, Kuoting Ho, Zhongliang Shen, Xiaoying Fu, Hongbo Huang, Delun Wu, et al. (+7)
1189 [GO] 2021―Aug―03 Host genetic analysis should be mandatory for proper classification of COVID-19 reinfections Laura Pérez Lago, Marina Machado, Marta Herranz, Pedro J Sola-Campoy, Julia Suárez-González, Carolina Martínez-Laperche, et al. (+5)
1190 [GO] 2021―Aug―02 Defective SARS-CoV-2 immune responses in an immunocompromised individual with prolonged viral replication Claire L Gordon, Olivia C Smibert, Natasha E Holmes, Kyra Y L Chua, Rose Morgan, George Drewett, et al. (+17)
1191 [GO] 2021―Jul―31 Risk Factors for SARS-CoV-2 Infection and Presence of Anti-SARS-CoV-2 Antibodies among University Student Dormitory Residents, September-November 2020 Hannah E Segaloff, Devlin Cole, Hannah G Rosenblum, Christine C Lee, Clint N Morgan, Patrick Remington, et al. (+15)
1192 [GO] 2021―Jul―29 Vitamin K & D Deficiency Are Independently Associated With Covid-19 Disease Severity Ankita P Desai, Sahera Dirajlal-Fargo, Jared C Durieux, Heather Tribout, Danielle Labbato, Grace A McComsey
1193 [GO] 2021―Jul―29 Serological and RT-PCR surveillance for COVID-19 in an asymptomatic U.S. Army trainee population Shilpa Hakre, Aaron D Sanborn, Stephen W Krauss, Jennifer L Burns, Kenya N Jackson, Melanie D McCauley, et al. (+18)
1194 [GO] 2021―Jul―29 Discordant Virus-Specific Antibody Levels, Antibody Neutralization Capacity and T Cell Responses Following Three Doses of SARS-CoV-2 Vaccination in a Patient with Connective Tissue Disease Michael J Peluso, Sadie E Munter, Kara L Lynch, Cassandra Yun, Leonel Torres, Nikita S Iyer, et al. (+6)
1195 [GO] 2021―Jul―27 Response to Letter to the editor - Viral Ribonucleic Acid Shedding and Transmission Potential of Asymptomatic and Paucisymptomatic Coronavirus Disease 2019 Patients Arghadip Samaddar, Ravisekhar Gadepalli
1196 [GO] 2021―Jul―27 SARS-CoV-2 Cumulative Incidence and Period Seroprevalence: Results from a Statewide Population-Based Serosurvey in California Katherine Lamba, Heather Bradley, Kayoko Shioda, Patrick S Sullivan, Nicole Luisi, Eric W Hall, et al. (+8)
1197 [GO] 2021―Jul―27 Post-acute sequelae of SARS-CoV-2 infection and impact on quality of life 1-6 months after illness and association with initial symptom severity James B O’Keefe, H Caroline Minton, Mary Morrow, Colin Johnson, Miranda A Moore, Ghazala A D O’Keefe, et al. (+3)
1198 [GO] 2021―Jul―24 Real-world Effect of Monoclonal Antibody Treatment in COVID-19 Patients in a Diverse Population in the United States Kaitlin Rainwater-Lovett, John T Redd, Miles A Stewart, Natalia Elías Calles, Tyler Cluff, Mike Fang, et al. (+8)
1199 [GO] 2021―Jul―24 Cohabitation With a Known Coronavirus Disease 2019 Case Is Associated With Greater Antibody Concentration and Symptom Severity in a Community-Based Sample of Seropositive Adults Joshua M Schrock, Daniel T Ryan, Rana Saber, Nanette Benbow, Lauren A Vaught, Nina Reiser, et al. (+8)
1200 [GO] 2021―Jul―20 Transmission of SARS-CoV-2 alpha variant (B.1.1.7) from a BNT162b2-vaccinated individual Solen Kernéis, Delphine Planas, Sandrine Imbeaud, Isabelle Staropoli, Julien Puech, Nicolas Robillard, et al. (+7)
1201 [GO] 2021―Jul―17 Characteristics of high titer convalescent plasma and antibody dynamics following administration in patients with severe COVID-19 Emma D Bainbridge, Priscilla Y Hsue, Jonathan H Esensten, Kara L Lynch, Carolyn M Hendrickson, Sarah B Doernberg, et al. (+7)
1202 [GO] 2021―Jul―16 Long term COVID-19 complications in inpatients and outpatients: a one-year follow up cohort study Michele Davide Maria Lombardo, Andrea Foppiani, Giuseppe Michele Peretti, Laura Mangiavini, Alberto Battezzati, Simona Bertoli, et al. (+2)
1203 [GO] 2021―Jul―16 Tool for estimating the probability of having COVID-19 with one or more negative RT-PCR results Alejandro Jara, Eduardo A Undurraga, Rafael Araos
1204 [GO] 2021―Jul&horba